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English summary
The work presented in this dissertation is situated in the field of multimodal
medical imaging, specifically in the combination of emission tomography
with magnetic resonance imaging (MRI). Emission tomography is based on
the tracer principle, in which a radioactive isotope linked to a biochemically
interesting molecule is administered to the patient. By recording the radia-
tion emitted by the isotope and using specialized reconstruction algorithms,
the distribution of the tracer within the body can be derived. Two types
of isotopes are used in emission tomography: positron emitters and single
photon emitters, used in positron emission tomography (PET) and single
photon emission computed tomography (SPECT) respectively. Currently,
there is a lot of research into combining the functional information obtained
with PET or SPECT with anatomical information from MRI. MRI is a med-
ical imaging technique which is based on the acquisition of RF signals from
protons and offers high resolution as well as very good soft tissue contrast.
In PET or SPECT, different image-degrading effects are present which
need to be corrected for in the reconstruction algorithm. Photon attenuation
is one of the major effects in both modalities. To correct for photon atten-
uation, the distribution of attenuation coefficients throughout the imaging
volume is needed. This distribution is called the attenuation map. The
attenuation coefficient of a certain material (e.g. biological tissue) is related
to the electron density of that material. In current PET or SPECT systems
the attenuation map is usually derived from a X-ray computed tomography
(CT) image or a transmission scan. This is straightforward as the signal
obtained with those acquisitions is related to electron density. In PET-MRI
or SPECT-MRI, the attenuation map should ideally be derived from the
MRI image. This is much more difficult, as the MRI signal of a certain
tissue is related to the proton density and relaxation properties of that
tissue, not to its electron density. An additional problem is that lung and
cortical bone, two important tissue types for attenuation, are not visible on
images acquired with conventional MRI sequences. This problem is solved
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in most currently available MRI-based attenuation correction methods by
making assumptions on patient anatomy. However, these methods may
fail when anatomic abnormalities are present. The purpose of this work
is to derive a MRI-based attenuation correction method which derives the
attenuation map from MRI image intensity alone, without assumptions on
patient anatomy.
Before the design of a new method was started, the requirements for
a MRI-based attenuation correction method were first investigated. Using
simulation studies, the effect of errors or simplifications in the attenuation
map on the reconstructed PET images was investigated. As the effect of
attenuation depends on the size of the object under study, this was done for
a rat study, a human brain study and a human whole-body study. The results
indicated that for rat imaging, three tissue types need to be discriminated
to obtain accurate quantification: air, lung and soft tissue. If bone is also
discriminated, this yields even better quantification. It was also shown that
a relatively high fraction (20 %) of classification errors in bone and lung
tissue can be tolerated. For human brain imaging, air, soft tissue and bone
should be discriminated. Classification errors which assign the attenuation
coefficient of soft tissue to voxels containing bone can be tolerated, but
assigning the attenuation coefficient of air to bone voxels should be avoided.
For human whole-body imaging, five tissue types should be discriminated
to obtain accurate quantification: air, lung, soft tissue, spongeous bone and
cortical bone. Additionally, the discrimination of adipose tissue can also be
interesting but is not strictly necessary. It was also shown that inter-patient
variability of the attenuation coefficient of lung tissue can lead to significant
errors. As in the human brain study, we observed that limited classification
errors from cortical bone to soft tissue can be tolerated, but classification
errors from cortical bone to air or lung can not. We also showed that for
lung tissue, misclassification into air is acceptable when less than 10 %
of voxels are misclassified, but classification of lung voxels as bone or soft
tissue should be avoided.
The results from the simulation study indicated that, apart from air, soft
tissue and spongeous bone, a new MRI-based attenuation correction method
should be able to discriminate cortical bone and lung as well. To that
extent, ultrashort echo time (UTE) MRI sequences were introduced. UTE
sequences use special fast acquisition schemes which allow recording the
signal of tissues with very fast relaxation, such as tendons and ligaments.
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Lung and cortical bone exhibit even faster relaxation. Therefore, the MRI
properties of both tissue types were first investigated to determine if signal
from lung and cortical bone could be acquired with a UTE sequence. It was
shown that this was possible.
A general method for creating contrast between the different tissue types
relevant for attenuation correction was then introduced. A UTE sequence
usually acquires two images: the free inductive decay (FID) image, acquired
as quickly as possible after RF excitation, and a normal gradient echo image.
From these two images, the transverse relaxation map or R2-map can be
calculated. R2 is a quantitative parameter, contrary to MRI image intensity
which can change between different scans as it depends on scanner settings
such as receiver gain. The R2-map shows high values in tissues which have
fast relaxation, such as cortical bone and lung, and low values in tissues with
slower relaxation such as soft tissue. The R2-map can also show high values
in voxels containing air due to noise. Therefore, it needs to be corrected with
a binary mask to set all voxels containing air to zero, yielding the corrected
R2-map. In this work, all UTE-MRI-based attenuation maps were derived
from the corrected R2-map. As a proof of principle, we first showed the
feasibility of discriminating air, soft tissue and cortical bone on a segment
of bovine femur bone.
Before testing our method on real animal or human data, it was tested
on phantoms. As no suitable phantoms were available, two new phantoms
were designed. The first was a pig head, used as a model for human brain
imaging. Evaluation of the classification accuracy of our method versus
a segmented CT image showed a classification accuracy of approximately
90 % in soft tissue and cortical bone and approximately 80 % in air. The
results from the simulation study indicate that this should be sufficient to
allow accurate quantification. To assess the feasibility of discriminating
lung tissue with our method, a human thorax phantom was also designed.
It consisted of a PMMA cylinder containing a segment of bovine femur
bone and a lobe of a pig lung. The phantom was filled with activity and
PET images reconstructed with CT-based and UTE-MRI-based attenuation
correction were compared. A quantitative difference of 2 % was found in
two hot spots and one cold spot inserted into the phantom. This showed
that the discrimination of lung tissue was possible with our method.
Subsequently, our method was tested on small animal data. First, an
extensive micro-SPECT study was described, using a total of 18 rats in-
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jected with different 99mTc labeled tracers that targeted different organs.
The images reconstructed with different MRI-based attenuation maps were
compared to the images reconstructed with micro-CT-based attenuation
correction. It was shown that good results can be obtained in most studies
with a simple uniform attenuation map. However, when accurate quantifi-
cation is required, a UTE-MRI-based attenuation map is preferred. Using
our method, average quantitative errors below 1 % were obtained in the
lung, kidney, liver and spleen and errors of 5 - 8 % were obtained in the
brain. A more limited micro-PET study was also performed, acquiring im-
ages of three dead rats in which artificial 18F-FDG lesions were implanted.
The micro-PET images were again reconstructed with different attenuation
maps. Comparable results as in the micro-SPECT study were obtained.
As a last step, our method was also tested on human data. A first study
showed the feasibility of performing UTE-MRI-based attenuation correction
for clinical brain imaging on 5 patient PET-CT-MRI data sets. The classifi-
cation accuracy of our method was shown to be between 80 and 90 % for
all patient data sets, with discrimination between tissue and air above 95
% for all cases. The reconstructed PET images showed an average relative
error of 3 % in 12 clinically relevant volumes of interest (VOIs). No artificial
hot or cold spots were observed in any of the data sets. These numbers are
acceptable for clinical imaging.
Human thoracic imaging is a lot more difficult, as was shown on a single
patient data set. The discrimination of air, lung, soft tissue and bone based
on MRI image intensity alone was not possible, as too many classification
errors were made. These classification errors led to significant errors in the
reconstructed PET images, showing numerous artificial hot spots. Therefore,
a more advanced algorithm was designed. It used Markov random fields
(MRF) to accurately segment the lungs, and only attempts to detect bone
in the spine region. Using this modified method, better results were obtained.
Accurate quantification in the heart, lung and spine was possible. However,
a single artificial hot spot was created in the lungs. Therefore, this method
can only be used in thoracic imaging with caution.
No experiments were done on whole-body data sets. This is partly due to
the fact that we did not have the possibility to acquire such data sets, but
mostly because we believe further work is needed to allow the application of
our method to whole-body data. Some of the issues that need to be solved
include the difficulties in tissue discrimination as shown in the thoracic data
set and the long acquisition time that is needed for UTE imaging. Also, the
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method should first be tested and optimized for other regions of the body,
such as the pelvis or abdomen. When good performance has been shown for
all regions of the body, a method for whole-body imaging can be derived.
As a final conclusion, we have shown that air, lung, soft tissue and bone
can be discriminated with the method developed in this work. Using this
method, the feasibility of performing UTE-MRI-based attenuation correction
in small animal (micro-PET and micro-SPECT) and human brain studies was
shown. To evaluate the robustness of our method and the possibility of full
automation for clinical use, it would be interesting to perform a clinical brain
study with more subjects. More work is also needed on the subject of human
thoracic or whole-body imaging.
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Nederlandstalige
samenvatting
Het onderzoek dat in dit proefschrift beschreven wordt is gesitueerd bin-
nen de context van multimodale medische beeldvorming. Meerbepaald is
het van toepassing op de combinatie van emissie tomografie met magneti-
sche resonantie beeldvorming (magnetic resonance imaging, MRI ). Emissie
tomografie is gebaseerd op het speurstof principe, waarin een radioactief
isotoop verbonden aan een biochemische molecule wordt toegediend aan de
patient. Door de straling van het radioactief isotoop te detecteren kan men
met behulp van gespecialiseerde reconstructie-algoritmes de distributie van
de speurstof in het lichaam van de patient afleiden. Twee soorten isotopen
worden gebruikt in emissie tomografie: positron emitters en single photon
emitters, respectievelijk gebruikt in positron emission tomography (PET) en
single photon emission computed tomography (SPECT). Er wordt momen-
teel veel onderzoek gedaan naar de mogelijkheid om de functionele informatie
die verkregen wordt met PET of SPECT te combineren met de anatomische
informatie uit MRI beelden. MRI is een medische beelvormingstechniek die
gebaseerd is op het detecteren van radiofrequente (RF) signalen van proto-
nen. MRI maakt het mogelijk om anatomische beelden op te nemen met
hoge resolutie en hoog zacht weefsel contrast.
In PET en SPECT zijn er verschillende effecten die de beeldkwaliteit
verminderen. In het reconstructie-algoritme dient een correctie voor deze
effecten geïmplementeerd te worden. Foton attenuatie is een belangrijk
effect in zowel PET als SPECT. Om hiervoor te corrigeren dient de ver-
deling van attenuatiecoëfficienten binnen het beeldvolume gekend te zijn.
Deze verdeling wordt de attenuatiemap genoemd. De attenuatiecoëfficient
van een bepaald materiaal, bijvoorbeeld biologisch weefsel, wordt bepaald
door de elektronendensiteit van dat materiaal. In huidige PET en SPECT
systemen wordt de attenuatiemap meestal afgeleid van een X-stralen to-
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mografie beeld (X-ray computed tomography, CT ) of transmissiescan. Dit
is eenvoudig aangezien het signaal dat verkregen wordt met die methoden
direct gerelateerd is aan de elektronendensiteit. In PET-MRI of SPECT-
MRI zou de attenuatiemap best uit de MRI beelden afgeleid worden. Dit
is moeilijk aangezien het MRI signaal van een weefsel gerelateerd is aan
de protondenstieit en relaxatie eigenschappen van dat weefsel, niet aan de
elektronendensiteit. Een bijkomend probleem stelt zich doordat long en
corticaal bot, twee weefsels die van belang zijn voor attenuatie, onzichtbaar
zijn op conventionele MRI beelden. In de meeste momenteel beschikbare
MRI-gebaseerde attenuatiecorrectie methodes wordt dit opgelost door be-
paalde veronderstellingen te doen met betrekking tot de anatomie van de
patiënt. Dergelijke methoden kunnen echter fouten maken indien de pati-
ënt niet voldoet aan die veronderstellingen. Het doel van dit onderzoek is
om een MRI-gebaseerde attenuatiecorrectie methode te ontwikkelen die de
attenuatiemap afleidt van de informatie in de MRI beelden alleen, zonder
veronderstellingen te doen met betrekking tot de anatomie van de patiënt.
Alvorens een nieuwe methode te ontwerpen, onderzochten we eerst
de voorwaarden waaraan een MRI-gebaseerde attenuatiecorrectie methode
moet voldoen. Met behulp van simulaties werd het effect van fouten en
vereenvoudigingen in de attenuatiemap op de gereconstrueerde PET beel-
den onderzocht. Aangezien het effect van attenuatie afhankelijk is van de
grootte van het object dat in beeld gebracht wordt, werd dit gedaan voor een
rat studie, een humane hersenstudie en een humane studie van het volledige
lichaam. Uit de resultaten kon afgeleid worden dat voor rat beeldvorming
drie verschillende weefsels dienen te worden onderscheiden in de attenua-
tiemap: lucht, long en zacht weefsel. Indien bot ook in rekening gebracht
wordt bekomt men nog betere resultaten. Er werd ook aangetoond dat een
relatief grote fractie (20 %) van bot of long voxels verkeerd geclassificeerd
mogen worden. Uit de humane hersenstudie konden we afleiden dat zowel
lucht, zacht weefsel als bot dienen onderscheiden worden. Classificatie fou-
ten van bot naar zacht weefsel kunnen getolereerd worden, maar men dient
te vermijden dat de attenuatiecoefficient van lucht toegewezen wordt aan
voxels die bot bevatten.
In de humane studie van het volledige lichaam werd gezien dat vijf verschil-
lende weefsels moeten onderscheiden worden in dat soort studie: lucht, long,
zacht weefsel, spongieus bot en corticaal bot. Eventueel kan vetweefsel ook
in rekening gebracht worden. Er werd ook aangetoond dat de variabiliteit
van de attenuatiecoefficient van de longen tussen verschillende patiënten
een significant effect kan hebben. Net zoals in de humane hersenstudie
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werd gezien dat beperkte classificatie fouten van bot naar zacht weefsel
geen probleem vormen, maar classificatie van bot als lucht of long moet
vermeden worden. Tot 10 % van de voxels met longweefsel mogen verkeerd
geclassificeerd worden als lucht, maar fouten die long voxels classificeren als
zacht weefsel of bot leiden snel tot significante afwijkingen.
Uit de resultaten van de simulatiestudies kon afgeleid worden dat een
nieuwe MRI-gebaseerde attenuatiecorrectie methode naast lucht, zacht weef-
sel en spongieus bot ook long en corticaal bot dient te kunnen onderscheiden.
Om dit mogelijk te maken werden ultrakorte echo tijd (ultrashort echo time,
UTE ) sequenties geïntroduceerd. Deze gebruiken speciale acquisitiemetho-
den om signaal op te nemen in weefsels met zeer snelle relaxatie, zoals pezen
en ligamenten. Long en corticaal bot tonen nog snellere relaxatie dan deze
weefsels. Daarom werden de MRI eigenschappen van long en corticaal bot
eerst onderzocht om te zien of het mogelijk was om signaal uit die weefsels
te detecteren met een UTE sequentie. De resultaten toonden dat dit het
geval was.
Vervolgens werd een methode ontworpen om contrast te genereren tussen
de verschillende weefsels die van belang zijn voor attenuatiecorrectie. Een
UTE sequentie neemt gewoonlijk twee beelden op: een beeld van het vrij
inductief verval (free inductive decay, FID) en een normaal gradient echo
beeld. Uit deze twee beelden kan de transversale relaxatiemap of R2-map
berekend worden. R2 is een kwantitatieve parameter, in tegenstelling tot
MRI beeldintensiteit, die kan veranderen tussen verschillende acquisities
omwille van scanner instellingen zoals signaalversterking. De R2-map toont
hoge waarden in weefsels die snel relaxeren, zoals corticaal bot en long, en
lage waarden in weefsels die trager relaxeren zoals zacht weefsel. In voxels
waarin lucht zit kan de berekende R2 ook hoog zijn omwille van ruis. Daarom
moet de R2-map gecorrigeerd worden met een binair masker waardoor alle
voxels met lucht op nul gezet worden. Dit geeft de gecorrigeerde R2-map.
In dit onderzoek werden alle attenuatiemappen afgeleid van de gecorrigeerde
R2-map.
In een volgende stap hebben we deze methode getest op fantomen. Aan-
gezien geen bruikbare fantomen bestaan, werden twee nieuwe fantomen
ontworpen. Het eerste fantoom was een varkenskop, en werd gebruikt
als model voor beeldvorming van humane hersenen. De juistheid van de
classificatie van onze methode werd geëvalueerd ten opzichte van een ge-
segmenteerd CT beeld. Deze was ongeveer 90 % in zacht weefsel en bot
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en ongeveer 80 % in lucht. De resultaten van de simulatie studie doen
vermoeden dat dit voldoende accuraat is om goede beelden te bekomen.
Om te evalueren of longweefsel kon onderscheiden worden met de ontworpen
methode werd ze ook getest op een humaan thorax fantoom. Dat fantoom
was opgebouwd uit een PMMA cylinder waarin een segment bovien femur-
bot en een lobe van een varkenslong werden geplaatst. Het fantoom werd
gevuld met radioactiviteit en de PET beelden werden gereconstrueerd met
CT-gebaseerde en UTE-MRI-gebaseerde attenuatiecorrectie. Een kwantita-
tief verschil van 2 % werd gezien in drie lesies die in het fantoom waren
aangebracht. Dit toont aan dat longweefsel onderscheiden kan worden met
de methode.
Vervolgens werd de voorgestelde methode getest op data van kleine
proefdieren. Eerst werd een omvangrijke micro-SPECT studie beschre-
ven, waarin 18 ratten geïnjecteerd werden met speurstoffen voor verschil-
lende organen. De micro-SPECT beelden gereconstrueerd met verschillende
MRI-gebaseerde attenuatiemappen werden vergeleken met de beelden ge-
reconstrueerd met micro-CT-gebaseerde attenuatiecorrectie. De resultaten
toonden dat uniforme attenuatiecorrectie goede resultaten geeft in de meeste
studies. Wanneer zeer accurate kwantitatieve beeldvorming vereist is, kan
best een UTE-MRI-gebaseerde attenuatiemap gebruikt worden. Deze leidt
tot gemiddelde fouten van 1 % in de longen, nieren, lever en milt en 5
- 8 % in de hersenen. Een kleinere micro-PET studie werd ook gedaan,
waarin beelden werden opgenomen van drie dode ratten met geïmplanteerde
artificiële lesies. De micro-PET beelden werden gereconstrueerd met ver-
schillende attenuatiemappen. Er werden vergelijkbare resultaten bekomen
als in de micro-SPECT studie.
Tenslotte evalueerden we onze methode op humane data. In een eerste
studie werd aangetoond dat UTE-MRI-gebaseerde attenuatiecorrectie voor
klinische beeldvorming van de hersenen mogelijk is. Dit werd gedaan op 5
PET-CT-MRI data sets van patiënten. De classificatie was juist voor 80 -
90 % van de voxels voor alle data sets. Het onderscheid tussen weefsel en
lucht was juist in meer dan 95 % van de voxels. In de gereconstrueerde PET
beelden werd een gemiddelde relatieve fout gezien van 3 % in 12 klinische re-
levante regio’s. Er werden geen artificiële lesies gezien in de gereconstrueerde
beelden. Deze resultaten zijn acceptabel voor klinische beeldvorming.
Beeldvorming in de humane thorax is veel moeilijker. Dit werd aangetoond
op een enkele data set. Het onderscheid tussen lucht, long, zacht weefsel en
Nederlandstalige samenvatting xxxvii
bot was niet mogelijk op basis van de MRI informatie alleen, aangezien dan
teveel classificatie fouten gemaakt werden. Deze classificatie fouten leidden
tot significante fouten in de gereconstrueerde PET beelden, met verschillende
artificiële lesies tot gevolg. Daarom werd een meer geavanceerd algoritme
ontwikkeld. Markov velden (Markov random fields, MRF ) werden gebruikt
om de longen te segmenteren, en de detectie van bot werd beperkt tot
de wervelzuil. Met deze methode werden betere resultaten bekomen, met
accurate quantificatie in het hart, de longen en de wervelzuil. Eén enkele
artifiële lesie werd wel gezien. Daarom kan deze methode enkel gebruikt
worden in humane thorax beeldvorming indien er zorgvuldig mee gewerkt
wordt.
Er werden geen experimenten gedaan met beeldvorming van het volle-
dige lichaam. Dit was deels omdat we niet de mogelijkheid hadden om
dit soort data sets te verkrijgen, maar ook omdat we ervan overtuigd zijn
dat er momenteel nog meer werk nodig is vooraleer onze methode kan
toegepast worden op dat soort beeldvorming. Een aantal problemen dienen
eerst opgelost te worden, zoals het feit dat verschillende weefsels moeilijk
kunnen onderscheiden worden op basis van MRI informatie alleen en de
lange acquisitietijd die nodig is om UTE beelden op te nemen. De methode
moet ook eerst getest en geoptimaliseerd worden voor andere regio’s van
het lichaam, zoals het bekken of het abdomen. Van zodra aangetoond is
dat de methode werkt in all regio’s van het lichaam kan een gecombineerde
methode ontwikkeld worden voor het volledige lichaam.
In dit proefschrift werd aangetoond dat lucht, long, zacht weefsel en bot
kunnen onderscheiden worden met behulp van een nieuwe methode. De
mogelijkheid om UTE-MRI-gebaseerde attenuatiecorrectie te gebruiken in
beeldvorming van kleine dieren (micro-PET en micro-SPECT) en in humane
hersenstudies werd aangetoond. Om de betrouwbaarheid van de methode te
evalueren, zou het interessant zijn om een klinische hersenstudie op te zetten
met meer patiënten. Er is ook nog extra onderzoek nodig met betrekking
tot beeldvorming van het volledige lichaam.
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Chapter 1
Introduction
1.1 Situation
The work presented in this dissertation is situated in the field of multimodal
medical imaging, specifically in the combination of emission tomography with
magnetic resonance imaging (MRI). Emission tomography is based on the
tracer principle, in which a radioactive isotope is linked to a tracer molecule.
After the tracer is administered to the patient, the radiation emitted by the
isotope is recorded by the emission tomography scanner. Using specialized
reconstruction algorithms, the distribution of the tracer within the body of
the patient can be derived from this information. Two types of isotopes are
used in emission tomography: positron emitters and single photon emitters,
used in positron emission tomography (PET) and single photon emission
computed tomography (SPECT) respectively. PET and SPECT provide
information on the function of the body, contrary to anatomical imaging
techniques such as X-ray computed tomography (CT) or MRI. MRI works
by recording radiofrequency (RF) signals from protons in the body when the
patient is inside the strong magnetic field in the scanner. Contrast between
tissues can be created because protons in different tissues have a different
chemical environment. Therefore they respond differently to the changes in
magnetic field that are created by the scanner. By using various imaging
sequences, different kinds of contrast can be created.
PET and SPECT have a very high sensitivity: tracer concentrations as
low as picomolars can be visualized. Unfortunately, the resolution of PET
and SPECT is limited and they can not provide a good anatomical back-
ground on which the tracer distribution can be situated. MRI has the ad-
vantage of acquiring high-resolution images, which accurately depict patient
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anatomy. Therefore, there is currently much interest in combining either
PET or SPECT with MRI. In part, this is inspired by the success of the
combination of PET with CT. Combining PET and CT was quite straight-
forward, as both scanners can just be placed adjacent to each other and use
the same bed. For PET-MRI or SPECT-MRI, the design is more difficult,
especially if a fully integrated scanner is the goal. The main issue is the
development of PET or SPECT detectors that can be used inside the high
magnetic field of the MRI scanner. In the last 15 years, different small an-
imal PET inserts for MRI systems have been designed. Most recently, the
first human PET-MRI systems have become available.
Apart from the design issues related to constructing an integrated PET-
MRI or SPECT-MRI scanner, other difficulties also need to be overcome
before these new scanners can be routinely used. One of the important prob-
lems is the correction for different image-degrading effects that are present in
emission tomography images. In PET and SPECT, one of the major effects
is photon attenuation. To correct for photon attenuation, the distribution
of the attenuation coefficients throughout the imaging volume needs to be
known. This distribution is called the attenuation map and reflects the elec-
tron density distribution of the patient. In standalone PET or PET-CT, a
transmission scan or a CT image is used to obtain the attenuation map.
This is straightforward as the signal measured with a transmission scan or
a CT is directly related to the electron density of tissue. In PET-MRI and
SPECT-MRI, the attenuation map should ideally be derived from MRI im-
ages. However, this is difficult as MRI signal is related to proton density and
relaxation properties of tissue, not to electron density. Additionally, lung
tissue and cortical bone, which are two important tissue types for attenua-
tion, exhibit no signal on images acquired with conventional MRI sequences.
Therefore, it is difficult to create contrast between air (which also has no
signal), lung and cortical bone based on images acquired with conventional
MRI sequences alone. In most current MRI-based methods for deriving the
attenuation map, this problem is solved by making certain assumptions on
patient anatomy. However, this may lead to problems if the patient has
anatomical abnormalities.
In this work, we have developed a MRI-based attenuation correction
method which discriminates air, lung, soft tissue and bone based on MRI
intensity alone. This is done by acquiring images with an ultrashort echo
time (UTE) MRI sequence. This sequence enables the acquisition of MRI
signal in lung and cortical bone. By performing a number of image process-
ing steps, the attenuation map can be derived from images acquired with
this sequence.
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1.2 Outline
In chapter 2, the different imaging modalities that are used in this work
are introduced. First the principles of PET and SPECT are described, fol-
lowed by a brief discussion of image reconstruction methods. The different
image-degrading effects that need to be corrected for in PET and SPECT
are explained. An introduction to Monte Carlo simulations is also given, as
well as a description of the most important clinical and preclinical applica-
tions of PET and SPECT. Then, the principles of MRI are introduced, from
the description of spin physics to the general structure of MRI sequences.
After an overview of MRI hardware, the different applications of MRI are
also covered. Subsequently, multimodality imaging is introduced. The de-
sign issues of PET-MRI and SPECT-MRI scanners are explained, followed
by an overview of systems that have been designed. The last part of chapter
2 is devoted to attenuation correction. The effect of attenuation on the re-
constructed images is discussed as well as the implementation of attenuation
correction into the reconstruction algorithm. Finally, the different methods
that can be used to derive the attenuation map are described, with special
attention for the MRI-based attenuation correction methods that have been
proposed.
Before we derive our new method, the effect of errors in the attenuation
map on the reconstructed PET images is evaluated. This is done using sim-
ulations in chapter 3. Using simulations of a rat, human brain and human
whole-body phantom, the requirements for a MRI-based attenuation cor-
rection method are derived. These requirements are then used in the next
chapters as a guideline.
In chapter 4, UTE imaging is introduced. After a description of the origin
of short T2 in tissues, UTE imaging principles are described along with a
more detailed description of the Philips UTE sequence that will be used for
most experiments described in this thesis. Next, the MRI properties of lung
and cortical bone are investigated, to evaluate if visualization of those tissues
with UTE sequences is possible. In the last section of chapter 4, the basic
method which will be used throughout the rest of this work is introduced.
Before evaluating the proposed method on real animal and human data,
we will test it on phantom data. As no suitable phantoms are currently
available, we have designed new phantoms. The design of two phantoms,
one for human brain imaging and one for human thorax imaging, is described
in chapter 5. These phantoms are then used to evaluate the performance of
our method.
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In chapter 6, the UTE-MRI-based attenuation correction method will be
tested on small animal data. Two studies will be described. The first is
a micro-SPECT study using 18 rats injected with different tracers, which
evaluates the feasibility of using the proposed method on micro-SPECT
scans. A smaller micro-PET study, using 3 rats, will also be described.
The eventual goal of developing a UTE-MRI-based attenuation correction
method is to use it in clinical practice. Therefore, we will test the developed
method on human data in chapter 7. The performance in human brain
imaging will be evaluated on 5 patient brain PET-CT-MRI data sets. To
assess the feasibility of using our method for thoracic imaging, it is also
tested on a single human thorax data set. In the last part of chapter 7,
whole-body imaging will be discussed.
A summary of the results that are described in this thesis, along with the
conclusions that can be drawn from them is given in chapter 8. A final
conclusion is also presented there.
Chapter 2
Multimodal medical
imaging
2.1 Introduction
In this chapter the different medical imaging modalities that are used
throughout this work are described. In the first section, the principle of
emission tomography is explained, as well as the methods used for acqui-
sition of the data and reconstruction of the images. The image degrading
effects are also described, and a brief overview of current applications of
emission tomography is given. In the second section, magnetic resonance
imaging (MRI) is introduced. First the principles of nuclear magnetic reso-
nance are described, followed by the imaging principles. The main hardware
components of a system are discussed, as well as the applications of MRI
that are of interest for this work.
In the third section, multimodality imaging modalities and their applica-
tions are introduced. Special focus is given to the combination of MRI with
emission tomography. Apart from the design issues relevant to that combi-
nation, the prototype systems that have been presented are also described,
as well as the first clinical systems. As the subject of this work is attenu-
ation correction, a detailed description of attenuation correction is given in
the last section. It describes the effect of attenuation on (clinical interpre-
tation of) the images, the methods for including attenuation correction into
the reconstruction algorithm, and the methods for obtaining the attenuation
map that are currently available.
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2.2 Emission tomography
2.2.1 Early history
The earliest nuclear medicine experiments were done using naturally abun-
dant radioactive isotopes. Cyclotron and reactor sources became available
after World War II, in part due to technology developed in the Manhattan
project. This enabled the use of fabricated radiotracers, but at that moment
there were still too many technical limitations to develop an adequate imag-
ing device. In 1957, Anger invented the Anger camera or gamma camera,
which can be considered the start of modern nuclear medicine imaging[1].
Anger himself developed many modifications of his camera, such as pin-
hole collimators and images acquired at different projections by rotating
the patient in front of the camera. Subsequent developments led to the
design of rotating gamma cameras, allowing the reconstruction of tomo-
graphic images[2, 3]. These were the first single photon emission computed
tomography (SPECT) images.
The development of positron imaging followed a different track than single-
photon imaging. The first Anger camera with positron-imaging capability
was presented by Anger and Rosenthal in 1959[4]. The first application was
imaging of 52Fe distributed in the bone marrow of patients with hematolog-
ical diseases[5]. The first design that resembles the currently used scanners
was designed by Robertson et al. in 1964, but computer systems were at
that time not powerful enough to allow widespread use[6]. More than a
decade later, and after several modifications, the device was used for brain
imaging[7]. By the early 1980s, positron emission tomography (PET) was
used in many major hospitals.
2.2.2 Tracer principle
Emission tomography is based on the tracer principle. An emission tomogra-
phy tracer, consisting of a radioactive isotope linked to a specific biological
molecule, is administered to an animal or a patient. The gamma photons
emitted by the tracer when it decays are acquired by the emission tomog-
raphy scanner. Using specialized reconstruction algorithms, the distribution
of the tracer in the body can be derived from the acquired data. Hence
emission tomography enables the evaluation of the function of the body.
It provides different information than a purely anatomical medical imaging
technique such as X-ray computed tomography (CT). While emission to-
mography does not achieve the same spatial or temporal resolution as most
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anatomic imaging modalities, it does provide a sensitivity that is unmatched:
concentrations as low as picomolars can be measured.
The tracers used in emission tomography can be divided into two cate-
gories, depending on the type of radiation emitted by the isotope: positron
emitters and single photon emitters. Both types of isotopes are described in
the next paragraphs. The principles of the acquisition of the photons emit-
ted by these isotopes are discussed in the next section. It is important to
keep in mind that radioactive decay is a random process, following a Poisson
distribution. The data acquired by the scanner will therefore contain Poisson
noise.
2.2.2.1 Positron emitters
The first category are the positron emitters, which are used in positron
emission tomography (PET). When an unstable nucleus has an excess of
protons, a proton can be converted into a neutron by emitting a positron or
β+ particle. The decay of 18F to 18O is an example of this transition:
18F→ 18O + β+ + ν + 0.634 MeV (2.1)
In which a positron and a neutrino (ν) are emitted. The positron emitted
by 18F has a kinetic energy of 0.634 MeV. Other isotopes can emit positrons
with different kinetic energies. The positron then loses this kinetic energy in
atomic collisions, traveling a random path until it has lost all kinetic energy.
At that moment, it will annihilate by interacting with its antiparticle, an
electron (β−) from a nearby atom. The combined mass of the positron
and the electron is converted into two gamma photons emitted in (almost)
opposite directions. Each of the gamma photons has a photon energy of
511 keV, in accordance with Einstein’s E = mc2 equation.
Positron emitters are created in a cyclotron, by bombarding stable nuclei
with charged particles. To obtain 18F, water enriched with 18O is bombarded
with protons. The advantage of most positron emitters is that the stable
isotopes of these elements are present in many molecules in the human body,
and they can therefore be incorporated into many biological molecules. The
downside is that most of them have a short half-life, which is not a hazard
for 18F (110 minutes) but makes studies with 11C (20 minutes) and 15O (2
minutes) very difficult. For studies with those isotopes, a cyclotron needs to
be present close to the PET scanner, which is not possible in many hospitals.
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2.2.2.2 Single photon emitters
The second category of isotopes used in emission tomography consists of the
single photon emitters, used in planar scintigraphy and single photon emis-
sion computed tomography (SPECT). These isotopes only emit a gamma
photon. This photon can arise from two different types of nuclear decay:
isomeric transitions or electron capture. Most unstable nuclei that undergo
α or β decay are in an unstable excited state after the emission of the α or
β particle. The transition from this unstable state to a stable state of the
same isotope, through emission of a gamma photon, is called an isomeric
transition. Usually the emission of the gamma photon occurs very quickly
after the emission of the particle (10−12 s on average). However, some ex-
cited states are called metastable, because the half-life of the excited state is
much longer. The most used isotope in nuclear medicine is 99mTc, which is
a metastable isotope of technetium. It is derived from the unstable mother
isotope 99Mo, which decays to 99mTc by β− emission:
99Mo→ 99mTc + β− + ν¯ (2.2)
where an antineutrino ν¯ is also emitted. The metastable 99mTc then
decays to the stable isotope through emission of one 140 keV gamma photon:
99mTc→ 99Tc + γ (2.3)
99Mo has a half life of 66 hours and is usually obtained as a product of
nuclear fission through neutron bombardment of a 235U target. A genera-
tor with 99Mo continuously produces 99mTc. Usually, the generator consists
of 99Mo in the form of molybdate (MoO2−4 ) adsorbed to a column of acid
alumina (Al2O3). When molybdate decays to pertechnate (TcO−4 ), it be-
comes less tightly bound to the alumina because it only has a single charge.
Pertechnate can therefore be extracted by pulling saline solution through the
column. 99mTc has a half-life of 6 hours, which is very practical for emission
tomography.
The other type of nuclear decay that produces a single gamma photon is
electron capture. This happens when a nucleus with an excess of protons
captures an electron and thereby converts a proton to a neutron. An example
used in emission tomography is 123I, which decays to 123Te by capture of an
electron and emission of a gamma photon:
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123I + β− → 123Te + ν + γ (2.4)
The most prominent gamma photon energy emitted by 123I is 159 keV.
123I is produced in a cyclotron through proton bombardment of 124Xe, com-
parable to the production of 18F from 18O. It has a half-life of 13.2 hours.
Another frequently used isotope, 67Ga, is also produced in this manner.
Compared to positron emitters, single photon emitters have longer half
lives, ranging from 6 hours (99mTc) to 76 hours (67Ga). They are therefore
easier to use than positron emitters, and do not require a cyclotron on-site.
This makes imaging of single photon emitters much more accessible, also
for smaller hospitals.
2.2.3 Imaging principles
2.2.3.1 Gamma detector
The photons emitted by PET and SPECT isotopes can not be acquired with
normal optical cameras, as they have a much higher photon energy than
optical photons. A special type of detector is therefore used in emission
tomography, which converts gamma rays into electrical information[1]. A
schematic drawing of such a detector is shown in fig. 2.1. In a gamma
detector the photon is first absorbed by a scintillation crystal, which converts
the gamma photon to a visible light pulse. The intensity of the pulse,
i.e. the number of visible photons produced by the scintillation crystal,
is proportional to the energy of the incident gamma photon. The most
important properties of scintillation materials are a high stopping power, high
light output and fast operating speed. A high stopping power is needed so
that the crystal does not need to be too thick, as this would have a negative
influence on spatial resolution. High light output is needed to obtain a high
energy resolution. Fast operating speed, which requires a fast rise time of the
light pulse and no afterglow, allows operation at high gamma count rates.
Ideally a scintillation material is also cheap, easy to produce, robust and non-
hygroscopic. Obviously, none of the available scintillation materials exhibit
all these properties. Common scintillation materials are NaI, CsI, lutetium
oxyorthosilicate (LSO) and lutetium-yttrium oxyorthosilicate (LYSO).
In a second step, the scintillation light is spread by a lightguide onto
the next component, which converts the optical photons emitted by the
scintillation crystal to an electric pulse. In most PET and SPECT scanners
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Figure 2.1: A gamma camera.
this is done using photomultiplier tubes (PMTs). These convert an incident
optical light pulse into an amplified electric signal. This electric signal can
then be recorded using electronic components. As PMTs are generally much
larger than the size of a scintillation crystal, they are not coupled to a
single crystal. Special positioning algorithms are therefore used to obtain the
position of incidence of the gamma photon on the detector surface. This is
done using Anger logic, named after the inventor of the gamma detector[1].
Using the relative signals of the different PMTs, a two-dimensional position
can be obtained, which can then be mapped to one of the scintillation
crystals. The total energy deposited in the crystal can be obtained from
the total electric signal produced by all PMTs. Timing information is also
obtained from the PMT signal.
In summary, a gamma detector will acquire three properties for each
gamma photon:
1. the incidence location on the detector surface,
2. the energy deposited in the crystals,
3. the incidence time.
The ideal gamma detector will detect these properties with infinite reso-
lution. Currently available detectors have limited spatial, energy and timing
resolutions. These properties depend on the scintillation crystal, the light
detector and the electronics that are used.
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2.2.3.2 Positron emission tomography
PET imaging is based on the acquisition of both 511 keV photons that are
emitted when a positron annihilates with an electron. If two 511 keV photons
are detected by the scanner shortly after each other, they are assumed to
have originated from the same positron emission. In that case, the detection
of both photons is called a coincidence. By detecting both annihilation
photons, the line along which the annihilation occured is determined. This
line is called the line of response (LOR). By acquiring several millions of these
coincidences, information is obtained on the distribution of the tracer inside
the patient. The algorithm used for deriving the distribution image from the
coincidence information is described in the section on image reconstruction
below.
All current PET scanners consist of a full ring of acquisition modules (fig.
2.2). For simplicity’s sake, suppose each of these modules can be seen as a
gamma detector. The actual design is more complex, but this is described
in more detail in the literature[8]. For PET imaging, the timing information
provided by the module is important, as two incident photons can only be
considered a coincidence if both photons are detected within a certain time
window (the coincidence window). Coincidence detection is performed on-
line by the coincidence electronics of the scanner. The coincidence window is
determined by the size of the scanner and the timing resolution of the mod-
ules. In a scanner with a perfect timing resolution, the coincidence window
should be set to the time it takes one photon to travel across the maximum
distance between two crystals. In real scanners the timing resolution is never
perfect, hence the coincidence window is larger.
For many years, full-ring PET scanners were operated in 2D-mode only,
meaning that only coincidences that occur between crystals within the same
ring were recorded. In theory, this means that in each ring, only data from
the plane of the ring was acquired (called a slice). To avoid contamination of
the data by photons from other slices, septa were placed between the rings.
Although this avoids contamination, sensitivity is reduced by the septa, as
all coincidence photons that are not emitted within a transaxial plane are not
recorded. The sensitivity of 2D PET was approximately 0.2-0.3 %. Since
the early 1990’s PET scanners have been operated in 3D mode, acquiring
coincidences between different rings[9]. This was done by retracting the
septa. This yields a much higher sensitivity (up to 3 %) at the cost of a higher
scatter fraction and random fraction, as discussed below. 3D reconstruction
algorithms are also far more computationally demanding[10, 11]. Currently
most PET scanners do not have septa anymore and operate in 3D mode
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Figure 2.2: Schematic drawing of a PET (left) and SPECT (right) scanner.
only.
2.2.3.3 Single photon emission computed tomography
While two collinear photons are available per disintegration in PET imaging,
only one photon is available in SPECT imaging, as SPECT tracers are single
photon emitters. This means that, when the photon is detected in a gamma
camera as described above, it is unclear where it originated from: the line
along which it traveled from the emission towards the detector can not be
determined. This line can be compared to a LOR in PET. Although the term
’LOR’ is not used in SPECT in general, we will use it here to conserve analogy
with PET imaging. To determine the LOR of a detected gamma photon, an
extra component is added in a SPECT scanner: the collimator (fig. 2.2). A
collimator is usually fabricated in a material with a high stopping power for
gamma photons, e.g. tungsten or lead. The most frequently used collimator
in clinical SPECT imaging is a parallel hole collimator, consisting of a thick
lead plate with parallel cylindrical or hexagonal holes. When the collimator
is placed in front of the gamma camera, only photons that are traveling
perpendicular to the module surface will reach the scintillation crystal. This
way a LOR can be determined, as the location of the incidence as well as
the incidence angle is known.
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Another type of collimator is a pinhole collimator, which has small pinhole
openings[12]. A LOR can also be determined using a pinhole collimator, as
two points on the LOR are known: the incident point on the scintillation
crystal and the pinhole opening. Pinhole collimators provide the possibility
of magnification of the object under study on the crystal surface, yielding a
higher resolution. Therefore pinhole collimators are frequently used in small
animal imaging, where resolution is very important[13].
SPECT scanners generally do not consist of a complete ring like PET
scanners, but usually have 2, 3 or 4 heads that are rotated to sample a
sufficient number of angles, as shown in fig. 2.2. Because the use of a
collimator limits the acceptance angle for photons traveling towards the de-
tector, the sensitivity of SPECT is much lower than PET[14]. In clinical
SPECT imaging, a sensitivity of ≈ 0.03 % can be achieved with parallel hole
collimators. There is also a trade-off between sensitivity and resolution in
SPECT[15, 16]. For example, a parallel hole collimator with large holes will
provide a higher sensitivity but will lead to resolution degradation and vice
versa. In SPECT scanners different collimators are also needed for different
isotopes. An isotope which emits high energy photons, such as 131I (362
keV), requires a thicker collimator than isotopes which emit lower energy
photons, such as 99mTc (140 keV).
2.2.4 Image reconstruction
The goal of image reconstruction in emission tomography is to derive a
cross-sectional image from the acquired data, i.e. the counts on the LORs.
This can be illustrated through the following equation:
E [p(λ)] =
∫
λ
f (x , y , z) dx dy dz (2.5)
where p(λ) is the projection along the LOR λ and f (x , y , z) is the tracer
distribution throughout the imaging volume. As radioactive decay is a ran-
dom process, the acquisition of photons originating from radioactive decay
is also a random process. The expectation operator E [] is therefore needed
in eq. 2.5. The purpose of tomographic image reconstruction is to obtain
f (x , y , z) from all acquired p(λ). There are two general approaches to this
problem: analytical and iterative image reconstruction. In this thesis only
iterative image reconstruction methods were used, but a brief description of
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analytical reconstruction methods is given below for completeness.
2.2.4.1 Analytical image reconstruction
Analytical reconstruction methods try to reconstruct the image directly from
the acquired data, through a direct inversion of eq. 2.5[17]. This is only
possible with a number of simplifying assumptions:
• continuous samples of P(λ) are available,
• absence of physical data-degrading effects such as attenuation or scat-
ter,
• absence of statistical noise, i.e. radioactive decay is a non-random
process.
Analytical image reconstruction is based on the central section theorem,
which states that the Fourier transform of a one-dimensional projection of
an object is equivalent to a section through the the two-dimensional Fourier
transform of that object:
P(vxr ,φ) = F (vx , vy )|vyr=0 (2.6)
where vx and vy are the spatial frequency coordinates and xr and yr are
the spatial coordinates in a cartesian system that is rotated over an angle
φ. P(vxr ,φ) is then the one-dimensional Fourier transform of projection
p(xr ,φ), which is obtained by projecting along the LORs at angle φ with
distance from the origin defined by xr . F (vx , vy ) is the two-dimensional
Fourier transform of the tracer distribution f (x , y).
Reconstruction can now be done by performing a backprojection of all
acquired projections into the image. However, this will lead to overestimation
at the center of the image as the center of the image was oversampled by the
projection. Therefore, a filtering step is also needed. This leads to the best
known analytical reconstruction algorithm: filtered backprojection (FBP):
f (x , y) =
pi∫
0
F−11 { |vxr | F1[ p(xr ,φ) ] } dφ (2.7)
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where the integration over φ represents the backprojection, F1 and F−11 are
the direct and inverse one-dimensional Fourier transforms and |vxr | represents
filtering with the ramp filter.
2.2.4.2 Iterative image reconstruction
While analytical reconstruction is possible, many assumptions are needed to
achieve a mathematically accurate result. This is because the model used for
the imaging process in the analytical method described above is too simple.
A better description of the model, allowing incorporation of physical effects
such as attenuation, scatter, etc., would lead to a more accurate description
of the imaging process. By including the statistical properties of the data
into the model as well, even better results could be achieved. Unfortunately,
incorporation of all these elements into the model inadvertently leads to
a more complex model, for which an analytical solution in a closed form
is either not available or impractical to compute. Therefore, these models
can usually only be used to solve the reconstruction problem in an iterative
manner[18]. As multiple forward- and backprojections are needed in iterative
reconstruction algorithms, their development has only been possible from the
moment sufficient computation power was available.
In iterative image reconstruction, the imaging volume is discretized into
a two- or three-dimensional matrix. This matrix is called the image and
each element from the matrix is called a pixel (in 2D) or a voxel (in 3D).
Each value in the image represents the estimation of the tracer distribution
in a single point, e.g. in the center of the voxel. After each iteration, the
estimation of the tracer distribution in each point becomes more accurate.
A general model of an iterative algorithm is depicted in fig. 2.3. The
algorithm starts with a first estimate of the image. This can be any image,
but usually it is a uniform image. This estimate is then forward projected,
meaning that the data that would be acquired by the scanner if the estimate
was being imaged is derived. This projection is compared to the actual
acquired data, e.g. by a division. The ratio between both projection sets
(the error projection) is then backprojected into the image volume, yielding
an error image. The image estimate is then multiplied by the error image,
yielding a new estimate. The whole process is iterated a number of times
until the algorithm converges.
In this work, all image reconstruction is done using the maximum-likelihood
expectation maximization algorithm (ML-EM), therefore only that algorithm
is described here[19, 20]. For a description of other iterative reconstruction
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Figure 2.3: Schematic overview of an iterative reconstruction algorithm.
algorithms, the reader is referred to the literature on the subject[18]. The
ML-EM algorithm is based on the maximum likelihood criterion, proposed
by Fischer in 1921[21]:
fˆ = arg max p(g; f) (2.8)
which means that the reconstructed image fˆ should be chosen for which
the measured data g has the largest probability. The ML-EM algorithm can
be summarized in a single equation:
fˆ
(n+1)
j =
fˆ
(n)
j∑
i ′
hi ′j
∑
i
hij
gi∑
k
hik fˆ
(n)
k
(2.9)
where fˆ (n)j represents the image element j in estimation n, gi is the number
of counts in projection bin i and hij are the system matrix elements. The
system matrix is the matrix that determines the projection: it defines for each
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image element j what the probability is that an emission from this element
will be detected in projection bin i . In this equation, the denominator of
the last fraction is the forward projection, which is then compared to gi .
The sum over i represents the back projection, and the multiplication with
fˆ
(n)
j is the update step. The denominator of the first fraction is needed for
normalization.
2.2.5 Image degrading effects
Apart from the noise in the data, which is inherent to the Poisson nature of
radioactive decay, there are other effects that lead to lower quality PET and
SPECT images. Image degrading effects can be divided into those mainly
caused by the system and those mainly caused by the object or patient. As
described above, they can be corrected for by incorporating them into the
imaging model in iterative reconstruction algorithms. The most important
effects are discussed here, together with common correction methods.
2.2.5.1 System-dependent image degrading effects
Sensitivity
The probability that an emission will be detected by the PET or SPECT
scanner depends on the location of emission. This non-uniform sensitivity
is in part due to the geometry of the scanner. This is corrected using geo-
metric sensitivity correction, which can be calculated based on the system
geometry[22]. It can also be due to non-uniformity of the detector response:
there are variations in the responses of crystals and PMTs to a source.
Normalization is used to correct for this effect, which requires normalization
measurements[23, 24, 25].
Resolution
The scanners used in emission tomography have a limited resolution, which
limits the capability of the system to discriminate two neighboring sources.
Resolution in SPECT is affected by two components: the intrinsic resolution
of the detector and collimator-dependent effects. In theory, there is no limit
to the resolution that can be obtained with SPECT systems, but there is a
trade-off between resolution and sensitivity for a certain field of view. There
are currently micro-SPECT systems available for small animal research which
enable sub-mm resolution[13]. In clinical SPECT imaging, current systems
achieve resolutions of 7-10 mm[14].
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As described above, the sensitivity of PET is much higher as no collimator
is needed. However, there is a fundamental limit on resolution, determined
by the positron range[26]. For low-energy positron emitters (such as 18F)
the positron range in water is small (≈ 0.5 mm). The resolution in PET is
also affected by the acollinearity of the emitted gamma photons, which can
have a large effect in scanners with a large bore such as human whole-body
scanners. Obviously, PET resolution also depends on the detector resolution.
The resolution of current clinical PET scanners is in the range of 4-6 mm.
By implementing resolution-recovery algorithms, the resolution of the re-
constructed images can be improved[27]. However, this is not routinely used.
Random coincidences
Random coincidences are only relevant for PET. A random coincidence is
a coincidence detected by the PET scanner within the coincidence window
but in which both detected photons originated from a different positron
emission. The detected coincidence does not contain any relevant informa-
tion for the reconstruction process and even leads to incorrect information,
as shown in fig. 2.4. Random coincidences can be limited by keeping the
count rate low enough. In general, random coincidence correction is imple-
mented by using a delayed coincidence window[28]. Regular coincidences
("prompts") are obtained by opening the coincidence window immediately
after the first photon is detected. Delayed coincidences are obtained by
opening a coincidence window of the same length a certain delay after the
first photon was detected. As the delayed coincidences are all randoms, they
provide an estimation of the randoms fraction. These delayed coincidences
can be subtracted from the prompts to correct for random coincidences.
Other effects
Apart from the three effects discussed here, there are still other image-
degrading effects in emission tomography. In both PET and SPECT, the
system performance can decline when a lot of activity is present in the
scanner. This determines the count rate performance of the scanner. In
SPECT, there are additional effects related to collimator performance such
as collimator penetration, scatter and X-ray production.
2.2.5.2 Object-dependent image degrading effects
Attenuation
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Figure 2.4: Illustration of attenuation, scatter and random coincidences in a PET
scanner with a water phantom.
When a photon travels through matter for a certain distance, it has a prob-
ability of being absorbed (attenuated) and hence not reaching the detector.
This is illustrated in fig. 2.4. The fraction of photons that penetrate through
the tissue, the transmitted fraction TF , is determined by the attenuation co-
efficient of the tissue it travels through:
TF = e
R−µ(s) ds (2.10)
where the line integral is taken over the path that is traveled by the
photon. The attenuation coefficient µ depends on the material and the
energy of the photon. It is clear that this effect is larger for photons that
are emitted from the center of an object than for photons that are emitted
from the border of the object. If no correction is performed, this will lead to
image artefacts. This is clear on a non-corrected reconstruction of a uniform
cylinder filled with 18F-FDG and water, shown in fig. 2.5: the center of the
cylinder appears darker whereas the border appears brighter. A comparable
effect can be observed in a whole-body PET image, also shown in fig. 2.5:
as the lungs are much less dense than soft tissue, they will appear much
brighter on an uncorrected image. As attenuation correction is the subject
of this work, it is discussed extensively in section 2.5.
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Figure 2.5: Example of the effect of attenuation. An uncorrected (A) and cor-
rected (B) image of a water cylinder filled with a uniform 18F-FDG concentration
is shown. The effect of attenuation on whole-body imaging is also shown, with an
uncorrected (C) and corrected (D) image.
Scatter
If an emitted photon is scattered along its path, it changes direction. When
the photon is detected by a PET or SPECT scanner, the LOR that is at-
tributed to the photon will be incorrect as illustrated in fig. 2.4. In most
current systems, scatter is handled in two ways. The first way, used in PET
and SPECT and aimed at reducing the amount of scatter in the acquired
data, is based on the principle that scattering of a photon leads to a reduc-
tion of the energy of the photon. Therefore an energy window is set, and
all photons that have a detected energy outside this window are disregarded
as they were probably scattered. The amount of scatter inside the energy
window can be estimated from the data outside the energy window using
different methods, and can also be subtracted[29, 30, 31].
The second way of correcting for scatter is done by estimating the re-
maining amount of scatter in the acquired data. This information is then
incorporated into the imaging model during reconstruction. Estimation of
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the scatter can be done in different ways. Fast Monte Carlo simulations can
be used to estimate the amount of scatter, which has been done in SPECT
and PET[32, 33, 34, 35]. Currently, most PET system use an algorithm
called single scatter simulation (SSS)[36], which is a model-based approach
using the Klein-Nishina formula[37]. In SSS a crude estimation of the scatter
is calculated based on the current image estimate and the attenuation map.
This estimation of scatter is then subtracted from the original data.
Motion
In both PET and SPECT physiological motion of the organs (e.g. breathing
or cardiac motion) or motion of the complete patient can lead to image
blurring. Correcting for breathing motion can be done using gated acquisi-
tions, in which only the data acquired at a specific point in the respiratory
cycle is used for reconstruction[38, 39, 40]. This leads to a lower sensitivity
but to higher resolution. Possible correction methods for patient motion
have also been investigated, especially in brain PET imaging[41, 42, 43].
2.2.6 Simulation methods
Simulation techniques are very useful for research in emission tomography.
A first application of simulations is in system design. Simulations allow to
investigate the optimal configuration of different parameters, without the
need for building numerous expensive prototypes. Possible parameters to be
tuned include crystal size, scanner radius, collimator thickness, etc. Another
advantage of simulations is that they allow the investigation of different ef-
fects with knowledge of the ground truth. As an example, this can be very
useful in motion correction research. With real patient data, it is impossi-
ble to know the actual patient motion with 100 % certainty and hence the
ground truth is unknown. With simulated data, the motion was included
in the simulated model and the ground truth is therefore known. This al-
lows accurate determination of the performance of the designed method. A
similar approach can be used to assess performance of scatter correction or
attenuation correction methods.
2.2.6.1 Principles of Monte Carlo simulation
The Monte Carlo (MC) method can be used to tackle statistical problems,
and is currently used in many fields. The name was coined by Meteopolis and
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Uman in 1949, and refers to the Monte Carlo casino in Monaco and to the
random nature of the events modeled with the technique[44]. As radioactive
decay as well as the detection of gamma radiation are stochastic processes,
MC is ideally suited for use in emission tomography. The principles of MC
simulation are described briefly here. For an extensive description of MC
methods in emission tomography, the reader is referred to the literature[45,
46, 47, 48].
In order to use MC, there are a number of requirements. First of all,
a complete description of the environment in which the simulation is tak-
ing place is needed. Secondly, a thorough understanding of all the physical
processes that need to be modeled is required. In particular, a probability
density function is needed for each possible phenomenon that can occur.
Thirdly, a random number generator is required. MC simulation uses gen-
erated random numbers to sample stochastic variables from the probability
density functions. These stochastic variables then determine the course of
the simulation. This allows realistic simulation of the physical processes, if
they are modeled accurately.
As a simple example, suppose one single photon emitting nucleus is simu-
lated. First of all the emission needs to be simulated. As radioactive decay
is a Poisson process, the time of decay can be sampled from the Poisson dis-
tribution determined by the half-life of the isotope. At the time of decay, the
direction of the emitted photon is also sampled from a distribution, which is
uniform in this case. As the photon travels along this path, it will encounter
other particles. Suppose it encounters an electron of another atom. Then
there is the possibility that the photon is scattered, and the angle under
which it is scattered is also determined by a probability density function,
which is also sampled, and so on.
2.2.6.2 GATE: Geant Application for Tomographic Emission
In this thesis, all simulations have been performed with the GATE simulation
toolkit[49]. This was developed by the OpenGATE collaboration, and was
built on top of the well-validated high energy physics package GEANT4[50].
Other simulation toolkits for emission tomography are also available, such
as SimSET and EGS4[51]. GATE was chosen because of the extensive ex-
perience that exists within our research group. Also, validated models for
different scanner geometries are available for GATE[52, 53, 54, 55].
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2.2.6.3 Digital phantoms
To determine system characteristics such as resolution and sensitivity, sim-
ple analytical phantoms, such as point sources, spheres and cylinders, can
be used. For realistic simulations, realistic digital phantoms are needed.
Specifically, phantoms which represent the human body are required to re-
alistically model object-based image degrading effects such as attenuation,
scatter and motion. Since the development of simulation methods for tomo-
graphic imaging, these types of phantoms have been developed. The first
antropomorphic phantoms were based on a composition of analytical shapes
such as ellipsoids and cylinders. An example is the MIRD phantom, used for
dosimetry[56].
A more detailed description of the human anatomy requires the possibility
to use non-analytical shapes and hence requires the use of discrete, so-called
voxellized phantoms. The first voxellized antropomorphic phantom was de-
signed by Zubal and Harrell, based on a detailed CT study of a male[57]. We
have used the XCAT phantoms in this work, which is based on the earlier
design of the MCAT and NCAT phantoms[58, 59, 60]. These phantoms
have been designed based on the data sets obtained from the visible hu-
man project. They allow the simulation of respiratory and cardiac motion.
From the same developers, realistic digital rat (ROBY) and mouse (MOBY)
phantoms are also available.
2.2.7 Applications
2.2.7.1 Clinical PET imaging
The specificity of the images obtained using emission tomography strongly
depends on the tracer. 18F is by far the most widely used isotope in PET,
mainly in 18F-fluorodeoxyglucose (FDG)[61]. FDG is a glucose analogue that
is taken up by cells consuming glucose and gets blocked in the cell after the
first enzymatic reaction. 18F-FDG therefore enables the visualization of the
metabolic (glycolytic) function of tissue. As most tumors are metabolically
more active than normal tissue, 18F-FDG is used to detect tumors[62]. It
can also be used to determine regional brain activity[63]. An example brain
PET image is shown in fig. 2.6. Other applications of PET in neurology
include brain perfusion studies using 15O and tracers that ligate specific
neuroreceptors such as 11C-raclopride for dopamine D2/D3 receptors.
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Figure 2.6: From left to right: a transverse, coronal and sagittal slice of a 18F-FDG
brain PET image.
2.2.7.2 Clinical SPECT imaging
99mTc is currently the most widely used isotope in nuclear medicine and
accounts for 85 % of all diagnostic procedures. Bone scans, using 99mTc-
labeled medronic acid (MDP) to visualize osteoblastic lesions in the bones,
are one of the main applications of single photon emission. Myocardial
perfusion SPECT, using either 99mTc-sestamibi or 99mTc-tetrofosmin, is
widely used in cardiology to determine if there are significant stenoses in
the coronary arteries leading to perfusion defects in the myocardium[64].
99mTc-dimercaptosuccinic acid (DMSA) and 99mTc-mercaptoacetyltriglycine
(MAG3) are used in urology for visualization of kidney function. Many other
99mTc-labeled radiotracers are available.
123I is another single photon emitter that has been used in nuclear medicine
for a long time. It can be used for visualization of the thyroid gland without
linking to another molecule, as virtually all iodine in the human body is taken
up in the thyroid gland[65]. It can also be linked to tracer molecules, such as
metaiodobenzylguanidine (MIBG), which is used for visualization of adrener-
gic tumors such as phaeochromocytomas. It is also used in neurology for the
confirmation of Parkinson’s disease using 123I-ioflupane (DaTSCAN R©)[63].
Other commonly used single photon emitting isotopes include 67Ga, 111In
and 201Tl.
2.2.7.3 Quantitative PET and SPECT
In a clinical setting, both PET and SPECT are mostly used for lesion de-
tection. This means that a physician will look at the images for qualitative
differences. For example, a hot spot (region with high uptake) in a 18F-FDG
PET image could show a metastasis of a tumor. In cardiac SPECT imag-
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ing, a cold region (region with low uptake) in the wall of the left ventricle
could be related to a perfusion defect. However, emission tomography also
provides the possibility to obtain quantitative images. With absolute quan-
tification, the activity concentration (in Bq/ml) can be derived from the
PET or SPECT images. This enables better longitudinal follow-up, e.g. for
evaluation of response to therapy[66]. Absolute quantification is also needed
for accurate kinetic modeling of tracer uptake[67].
For absolute quantification, accurate system calibration is needed as well
as a very good image reconstruction algorithm, which takes into account all
image degrading effects. For clinical PET, absolute quantification has been
available for decades. The clinical advantage of quantitative PET for mon-
itoring the response of tumors to chemotherapy and radiotherapy has been
demonstrated in clinical studies[68, 69]. The applicability of quantitative
PET to kinetic modeling has also been shown[70, 71].
While absolute quantification is definitely possible in SPECT, the correc-
tions for image-degrading effects are more complex. Hence, quantitative
SPECT is still a developing field[72, 73]. Nevertheless, there are important
applications for quantitative SPECT, such as the use in individual dosime-
try for targeted radionuclide therapy[74, 75, 76]. Although the number of
studies showing absolute quantification with SPECT in a clinical setting is
limited, the feasibility has been demonstrated[77, 78, 79].
2.2.7.4 Preclinical imaging
Many medical treatments, such as drugs, are first tested on laboratory an-
imals before they are tested on humans. This stage of research is called
preclinical research, as it is done before the clinical studies start. Emission
tomography is widely used in preclinical research, as it enables the in-vivo
visualization of functional information[80, 81]. Without imaging techniques,
the laboratory animal needs to be sacrificed to obtain information on the
internal effects of the treatment under study. This is very expensive, and
it makes true longitudinal studies difficult or impossible. Most preclinical
imaging is done in small rodents (rats or mice), but other animals can also
be studied, such as rabbits, pigs, monkeys, etc.
Special scanners are needed to image small rodents, as they are much
smaller than humans. Most importantly, a higher resolution is needed.
Therefore, micro-PET and micro-SPECT scanners have been developed,
which have a much higher resolution than clinical scanners[82, 83]. One
of the main applications of preclinical imaging is their use in drug develop-
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Figure 2.7: A coronal (left) and sagittal (right) slice of a micro-PET image of a
mouse, injected with 18F-FDG.
ment studies[84]. Micro-PET and micro-SPECT are used in those studies
to investigate the distribution of drugs in the body after uptake, or to in-
vestigate the effect of drugs on functional parameters. An example of a
micro-PET image of a mouse injected with 18F-FDG is shown in fig. 2.7.
2.3 Magnetic resonance imaging
2.3.1 Early history
Contrary to what is usually stated, nuclear magnetic resonance (NMR) was
not first demonstrated by Bloch and Purcell in 1946. Instead, it was Rabi
who was the first to show the effect of a radiofrequency (RF) wave with the
Larmor frequency on nuclear magnetic moments[85, 86]. His experiments
were done on molecular beams. He received the Nobel prize in physics in
1944 "for his discovery of a resonance method for recording the magnetic
properties of atomic nuclei". In 1946, Bloch and Purcell were the first to
demonstrate NMR in condensed matter. Bloch did his experiments in liquid
water[87, 88], while Purcell studied NMR in solid paraffin[89]. They received
the Nobel prize in physics in 1946. Since then, NMR has been widely used
to study the magnetic properties of molecules.
The step from NMR to magnetic resonance imaging (MRI) was made by
the inventions of Lauterbur and Mansfield in 1973[90, 91]. Up to then, it
had been accepted in physics that when images were obtained using elec-
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tromagnetic waves, the size of the smallest object that could physically be
discriminated (the resolution) was approximately the wavelength of the elec-
tromagnetic wave. In the case of MRI, this would mean that the highest
possible resolution of MRI would be in the range of a few meters, which
is the wavelength of the RF waves used in NMR. However, Lauterbur and
Mansfield showed that, by manipulating the local magnetic field using gra-
dient fields, a much higher resolution could be obtained. This enabled MRI,
which has since then been a very successful imaging technique. For their
work, Lauterbur and Mansfield received the 2003 Nobel prize in medicine
and physiology.
There has been some controversy about the Nobel prize of Lauterbur and
Mansfield, as a third researcher has claimed to have an equal or larger impact
on the invention of MRI. Raymond Damadian was the first to show that the
relaxation properties of tissue, which define the NMR signal, differ between
cancer and normal tissue[92]. He was also the first to acquire a human body
image, showing a transverse slice through the thorax in 1977[93]. However,
his method used focused-field NMR, which is entirely different from the
current method of MRI. It was also not the first human MRI image: the
group of Mansfield had acquired transsectional images of a finger the year
before[94].
2.3.2 Nuclear magnetic resonance: spin physics
Before the principles of MRI can be described, the physical description of the
behavior of charged particles in a static magnetic field needs to be discussed.
This is done in this section. First the concept of a spin angular momentum
is introduced. Then the behavior of a single particle in a magnetic field
is described, including energy quantization. Subsequently we discuss what
happens when not a single particle but a collection of particles is observed.
In the last parts of this section, the principles of excitation and relaxation,
which are used to acquire the NMR signal, are described.
2.3.2.1 Angular momentum
The concept of angular momentum is used in classical mechanics when de-
scribing a rotating object. Different angular momenta exist. Take for exam-
ple the motion of earth. The motion of earth around the sun is described
by an orbital angular momentum. However, earth also rotates around its
own axis. This momentum is called the spin angular momentum in classical
mechanics. As an electron rotates around its nucleus, it also has an orbital
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angular momentum. An electron is a charged particle, and therefore its mo-
tion describes a current loop and induces a magnetic moment. Electrons also
possess a spin angular momentum[95]. However, relating this spin angular
momentum to the classical phenomenon of an object rotating around its
own axis is not correct, as the spin angular momentum of an electron does
not have a classical analogue and is purely a quantum mechanic property.
Electrons are not the only elementary particles that have spin. Protons
and neutrons also possess this property. The spin number of a nucleus is
determined from the spins of its protons and neutrons. As a general rule,
nuclei with an even number of protons and neutrons have no spin, nuclei
with an odd number of protons and neutrons have an integer spin, and nuclei
with an even number of neutrons and an odd number of protons or vice versa
have half-integer spin. Only nuclei which possess spin can be used in NMR.
We limit our description to nuclei with 1/2 spin, such as a proton. The spin
numbers of some nuclei frequently used in NMR are listed in table 2.1.
Nucleus Spin number
1H 1/2
13C 1/2
19F 1/2
31P 1/2
Table 2.1: Spin numbers of isotopes frequently used in NMR.
2.3.2.2 Magnetic moment of a single particle
In this paragraph, we give the classical description of the behavior of the
magnetic moment of a single charged particle, e.g. a proton, in an external
magnetic field. The external magnetic field ~B is oriented along the Z-axis
and has magnitude B0. If ~J is the angular momentum of that particle, the
magnetic moment associated with that angular momentum is:
~µ = γ~J (2.11)
with γ the gyromagnetic ratio, which depends on the nucleus. The be-
havior in time of ~J is now governed by the equation:
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d~J
dt
= ~τ (2.12)
where ~τ is the torque on ~J, which is given by:
~τ = ~µ× ~B (2.13)
.
Combining these equations yields:
d~µ
dt
= γ~µ× ~B (2.14)
.
The solution to this differential equation in the time domain, assuming
that ~B is constant, is:
µx(t) =µx(0)cos(ω0t) + µy (0)sin(ω0t)
µy (t) =−µx(0)sin(ω0t) + µy (0)cos(ω0t)
µz(t) =µz(0)
(2.15)
which describes a vector rotating clockwise about the Z-axis with angular
frequency ω0 = γB0. If we now switch to a reference frame rotating around
the Z-axis at angular frequency ω0, the equations become:
µx(t) =µx(0)
µy (t) =µy (0)
µz(t) =µz(0)
(2.16)
which is a static vector.
2.3.2.3 The Zeeman effect
The potential energy of the single particle in an external magnetic field,
described in the previous paragraph, is:
30 Multimodal medical imaging
B 
E 
Edown 
Eup 
Figure 2.8: The Zeeman effect: in an external magnetic field B, the energy of a
charged particle is quantized.
E = −~µ · ~B = −γJB0cos(θ) (2.17)
where θ is the angle between the external magnetic field and the magnetic
moment ~µ. In classical mechanics, there is no limitation on the energy of
the particle, and hence any value of E is possible. Unfortunately, this is not
true, as quantum mechanics dictate that the energy of a charged particle in
an external magnetic field is quantized. This means that the particle can
only have discrete energy levels:
E = −mγ~B0,m = −j ,−j + 1, ..., j − 1, j (2.18)
where j is the spin quantum number and ~ is the reduced Planck constant.
This effect, in which the energy of a particle is quantized in an external
magnetic field, is called the Zeeman effect[96]. For protons, with j = 12 , it
means that there are two energy levels:
Eup =−12γ~B0
Edown =
1
2γ~B0
(2.19)
.
These two energy levels are referred to as spin-up and spin-down, with spin-
up meaning that the spin angular momentum is oriented in the direction of
the ~B field, which has the lowest energy. The Zeeman effect for protons is
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illustrated in fig. 2.8. A transition from spin-up to spin-down can now only
be made by absorbing a photon with the correct energy. This is called the
resonance condition:
Edown − Eup = γ~B0 (2.20)
.
As the energy of a photon is ~ω0, this means that:
ω0 = γB0 (2.21)
in which ω0 is called the Larmor frequency. For protons, the Larmor
frequency is approximately 42.6 Mhz in a magnetic field of 1T. An elec-
tromagnetic wave in this frequency range is called a radio-frequency (RF)
wave.
2.3.2.4 Net magnetization vector
In NMR, not single particles, but collections of many particles are studied.
For simplicity, we will from hereon refer to charged particles as spins. One
would expect that, for the description of spins, the integration of the quan-
tummechanical descriptions of all spins individually should be done. Fortu-
nately, it has been shown that, for a large collection of spins, the classical
description can be used[87]. This means that the total magnetization of
a volume of matter can be described with a net magnetization vector, as
illustrated in fig. 2.9:
~M = Σ~µi (2.22)
where µi are the magnetic moments of the spins in the volume. Each spin
is either in the spin-up or the spin-down state, as described above. Because
the spin-up state has the lowest energy, most spins will be in that state.
The magnetic moments µi will also have a component in the XY-plane.
However, in steady state these components are randomly distributed as the
spins are not rotating about the Z-axis in phase. The net component of ~M
in the XY-plane will therefore be 0. This means that ~M is oriented along the
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M 
Figure 2.9: When observing a large collection of spins, the classical description
can be used. This means that the total magnetization can be described using the
net magnetization vector ~M.
direction of the external magnetic field. In non-steady state conditions (see
below) ~M can have a component in the XY-plane. The net magnetization
vector satisfies:
d ~M
dt
= ~M × γ~B (2.23)
and hence also precesses about the axis of the external magnetic field. In
the rotating reference frame described above, ~M stands still.
2.3.2.5 RF excitation and flip angle
The state of equilibrium described in the previous paragraph can now be
disturbed by transmitting photons with the Larmor frequency. Indeed, when
such a photon is absorbed by a spin in the spin-up state, it will be brought to
the spin-down state. This is done by transmitting an RF field ( ~B1) with the
Larmor frequency in the XY-plane. Next to the effect of bringing more spins
in the spin-down state, the RF field will also force all individual spins to rotate
in phase. This is called phase coherence, and makes it possible that the net
magnetization vector has a transverse component. In the rotating reference
frame, a RF wave will lead to a rotation of the net magnetization vector
away from the Z-axis and towards the XY-plane. The angle of rotation,
called the flip angle α, depends on the amplitude B1 of the RF field and on
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Figure 2.10: The effect of a 90◦ (left) and 180◦ pulse on the net magnetization
vector ~M.
the duration of the pulse t:
α =
∫ t
0
γB1dτ = γB1t (2.24)
By modifying B1 or t, any flip angle can be obtained. The most important
RF pulses are the 90◦ and 180◦ pulse, which lead to a net magnetization
vector oriented in the XY-plane (perpendicular to the Z-axis) and in the
opposite direction of the static magnetic field respectively (fig. 2.10).
2.3.2.6 Relaxation
When the transmission of the RF field is stopped, the net magnetization
vector will gradually return to its equilibrium state. It will do so by emitting
an RF wave itself, also at the Larmor frequency. This wave is called the free
inductive decay (FID). NMR is based on the recording of this RF wave in
the XY-plane. The return to the equilibrium state is called relaxation and is
governed by two physical phenomena: spin-spin relaxation and spin-lattice
relaxation. Both phenomena are illustrated in fig. 2.11.
As described above, all spins are in phase while the RF field is being
transmitted. Spin-spin relaxation leads to dephasing of the spins, and hence
disappearance of the transverse component of the net magnetization vector.
It is caused by the small differences in local magnetic field that are expe-
rienced by the spins. These small differences are caused by the chemical
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Figure 2.11: After the RF pulse, the net magnetization vector returns to its
equilibrium. On the left, the situation just after the RF pulse is shown: all spins
are in phase and the transverse component of ~M is maximal. The middle figure
illustrates T2 relaxation: the spins are dephasing in the transverse plane, leading to
a smaller transverse component of ~M. The right figure illustrates T1 relaxation: as
more spins return to the spin-up state, ~M rotates away from the transverse plane
toward the Z-axis. This also leads to a smaller transverse component of ~M
environment of the spins, i.e. the different atoms and binds surrounding
the protons. This effect therefore depends on material composition. The
transverse component of the net magnetization during spin-spin relaxation,
in the rotating reference frame, can be described as:
~Mtr (t) = ~Mtre
−t
T2 (2.25)
where T2 is called the spin-spin or transverse relaxation time constant.
While spin-spin relaxation is purely a phenomenon of dephasing of the
spins, spin-lattice relaxation is an energy phenomenon and describes the ac-
tual return to the energy equilibrium. As more spins return to the spin-up
position, they will transfer their energy to the surrounding macro-molecules.
This will lead to restoration of the longitudinal component of the net magne-
tization vector. Suppose a RF pulse with a flip angle of 90◦ was used. During
relaxation, the longitudinal component of the net magnetization vector can
then be described as:
Ml(t) = M0(1− e
−t
T1 ) (2.26)
where T1 is the spin-lattice or longitudinal relaxation time constant. It
is also dependent on material composition. The acquired NMR signal is
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therefore dependent on the T1 and T2 of the material under study.
In non-homogeneous media, such as the human body, there is another
effect that causes dephasing of the spins. It is caused by magnetic field
inhomogeneities of the static magnetic field. These inhomogeneities can
be related to the field itself (e.g. because the magnet does not provide a
homogeneous field), or by materials present in the field. The inhomogeneities
caused by materials are due to the different magnetic susceptibilities of the
materials in the field. This effect is called the T ∗2 effect.
2.3.3 Imaging principles
The NMR signal described above is obtained from the complete volume in
the static field, and does not contain any position-dependent information.
We need to add spatial encoding to the signal if images, either 2D or 3D,
are to be acquired. By adding spatial encoding, we move from the field of
NMR to the field of MRI. The principles of MRI are described in this section.
The hardware that is necessary for MRI is described in the next section.
2.3.3.1 Volume selection
If the static field is the same everywhere in the imaging volume, a RF pulse
with the Larmor frequency will excite all spins in the imaging volume. We
can excite only a specific part of the imaging volume by changing the static
field. This can be done using a linear magnetic gradient[90]. Consider a
linear gradient Gz in the Z-direction. When switched on, the static magnetic
field will now depend on the Z-position:
~B(z) = (0, 0,B0 + Gzz) (2.27)
which means that the Larmor frequency of the spins in the imaging volume
also depends on the Z-position:
ω(z) = γ(B0 + Gzz) (2.28)
.
When a RF pulse with a finite bandwidth is now transmitted, only the
spins in a limited part of the imaging volume will be excited, namely a
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Figure 2.12: The principle of volume selection: by applying a gradient Gz in the Z-
direction, the Larmor frequency of the spins becomes dependent on the Z-position.
By applying a RF pulse with a finite bandwidth ∆ω, only the spins in a slice with
thickness ∆z = ∆ωγGz are excited.
slice perpendicular to the z-direction. The location of the center of the
slice depends on the gradient. The principle is depicted in fig. 2.12. The
thickness of the slice depends on the bandwidth of the RF pulse and the
steepness of the gradient:
∆z =
∆ω
γGz
(2.29)
with ∆ω the bandwidth of the RF pulse. In 2D imaging, a narrow-
bandwidth pulse is used to excite only a limited slice. In 3D-imaging, a
broad-bandwidth pulse is used to excite a larger volume. In 3D-imaging the
excited volume is called a slab rather than a slice.
2.3.3.2 k-space theorem
Volume selection only allows position encoding in a single direction, and is
therefore not sufficient for imaging. We now introduce an important concept
in MRI: the k-space. First, recall that, after excitation, the transverse com-
ponent of the magnetization vector describes a rotation around the Z-axis:
~Mtr (t) = Mtr (cos(ωt),−sin(ωt)) (2.30)
which can be written in complex notation as:
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~Mtr (t) = Mtre
−iωt (2.31)
.
Suppose that we now apply a 3D gradient ~G . The Larmor frequency ω
then depends on the position within the imaging volume, which is given by
the position vector ~r :
ω(~r , t) = ~G (t) ·~r (2.32)
.
When the transverse component of the magnetization is recorded while
the gradient is switched on, the signal from all the spins in the imaging
volume is recorded. This can be seen as an integration in the space domain
over the entire imaging volume:
s(t) =
∫∫∫
ρ(~r) e−iγ
R t
0
~G(τ)·~r dτd~r (2.33)
where ρ(~r) is the position-dependent spin density. T1 and T2 relaxation
effects can be included by multiplying the spin density with two relaxation
functions:
s(t) =
∫∫∫
ρ(~r) g(t,T1(~r)) h(t,T2(~r)) e
−iγ R t0 ~G(τ)·~r dτd~r (2.34)
.
It is well known that the Fourier transform of a 3D function is:
F (~k) =
∫∫∫
f (~r) e−2pii~k·~r d~r (2.35)
where ~k is the spatial frequency vector. Equations 2.35 and 2.34 are
equivalent if the relaxation functions g and h are not time dependent. This
implies that the distribution of T1 and T2 over the imaging volume does not
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Figure 2.13: Based on the k-space theorem, a MRI image can be reconstructed
from the measured signal by applying an inverse Fourier transform. (A) shows
the 2D k-space raw data, and (B) shows the image reconstructed by applying the
inverse 2D Fourier transform.
change over time. If there is no motion, which is assumed here for simplicity,
this assumption is valid. ~k is then defined as:
~k(t) =
γ
2pi
∫ t
0
~G (τ) dτ (2.36)
.
This shows that an image can be reconstructed from the recorded signal by
applying an inverse 3D Fourier transform[91]. The spatial frequency domain
is called k-space in MRI, a concept introduced independently by Ljunggren
and Twieg in 1983[97, 98]. The sampling in k-space is determined by the
time evolution of the magnetic gradient ~G . By manipulating the gradients,
any point in k-space can be sampled. An example of the reconstruction of
a MRI image from raw data using the inverse Fourier transform is shown in
fig. 2.13.
2.3.3.3 MRI sequences
The signal acquired during MRI thus depends on:
• The protons in the volume and their properties:
– proton density,
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– relaxation properties: T1 and T2 time constants,
– the local field inhomogeneities : T ∗2 effects.
• The fields generated by the MRI system:
– the static B0 field, which aligns the spins,
– the B1 RF field, used for excitation of the protons (flip angle),
– the gradient fields, used for position-encoding.
The static B0 field can not be manipulated. However, the RF field and
the gradient fields can be changed in time. By using different sequences of
RF and gradient fields, different interactions with the spins in the imaging
volume are induced and the result of these interactions is recorded. This is
the source of contrast in MRI. The sequences are called MRI pulse sequences
or in short MRI sequences. The programming of MRI sequences is very
complex, but also enables the acquisition of images with many different
kinds of contrast. This is a big advantage of MRI over e.g. CT where only
contrast based on the electron density of tissue can be obtained.
The free inductive decay (FID) signal that is transmitted by the spins
returning to the equilibrium quickly vanishes and therefore does not allow
the complicated gradient switching that is needed to encode the k-space
trajectory (an exception to this is ultrashort echo time imaging, see below).
Therefore, MRI sequences use methods for rephasing the spins after the
gradients have been applied. The coherent RF signal that is emitted after
rephasing is called an echo. There are different ways to generate an echo.
Below, the principles of spin echo and gradient echo sequences are explained,
which are the two main acquisition schemes used in MRI.
Spin echo sequence
In a spin echo (SE) sequence, the refocusing of the spins is obtained by
applying a 180◦ RF pulse after the 90◦ RF excitation pulse[99, 91]. The
effect of the 180◦ pulse can be explained in the rotating reference frame.
Consider one of the spins, after excitation with a 90◦ pulse. This spin is now
oriented along the X-axis. Suppose it is dephasing in the clockwise direction,
meaning that the rotational frequency of the spin is slightly higher than the
expected Larmor frequency. In the rotating reference frame, it will move
away from the X-axis. By applying a 180◦ pulse, the spin is rotated 180◦
about the Y-axis. If it continues to rotate in the clockwise direction, it is
now moving towards the X-axis rather than away from it. The time it takes
for the spin to align with the X-axis, and be in coherence, is exactly the time
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Figure 2.14: Schematic of a 2D spin-echo sequence (left), and the k-space tra-
jectory in the kx , ky plane (right). The data is acquired while scanning the blue
line in k-space.
between the 90◦ and the 180◦ pulses. This is half of the echo time TE . In
a spin echo, T2 as well as T ∗2 dephasing effects are compensated.
A schematic overview of a SE sequence is depicted in fig. 2.14, together
with the trajectory that is sampled in k-space. The 90◦ RF excitation pulse
is applied together with a slice selection gradient. After the RF excitation, a
phase-encoding gradient is applied along the Y-axis. The amplitude of this
gradient determines the ky coordinate of the line that will be sampled in
k-space. The 180◦ RF pulse is then applied, together with the same slice
selection gradient, to flip the spins and make them rotate back towards co-
herence. The signal is then acquired around TE , while a frequency-encoding
gradient along the X-axis is switched on. This frequency-encoding gradient
scans a line in k-space in the kx direction. Usually, a frequency-encoding
gradient with the same polarity is applied during the phase-encoding gradi-
ent in order to move the k-vector towards the beginning of the line that is to
be acquired (negative kx). The next line in k-space is acquired in the same
manner after the repetition time TR .
The contrast that is achieved by a SE sequence is now determined by TE
and TR . In MRI, three main contrast types can be discriminated: proton
density (PD) weighted, T1-weighted and T2-weighted. To obtain a T1-
weighted image, a short TR is used: as the next excitation pulse follows
before T1 relaxation has been completed, the number of spins excited by
the pulse will depend on the T1 (a longer T1 means less excited spins). If
a long TR is used, T1 relaxation is finished before the next excitation. To
obtain a T2-weighted image, a long TE should be used, allowing for a long
T2 dephasing time before the spins are refocused. To obtain a PD-weighted
image (which has neither T1 or T2 contrast), a long TR is combined with a
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Figure 2.15: Schematic of a 2D gradient-echo sequence (left), and the k-space
trajectory in the kx , ky plane (right). The data is acquired while scanning the blue
line in k-space. Note the opposite polarities of the gradients along the X-axis and
the RF pulse which can have a flip angle smaller than 90◦.
short TE .
Gradient echo sequence
While SE sequences are very flexible, as many kinds of contrast can be
obtained by varying the TE and TR , they can lead to very long acquisition
times. This is especially the case in T2-weighted images, as the acquisition
of the next line in k-space can only be acquired if T1 relaxation of all spins
is finished. Because a SE sequence always uses a 90◦ RF excitation pulse,
T1 relaxation can take a long time. This can be avoided by using a gradient
echo (GE) sequence. As implied by the name, a GE sequence uses gradients
with opposite signs to dephase and rephase the spins (fig. 2.15). No 180◦
pulse is used, allowing lower flip angles for RF excitation. A shorter TR can
therefore be achieved, leading to shorter total acquisition times.
There are some downsides to GE sequences. The main problem is that,
as the refocusing of spins is purely based on gradients and not on a 180◦
pulse, the local field inhomogeneities due to susceptibility effects are not
compensated by the echo. The signal is therefore governed by T ∗2 rather
than T2. This leads to T ∗2 -weighted images instead of T2-weighted images.
GE sequences are therefore mainly used for very fast imaging techniques in
2D or 3D.
2.3.4 MRI hardware
Three magnetic fields are used in MRI: the static B0 field, the gradient field
G and the RF field B1. The components that are used to generate and/or
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Figure 2.16: A cut-through of the hardware in a MRI scanner. The static magnet
is depicted in green, the gradient coils in red and the RF coils in orange.
acquire these fields are discussed in this section. They are also depicted in
fig. 2.16.
2.3.4.1 B0-field
In MRI, the B0 field strength can vary from 0.1T to 14.7T. Systems currently
in use for clinical practice usually have a field strength of 3T or lower, most
commonly 1.5T. In most systems the B0 field is generated by a supercon-
ducting magnet, using a superconductor current loop. Usually niobium-tin
or niobium-titanium superconductors are used, cooled with liquid helium.
Resistive magnets can also be used, but they require more power and op-
erate at lower field strengths (≈ 0.2T). One of the advantages of resistive
magnets is that they can be used in so-called open-magnet MRI systems,
which are better tolerated by claustrophobic patients. In research, higher
field strengths are used, which can only be generated by superconductor
magnets. For human whole-body imaging, the maximum field strength cur-
rently used is 7T[100]. For brain imaging, there are 9.4T magnets[101]. For
preclinical research, magnets of up to 14.7T are currently being made.
2.3.4.2 Gradient coils
For position encoding, 3 pairs of gradient coils are used. They enable the
generation of linear magnetic gradient fields in the X, Y and Z directions.
The principle of a gradient coil can be easily explained, and is illustrated in
fig. 2.17. A magnetic gradient is created by placing two coils perpendicular
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Figure 2.17: Principle of a gradient coil generating a linear gradient in the Z-
direction. By using two coils perpendicular to the Z-axis on both sides of the
imaging volume, in which opposing currents are induced (left), a linear gradient
magnetic field is created in which the field depends on the Z-position (right).
to the axis along which the gradient needs to be created, on both sides of
the imaging volume. By inducing currents with opposing directions in the
coils, both coils will induce opposite magnetic fields along the axis. As the
strength of the field created by a coil depends on the distance from the loop,
the sum of the fields from both coils is a linear gradient.
2.3.4.3 RF coils
RF coils are used for both transmission and reception of signals in MRI. In all
clinical MRI systems a large integrated RF body coil is present. It is mostly
used for excitation of the spins. As the signal reception quality is strongly
dependent on the distance between the spins and the coil, using the body
coil for signal acquisition is not optimal. It is much better to have a coil that
is as close to the body as possible. Therefore, different RF coils are used
in MRI. Specific coils exist for the brain, head and neck, chest, spine, knee,
etc. As these coils are much closer to the body, the obtained signal quality
is much better. Some of these coils also have the possibility to transmit RF
waves. Currently most coils used in clinical practice are multi-channel coils,
which speeds up the acquisition process.
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2.3.5 Applications
Because of the many possibilities of MRI, it is difficult to give a short overview
of the applications of MRI. In this section, some applications of MRI in the
fields relevant for this work are described. For a more extensive description
of MRI applications, the reader is referred to the literature on the subject.
2.3.5.1 Neurology
MRI is the preferred imaging modality in neurology, as it has soft tissue con-
trast that is far superior to CT. The applications of purely anatomical MRI
imaging in neurology are numerous[102]. MRI can be used to visualize large
structural abnormalities, such as space-occupying lesions. It is also applied in
epilepsy, when searching for hippocampal sclerosis as the cause of temporal
lobe epilepsy. While CT is still the modality of choice for acute cerebrovas-
cular imaging, MRI can also be used to visualize cerebral haemorrhages. In
fact, it is superior in imaging cerebral micro-haemorrhages, which are the
hallmark of hypertensive brain disease. Structural images of the brain are
also used in the diagnosis of multiple sclerosis (MS), where the visibility of
white matter lesions on MRI is necessary for a definitive diagnosis.
MRI allows more than just anatomical imaging. In diffusion tensor MRI
imaging, the preferred diffusion direction of water is imaged[103]. In neurol-
ogy, this can be used to assess white matter, as it consists of axons, which
can be seen as fibers. This allows the visualization of structural connec-
tions in the brain using fiber tractography. It was mainly used in research,
but clinical applications are now also available. Examples include MS and
Alzheimers disease.
A special technique, which allows visualization of the functional activity
of the brain, is functional MRI (fMRI)[104]. This is based on the blood
oxygenation level dependent (BOLD) effect in brain tissue, leading to a
different MRI signal in parts of the brain that are active, i.e. consuming
oxygen. It can be used to map brain activity, for example during specific
tasks. This allows investigation of the distribution of functions within the
brain. It can also be used in pharmacological studies, where the effect of a
neurotropic drug on brain activity is evaluated non-invasively.
2.3.5.2 Cardiology
MRI has many applications in cardiovascular imaging[105]. It can be used
to determine the morphology of the ventricles as well as their function, e.g.
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Figure 2.18: Example of a structural (A) MRI image of the brain as well as an
fMRI activation image overlayed on a structural image (B).
by visualizing ventricular wall motion. In coronary artery disease, MRI can
be used to assess the viability of heart tissue after an infarct using delayed
contrast-enhanced imaging (DCE-MRI). Perfusion imaging, comparable to
99mTc-sestamibi-SPECT can also be done. MRI can be used for the evalua-
tion of cardiomyopathy by visualizing fibrosis or iron overload. In congenital
heart disease, cardiac MRI is used to visualize heart structures that can not
be observed with echocardiography.
MRI can also be used to visualize vascular disease. Structural imaging
of the aorta and great vessels can be done, e.g. for the detection of aortic
dissection. A special MRI technique called MR angiography (MRA) enables
the visualization of peripheral vascular disease, like X-ray angiography, but
without the radiation dose.
2.3.5.3 Oncology
As MRI is the preferential imaging modality used in the brain, it is obvious
that it is also the preferential imaging modality for the diagnosis of brain
tumors[106]. MRI is also the best available technique for imaging multiple
myeloma, and is more sensitive than bone scintigraphy in detecting skeletal
metastases[107]. Whole-body MRI can also be used as a screening method,
or to determine the total tumor load of a patient. Diffusion-weighted MRI
is a specific technique that can be used to differentiate tumor tissue from
healthy tissue[108]. In pregnant women with cancer, regardless of the type
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of tumor, MRI is always preferred because of the absence of radiation dose.
MRI is also the best imaging technique to discriminate different kinds of liver
lesions[109].
2.3.5.4 Preclinical imaging
As emission tomography, MRI is also used in preclinical research. Imaging of
large animals such as pigs or monkeys can be done on clinical MRI systems.
Specialized MRI systems have been developed for small animals such as
mice or rats. The smaller bore of these systems also enable the design
of systems with much higher magnetic field strengths, up to 14.7T[110].
Specific RF coils have also been designed for imaging mice and rats[111].
The fact that no radiation dose is delivered to the animal is a big advantage in
preclinical imaging, as the doses delivered by micro-CT, which is the other
anatomic imaging modality available for small animals, can be relatively
high[112]. Although it has not been demonstrated yet, it is conceivable
that the radiation dose could influence the study outcome in longitudinal
studies[113]. Small animal MRI is, among others, used in preclinical cancer
research and neurological studies[114, 115].
2.4 PET-MRI and SPECT-MRI
2.4.1 Advantages of multimodality imaging
In the last decades a lot of research has lead to the development of com-
bined imaging modalities. Especially the combination of functional imaging
modalities, such as PET and SPECT, with anatomical imaging modalities,
such as CT and MRI, has been investigated. While the first strategies for
multimodality imaging involved acquiring images on both modalities sepa-
rately and then combining them using coregistration techniques[116, 117],
the focus is now on combining two modalities into a single system. This
theoretically allows perfect registration, assuming the patient does not move
between both acquisitions.
The combination of PET with CT into a sequential PET-CT scanner
has been very successful[118]. Today, almost all PET scanners are sold in
combination with a CT. PET-CT scans are mostly used in oncology, using
18F-FDG as a tracer. The high sensitivity of PET for detecting tumor le-
sions is combined with the high resolution of CT, allowing accurate anatomic
localization of the lesions detected on PET. The use of PET-CT in the stag-
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ing and follow-up of different types of cancer has been shown to improve
clinical outcome in a statistically significant way[119]. Although less promi-
nent, SPECT-CT systems are becoming more popular[120]. SPECT-CT is
interesting for oncology as well as cardiology[121, 122].
As MRI has superior imaging capabilities to CT for many applications,
due to the superior soft tissue contrast of MRI, the combination of PET or
SPECT with MRI is also very interesting[123, 124, 125]. Another advantage
of this combination is that MRI does not deliver any radiation dose to the
patient, contrary to CT which delivers a significant dose. MRI also allows
other applications than simple anatomic imaging, such as MR angiography
(MRA), functional MRI (fMRI) or even the use of MRI tracers. Furthermore,
the total imaging time for a combined PET and MRI exam could be reduced
with truly simultaneous imaging. While the CT in PET-CT takes much less
time than the PET, in PET-MRI this would be the other way around as
MRI exams generally take longer than PET exams. However, it has been
argued by some authors that truly simultaneous imaging is only interesting
for research purposes, mainly in neurology[126]. For most other applications,
sequential imaging (comparable to a PET-CT) is sufficient. In addition to
oncology, the possible applications of PET-MRI and SPECT-MRI include
cardiology and neurology[127, 128, 129]. As described above, PET, SPECT
and MRI are already preferred imaging modalities in those fields.
2.4.2 Design issues
Three general designs are possible for combining PET or SPECT and MRI.
The first possibility is to use two separate scanners in different rooms. Al-
though this is not a real multimodal scanner, multimodal images can be
obtained if registration between both acquisitions is ensured. This can be
done using markers, or in the case of small animal imaging, by using the same
animal bed on both scanners. A second design is comparable to a PET-CT,
where the PET and MRI acquisitions are done on the same gantry, but not
simultaneously. The scanners can be mounted at a certain distance from
each other to limit interference. The third possibility is a fully integrated
scanner, which enables truly simultaneous imaging. The PET scanner then
needs to be fit into the MRI system. This is also the most difficult to design,
as it will lead to the most interference between both modalities.
There are many technical difficulties in designing a PET-MRI or SPECT-
MRI system, especially if the third design is aimed for[130, 131]. These
difficulties can be divided into problems with the PET or SPECT system
caused by the presence of the MRI system, and vice versa. The difficul-
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ties caused by the MRI system are mainly due to the presence of the high
magnetic field of the MRI scanner. First and foremost, the PMTs that are
used in most PET and SPECT scanners are extremely sensitive to magnetic
fields. They can therefore not be used close to the MRI scanner, let alone
inside the scanner. Another problem can be caused by the fast switching
gradient and RF magnetic fields. If the electronic components in the PET or
SPECT acquisition modules are not properly shielded, these fields may cause
interference with their function. As for the effects of the PET or SPECT
system on the MRI images, the main concern is that artefacts may be caused
by the presence of the metallic components of the PET or SPECT system
inside the MRI scanner. These components can cause inhomogeneities in
the magnetic field, which makes MRI imaging very difficult, especially if the
PET components are close to the object under study.
2.4.3 Prototypes and clinical systems
In this section a short overview of PET-MRI hardware development is given,
with brief descriptions of the systems that have been designed and their
innovations and challenges. The interested reader is referred to the review
paper by Pichler et al. for more detail[131]. At the end of this section the
(limited) current developments in SPECT-MRI are also discussed.
2.4.3.1 First images
The first simultaneous PET-MRI images were published by Shao et al in
1997, working with Paul Marsden and Simon Cherry[132]. They were ac-
quired with a prototype PET insert for a clinical MRI system, based on the
previous work of Cherry et al[133]. In this system, the interference between
the PET insert and the MRI system was limited by putting all electronic
components of the PET insert at a distance of 3 m from the center of the
MRI magnet, which was a 0.2T open magnet system (fig. 2.19). At this
distance, the fringe field of the magnet is limited to 10 mT. The only com-
ponents of the PET system inside the magnet were the scintillator crystals
(LSO). The scintillation light of the crystals was coupled to 4 m long optical
fibers, which conduct the light out of the magnet and toward the electronic
readout system. Readout was done with multi-channel PMTs, of which it
was shown before that a 10 mT field did not interfere with their function.
A line source phantom, consisting of 7 cylinders filled with a mixture of wa-
ter, 18F (for the PET signal) and NiCl2 (for the MRI signal), was imaged.
All cylinders could be discriminated on both the PET and the MRI images.
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Figure 2.19: Overview of the system used to acquire the first simultaneous PET
and MRI images. The LSO crystals are coupled to optical fibers, which guide the
scintillation light towards the PMTs, which reside outside the strong magnetic field.
Reproduced with permission from [132].
Images and magnetic resonance spectroscopy (MRS) spectra of isolated per-
fused rat hearts were also acquired[134]. The system is still being improved
at the moment[135, 136]. Another system which uses light fibers and PMTs
outside of the magnet was designed by Raylman et al[137]. Simultaneous
PET and MRI images of a rat and mouse brain were acquired with that
system, as well as simultaneous PET images and MRS spectra[138].
2.4.3.2 Modified MRI systems
Two designs in which a special MRI system was developed to allow operation
of the PET system have also been proposed. The first uses a 1T MRI split-
magnet MRI system, in which there is a 80 mm gap in the axial direction
between the two parts of the magnet[139]. In this gap, LSO scintillator
crystals were coupled to 1.2 m long optical fibers, which then guide the
scintillation light out of the magnet in the radial direction. Readout was
done with a slightly modified microPET Focus system[140]. The advantage
of this set-up is that the optical fibers are much shorter than in the systems
described above, and that they do not need to be bended from the radial to
the axial direction, which preserves a lot of space.
A second system uses a field-cycled MRI magnet, which means that the
PET and MRI acquisitions are not performed simultaneously[141, 142]. In-
stead, the MRI is switched of briefly while the PET data is acquired, and
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then switched on again. The switching between PET and MRI occurs at a
frequency of ≈ 1 Hz. The first images acquired with this system have been
published in 2011[143].
2.4.3.3 APD-based systems
While it allows the use of large parts of older PET detector systems, the
use of optical fiber coupling combined with PMTs outside of the magnet
also imposes many limitations. The reduction of light output, caused by
the attenuation of the optical fibers, leads to worsening of the energy and
timing resolution of the PET detector. The optical fibers and the coupling
of the optical fibers to the scintillation crystals also takes up a lot of space
inside the MRI scanner. Therefore, the possibility of using other readout
components, that were not so sensitive to magnetic fields, was investigated.
Two components could be used: avalanche photodiodes (APDs) and silicon
photomultipliers (SiPMs)[144, 145, 146]. SiPMs are very new and still being
developed[147, 148, 149]. The first systems were therefore designed using
APDs.
The first APD-based PET insert was designed by Catana et al[150]. In
order to limit interference of the PET system with the MRI, the scintillation
crystals were still coupled to optical fibers. However, these optical fibers
were much shorter than in the other systems (10 cm), and were only used
to allow moving all metallic PET detector components outside of the MRI
field of view. The system is depicted in fig. 2.20. The PET insert was
designed to be used inside a 7T preclinical MRI system, in combination with
a 35 mm mouse coil. Simultaneous PET-MRI images of a mouse have been
obtained and no significant interference between both imaging modalities
was observed.
The first design in which a larger part of the PET system was located
inside the MRI magnet was built by the group of Bernd Pichler[151]. In
that setup, the APDs are coupled directly to the scintillation crystals. As no
optical fibers are used, the performance of the PET imaging system is not
reduced. The amplified APD signals are then conducted toward the digital
PET electronics, located outside the magnet. The insert was designed to fit
inside a 7T small-animal MRI scanner. Simultaneous PET and MRI images
of a mouse have been acquired, and the presence of the APDs and the
amplification does not influence MRI image quality.
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Figure 2.20: The first APD-based MRI-compatible PET insert was designed by
Catana et al. It uses short optical fibers to guide the scintillation light out of
the center of the magnet. This is done to limit influence of the electronic PET
components on MRI field homogeneity. Reproduced with permission of the Society
of Nuclear Medicine from [150].
2.4.3.4 Clinical systems
All systems described above can only be used for imaging mice or rats.
Although this is very interesting for preclinical research, the end goal of PET-
MRI integration is to obtain simultaneous PET and MRI images of humans.
The first simultaneous brain PET and MRI images of human volunteers
were acquired with the Siemens BrainPET insert in 2007, a APD-based
PET detector ring that fits inside a Siemens clinical 3T MRI system[152,
153, 154]. A schematic overview of the system and images acquired with
the system are shown in fig. 2.21 and fig. 2.22. It is also strictly a research
system: no new BrainPET inserts will be produced.
The first clinical combined whole-body PET-MRI system was presented by
Philips in 2009[155]. The Gemini PET-MRI is a sequential PET-MRI system,
comparable to a PET-CT system, with the CT replaced by a MRI system.
The PET system is located at approximately 3m from the MRI system. A
standard Gemini TF PET system is used with conventional PMTs, but each
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Figure 2.21: Schematic of the Siemens BrainPET insert, used to acquired the first
simultaneous human PET-MRI images. Reproduced with permission from [154].
PMT is shielded additionally. Although this system does not provide the
possibility to acquire truly simultaneous PET and MRI images, it is still an
interesting system for research as well as clinical practice. The first clinical
experience with PET-MRI was obtained with this system[156]. In 2011,
Siemens presented the first fully-integrated whole-body PET-MRI system,
the molecular MR (mMR). The mMR is an APD-based system, based in
Figure 2.22: MRI (left), 18F-FDG PET (right) and fused PET-MRI image (cen-
ter) of a patient, acquired with the Siemens BrainPET insert. Reproduced with
permission from [154].
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part on the BrainPET insert. A whole-body PET ring is inserted into a
wide-bore MRI system. Although not much data is currently available from
this system, it will undoubtfully lead to very interesting research in the next
few years.
Entirely new systems are also being developed. One example is the system
that is being designed in the HYPERimage/SUBLIMA consortia, European
collaborations led by Philips Research[157, 158, 159]. The aim of the con-
sortium is to develop the first integrated whole-body PET-MRI that uses
SiPMs as light detector. Because entirely new components are used, and
the PET system is redesigned from scratch, the completion of such a system
is still several years away.
2.4.3.5 SPECT-MRI
The field of SPECT-MRI is much less advanced than PET-MRI, and only
prototype systems are being developed at the moment. This is in part
because the development of SPECT-MRI is even more difficult. There are
several reasons for this. Most importantly, a collimator needs to be added
to perform SPECT imaging, which will require more space inside the MRI
bore. The collimator also needs to be MRI-compatible.
The first combined SPECT-MRI images were acquired by Breton et. al
in 2007[160, 161]. They were acquired with a sequential system, in which a
small animal SPECT and a low-field (0.1T) MRI were moved close to each
other and the animals were moved from one modality to the other. SPECT
and MRI images of mice were acquired and showed no artefacts. However,
the use of a low-field MRI limits the MRI imaging capabilities, especially
for small animals. Therefore, truly MRI-compatible SPECT systems are
being designed. Two prototypes have been built. Tan et al. tested the
influence of a 3T MRI system on their SPECT insert using a 57Co point
source[162, 163]. Gamma Medica-Ideas is also designing a MRI-compatible
CZT SPECT system, together with the group of Tsui at Johns Hopkins and
the group of Nalcioglu at UC Irvine[164, 165]. The first truly simultaneous
SPECT-MRI images of a water phantom filled with 99mTc were acquired
with that system in 2010[166].
2.5 Attenuation correction
As attenuation correction is the subject of this work, it is described in more
detail here. First, the effect of attenuation on the reconstructed PET and
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SPECT images is discussed, together with the clinical evidence on the sub-
ject. The methods for including attenuation correction into the reconstruc-
tion algorithm are explained in the second part of this section. Then the
different methods used for deriving the attenuation map are described. In
the last section, the challenges and current state-of-the-art of MRI-based
attenuation correction is discussed.
2.5.1 Effect of attenuation
The necessity of attenuation correction in PET or SPECT depends on the
effect of attenuation on the reconstructed PET or SPECT images. For
SPECT, there has been a long debate on whether or not attenuation correc-
tion was necessary or clinically important. It has been shown that attenua-
tion correction is necessary to obtain absolute quantification[167], but does
this also mean that it is beneficial to use attenuation correction for clinical
interpretation? There have been studies which show no improvement with
attenuation correction, in cardiac as well as oncologic imaging[168, 169].
However, it has also been shown that not performing attenuation correction
on cardiac perfusion SPECT images can lead to significant artefacts, such
as the creation of artificial perfusion defects in the posterior wall of the left
ventricle due to liver attenuation[170]. From the current data, the clinical
advantage of performing attenuation correction in cardiac perfusion SPECT
is clear[171, 172]. The clinical effect of attenuation correction in oncologic
imaging has not been studied as extensively, but a positive effect on tumor
detection has also been shown[173, 174, 175].
The effect of attenuation in PET imaging is larger, as both annihilation
photons need to reach the detectors to detect an emission. The effect of
attenuation correction on PET quantification was studied already very early
in the development of PET by Huang et al[176]. The effect of misregistra-
tion between the attenuation map and the emission data, of a bias in the
attenuation coefficient, of nonuniform attenuation, etc. was investigated.
The authors concluded that performing correct attenuation correction was
necessary for quantification in PET. There has been a less extensive discus-
sion on the clinical need for attenuation corrected PET images, compared
to SPECT. However, a number of studies have shown the improvement of
clinical accuracy when attenuation correction is used[177, 178, 179, 180].
As the magnitude of attenuation depends on the distance photons have to
travel through matter, there is a difference in effect between human and small
animal imaging. While the effect of attenuation in a rat or a mouse is much
smaller, accurate quantification can be much more important in preclinical
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imaging. This is, for example, the case in studies with inocculated tumors,
which are often performed in small animals. As the location of the tumor is
known, the researcher is not interested in lesion detection - which is generally
more important in clinical imaging - but only in the uptake of the lesion. It
was shown by Hwang et al. that not performing attenuation correction on rat
micro-SPECT images of 99mTc labeled tracers leads to quantitative errors of
up to 25 %[181]. When low-energy isotopes, such as 125I are used, the error
can amount to 50 %. Chow et al. have investigated the effect of attenuation
correction in micro-PET imaging of rats. An underestimation of 40 % was
seen in the reconstructed non-corrected image[182]. These results show that
attenuation correction is needed for quantitative preclinical imaging.
2.5.2 Implementation
In analytical image reconstruction, the projection data needs to be corrected
before the start of the reconstruction to account for attenuation. In itera-
tive image reconstruction, correction for photon attenuation is implemented
in the imaging model. For this, the distribution of attenuation coefficients
across the imaging volume is needed in both PET and SPECT. This distri-
bution, which can be considered an image itself, is called the attenuation
map. As each patient has a specific body composition, a patient-specific
attenuation map needs to be derived if accurate attenuation correction is
to be performed. Below the implementation of attenuation correction into
an iterative reconstruction algorithm is described. As the implementation is
different for PET and SPECT, both are discussed separately.
2.5.2.1 PET attenuation correction
In PET, as a coincidence can only be detected when both photons are not
attenuated, the probability of attenuation depends on the distribution of
attenuation coefficients along the entire LOR connecting both detection
points. The probability that both photons reach the detector, called the
transmitted fraction, is:
TF = e
R
µ(r)dr (2.37)
where the line integral is calculated along the straight path connecting
both detection points. Attenuation correction can then be implemented into
the iterative reconstruction algorithm by multiplying the forward projection
56 Multimodal medical imaging
by TF for each LOR. This represents the implementation of attenuation into
the image acquisition model.
2.5.2.2 SPECT attenuation correction
In SPECT, attenuation correction can not be implemented as straightforward
as in PET. When a photon is detected in SPECT, it is unclear from what
point along the LOR it was emitted. Hence, it is also not certain what the
total attenuation was along the path from the emission to the detector. The
same method as in PET can therefore not be used. Two other methods
have been proposed for SPECT attenuation correction. The first method,
proposed by Chang in 1979, is performed in image space on the current
estimate[183]. Although it was first developed for analytical reconstruction,
it can also be used in iterative image reconstruction. For each voxel, a
correction factor is calculated:
C (x , y) =
1
M
ΣMi=1TF (x , y , θi ) (2.38)
where the sum is over a number of projection angles M, θi is the projec-
tion angle, (x , y) is the coordinate in the imaging matrix and TF (x , y , θi )
is the transmitted fraction, calculated over the LOR from pixel (x , y) at
projection angle θi towards the detector. C (x , y) represents the average
attenuation coefficient along all LORs coming from the pixel (x , y). In the
estimate, each voxel is divided by C (x , y) before forward projecting. This is
an approximation, as the TFs can not be separated from the activity when
summing over the angles.
The second method proposed for SPECT is more accurate. Instead of
performing the correction in image space as in Chang’s method, it is imple-
mented in the forward projection. In that method, the actual total attenu-
ation for each voxel is calculated along the line from the voxel towards the
detector at a certain angle. This is done by multiplying the activity of each
voxel by the total attenuation between the voxel and the detector at the
current projection angle. This yields the same equation as before in PET:
TF = e
R
µ(r)dr (2.39)
but in this case, the line integral is not calculated between both detection
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points, but from the voxel towards the detector. Hence, it yields a different
TF for each voxel, whereas in PET the TF is the same for all voxels along
a LOR. This method is more accurate, but computationally more expensive.
2.5.3 Methods for deriving the attenuation map
As discussed above, the attenuation map is needed to perform attenuation
correction. A number of methods have been proposed to derive the attenu-
ation map. A short overview of the most frequently used methods is given
in this section. As this work concerns MRI-based attenuation correction, a
separate section is dedicated to that subject.
2.5.3.1 Calculated attenuation map
The simplest way to obtain the attenuation map is to define the contour
of the body without a specific measurement and then assign attenuation
coefficients inside this contour based on general knowledge of anatomy. This
method is generally referred to as "calculation" of the attenuation map. It
can be done by manually defining an ellipse as the contour of the head or
by automatically detecting the contour based on the emission sinogram[184,
185]. An advantage of these methods is that no extra time is needed for
measurement of the attenuation map, and no extra dose is given to the
patient.
2.5.3.2 Transmission measurements
On standalone PET or SPECT scanners the attenuation map is measured by
a transmission scan. In PET, transmission measurements can be performed
with either a coincidence or a singles source. In the first case one or more
static rings or rotating rods containing a long-lived positron emitter such as
68Ge are used[186, 187, 188, 189]. The annihilation photons are detected in
two detectors: near to and far from the transmission source. A comparison
is made between a blank scan (without the patient) and a scan with the
patient in the bore to reconstruct the attenuation map. Acquisition after
the patient was injected with the PET tracer is possible, but interference
between the transmission and emission data will be present[190].
To achieve reasonable statistics for the transmission measurement a high
activity level in the transmission source is needed. This rapidly leads to
count rate problems in the near detector, definitely when using older (slower)
detectors. Singles transmission data is therefore mostly used in PET[191,
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192, 193]. In this configuration a rotating single photon source is used and it
is shielded on the back to reduce counts on the near detector. The photons
are detected in the opposite detector only and the attenuation map can then
be derived provided the location of the source is known at all times. For
PET singles transmission scanning, a singles source with high photon energy
is used, usually 137Cs (662 keV).
For SPECT coincidence-mode transmission imaging is obviously not pos-
sible. Therefore, only singles-mode transmission imaging is possible. The
setup is also different, as a SPECT scanner does not consist of a full ring
of detectors but rather a number of rotating heads. A rotating single pho-
ton source is therefore not a good design. Instead, different setups can be
used[194]. Some of them can be used with a parallel-hole collimator (e.g.
sheet source, scanning line source), others require a specific collimator (e.g.
a fixed line source with converging collimation).
Transmission scans have some benefits, especially for PET, as attenuation
values at 511 keV (in coincidence mode) or closer to 511 keV than with CT
(in singles mode) are acquired. However, the statistical quality of the images
remains low: noise levels of around 20 % are common. The resolution of
the attenuation map is also quite low, making it difficult to detect small
structures. Another disadvantage of transmission scans is that they require
relatively long times to obtain low quality images. As the transmission scan
can not be performed simultaneously with the acquisition of emission data,
this leads to a significant increase in total acquisition time.
2.5.3.3 CT-based attenuation correction
Since the advent of PET-CT, and more recently SPECT-CT, CT images
are used not only as an anatomic reference frame for the emission data but
also to derive the attenuation map[118]. CT has some advantages over PET
transmission data: the images contain less noise, have a higher resolution and
can be acquired in a very short time span, at the expense of a much higher
radiation dose. Some problems can also be encountered when using CT-
based attenuation correction. The smaller field of view of the CT can lead to
truncation of the attenuation map as the arms are not always inside the field
of view. Due to the short acquisition time only part of the respiratory cycle
may be acquired with CT, while the acquisition time for PET and SPECT is
still too long for breathhold scans. The mismatch between attenuation map
and emission data leads to motion artefacts in the reconstructed emission
data[195]. CT uses X-rays with average energy around 60 keV. CT µ-values
can therefore not be used directly as PET or SPECT attenuation coefficients.
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Although segmentation of the CT into different tissue types followed by
assigning the correct attenuation coefficients for the emission photon energy
to this tissue types can easily be done, bilinear scaling is a more accurate
method. It is now in general used in CT-based attenuation correction[196,
197]. Bilinear scaling works well with biological tissue[198], but problems
can arise when contrast agents are used[199, 200] or metallic implants are
present[201, 202].
2.5.4 MRI-based attenuation correction
2.5.4.1 Challenges
In a combined PET-MRI or SPECT-MRI scanner, no CT or transmission
source is available. The attenuation map should therefore be derived using
a different method. One option is to derive the attenuation map from MRI
data. Contrary to CT, where the acquired signal is related to the electron
density of the tissue, the MRI signal is determined by the proton density
and relaxation properties of tissue, as described above. As there is no direct
correlation between these properties and tissue electron density, a direct con-
version from a MRI image to the attenuation map is not possible. Therefore,
a different approach is needed.
An extra difficulty in MRI-based attenuation correction is that, in MRI
images acquired with conventional MRI sequences, there is no signal in lung
and cortical bone. This is caused by the low proton density and very short
T2 of these tissues, which makes the MRI signal of these tissues disappear
very quickly after RF excitation. There is therefore no contrast between
air (which also has no signal), lung and cortical bone. This may lead to
problems, as these three tissue types can then not be discriminated based on
the MRI data. As their attenuation coefficients are very different - especially
the attenuation coefficient of cortical bone, which is much higher - this may
lead to an inadequate attenuation map. This will in turn lead to errors in the
reconstructed PET or SPECT images. As the quantitative effect of these
errors has not been investigated, we have studied them in this work. These
investigations are described in chapter 3.
2.5.4.2 Current methods
In the last few years a number of methods for MRI-based attenuation cor-
rection have been proposed. As most research has been done on PET-
MRI rather than SPECT-MRI, none of these methods have been applied to
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SPECT-MRI data sets. However, as the main difficulty in MRI-based attenu-
ation correction is the derivation of the attenuation map, we can assume that
these methods would also be applicable to SPECT-MRI. The methods can be
divided into two main classes: template-based and segmentation-based[203].
In template-based methods, the MRI of the patient is coregistered to a tem-
plate MRI using nonrigid coregistration[204]. The same transformation is
then applied to a template of the attenuation map. This yields an attenu-
ation map which theoretically predicts the attenuation map of the patient.
Template-based methods have only been tested on brain data.
In segmentation-based methods the attenuation map is determined di-
rectly from the MRI image intensities. This is usually done in two steps.
First, the voxels in the MRI image are classified into different tissue classes
that are relevant for attenuation. In the second step predefined attenua-
tion coefficients are assigned to these tissues. The first segmentation-based
methods were only tested on brain data[205, 206]. The method proposed
by Zaidi et al. uses a fuzzy-clustering-based segmentation on T1-weighted
MRI images. It was tested on 10 patient data sets for which MRI, PET and
singles-mode transmission data was available. In the reconstructed PET
images, an average relative difference of 7 % or less was found in VOIs in
different brain structures. While this is a very good result, it is important to
note that the average was taken over all ten patients. It is therefore unclear
what the relative differences in individual patients were.
More recently, two segmentation-based methods have been proposed
which are designed to work on whole-body data. The first method, pro-
posed by Martinez-Moller et al., is based on a two-point Dixon method for
MRI imaging[207]. Dixon methods use gradient echo acquisitions at different
echo times to discriminate water and adipose tissue. The images acquired
with a Dixon acquisition therefore allow easy segmentation into voxels con-
taining soft tissue and adipose tissue. The lungs were defined using region
growing. Cortical bone was not identified. Because of low signal intensity,
some voxels containing cortical bone were classified as air. This was solved
by applying a morphological closing operation on air voxels inside the body.
The method was tested on two patient data sets, and no significant visual
differences between images reconstructed with CT-based and MRI-based at-
tenuation correction were observed.
A second segmentation-based method for whole-body MRI-based atten-
uation correction was designed for use on the Philips sequential PET-MRI
system[208]. It only discriminates lung and soft tissue, and ignores bone.
The method is based on connected-threshold region growing for segmen-
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tation of the body contour and on a more specialized approach for lung
segmentation. The algorithm was tested on 15 patient data sets, and rela-
tive differences of 5 - 10 % were seen in most patients.
A different method has also been proposed, which uses a combination of
pattern recognition and atlas registration to predict the attenuation map
from the MR image and a set of aligned MR-CT data sets[209]. In a first
step, atlas MR data sets are coregistered to the MR image of the patient.
The transformations are also applied to the corresponding CT atlas data sets.
A pseudo-CT data set is then generated for each voxel as a weighted contri-
bution of voxel values in the co-registered CT atlas images. The pseudo-CT
is then rescaled to 511 keV attenuation coefficients to obtain the PET atten-
uation map. The method was tested on 17 brain data sets, and an average
error of 3.2 % was found in specific regions of interest.
2.5.4.3 Limitations
A common property of all these methods is that they, in some form, take
standard anatomical knowledge into account. This implies that they assume
that the patient under study has a standard anatomy. In the registration-
based or atlas-based method this is explicit, as the attenuation map is derived
by transforming one or more standard attenuation maps. In the segmentation
based methods the assumption lies in the region-based segmentation of the
lungs. This imposes a limitation on the applicability of these methods, as
they may fail when the patient has non-standard anatomic features. This
could be the case e.g. when imaging head trauma patients. A method that
can derive the attenuation map solely from the MRI data would not have
this limitation. For that, a method must be derived which creates contrast
between the relevant tissues based on the MRI data alone. In this work, the
focus is on deriving such a method.
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Chapter 3
The effect of segmented
attenuation maps on PET
quantification
3.1 Introduction
In this chapter, the effect of errors in the attenuation map on the recon-
structed emission tomography images is investigated using Monte Carlo
simulations. First the reasons for performing this study are explained. In
the next sections the simulation setup and the reconstruction methods are
described. Afterwards, the derivation of attenuation maps with different
types of errors is discussed. This is followed by a description of the obtained
results and a discussion on their interpretation. In the last section, a summa-
rizing conclusion is given, which is used as a guideline for the development
of MRI-based attenuation correction methods in the next chapter.
3.2 Research goal
As discussed in the last section of the previous chapter, there are some diffi-
culties in performing MRI-based attenuation correction for emission tomog-
raphy. Most importantly there is no direct correlation between MRI signal
intensity and attenuation. In MRI images acquired with conventional MRI
sequences, there is also no contrast between air, lung, and cortical bone.
These problems are solved in most currently available MRI-based attenua-
tion correction methods by incorporating some form of prior knowledge of
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the anatomy of the patient (or animal). This may lead to problems if there
are anatomic abnormalities.
Our goal is to develop an attenuation correction method which does not
rely on assumptions about patient anatomy, and derives the attenuation
map directly from the MRI data using segmentation. Before developing this
method, one needs to know how accurate it needs to be. As the deriva-
tion of the attenuation map from MRI is inherently difficult, there can be
different types of errors in the derived attenuation map. If a specific error
has a significant effect on the reconstructed image, it needs to be avoided.
However, if this is not the case, improving the method to avoid that kind of
error is not interesting.
Different errors can arise with segmented MRI-based attenuation correc-
tion. Using a segmented attenuation map in itself yields an error as it uses
a discrete representation of the attenuation map, whereas a realistic rep-
resentation of the body should contain a continuous range of attenuation
coefficients. In a segmented attenuation map, only a limited number of
tissue classes are discriminated. Ignoring certain tissue types will also have
an effect on the accuracy of the attenuation map. Furthermore, errors can
be caused by a bias on the attenuation coefficient assigned to segmented
tissues. For example, this can be the case when there is a large variability
in actual attenuation coefficient of a certain tissue type between different
patients. Additionally, there can be tissue misclassification. This can espe-
cially occur in bone and lung, as these tissues are difficult to discriminate on
MRI images.
Some research has been done on the effect of using a segmented at-
tenuation map on reconstructed image quality. This was mostly done
in the context of segmented CT-based or transmission-based attenuation
correction[196, 210]. Therefore these studies did not focus on the specific
problems of MRI-based attenuation correction. Recently the search for MRI-
based attenuation correction has led to investigations into the necessity of
taking bone into account. It has been claimed that using a segmented atten-
uation map which ignores bone does not lead to clinically significant errors
in the reconstructed image[207]. However, in that study a clinically signifi-
cant error was defined as an error that led to a lesion not being seen by an
experienced radiologist. Ignoring bone in the attenuation map did lead to
average quantitative errors of 8 % in osseous lesions.
These results do not yield a complete answer on how accurate our MRI-
based attenuation correction method needs to be. Therefore, we will thor-
oughly investigate the effect of attenuation map errors on the reconstructed
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image. The results obtained in this investigation will then be used to de-
fine the requirements for the method that is developed in the next chapter.
Specifically, the following questions need to be answered:
• Is it possible to achieve accurate results with a segmented, i.e. non-
continuous, attenuation map?
• Which tissue classes need to be discriminated?
• Do we need to take into account inter-patient variability of tissue
attenuation coefficients?
• Can tissue misclassification be tolerated? And if so, which fraction of
voxels can be misclassified?
We will seek an answer to these questions using Monte Carlo simulations.
A simulation study is ideally suited for this kind of investigation, as it allows
to separate the effect of attenuation from other image degrading effects,
such as motion or scanner count rate performance. As quantitative imaging
is the most demanding application of emission tomography, our study will
be focused on the effect of attenuation map errors on quantification. It
could also be interesting to investigate the effect of attenuation map errors
on lesion detection, but a study using clinical data and experienced clinical
observers would be better suited for this. Also, it can be expected that
an image that gives an accurate quantitative representation will also allow
correct lesion detection.
As the magnitude of the effect of attenuation depends on object size, the
effects of attenuation map errors will be different in human and small animal
studies. In human studies, brain imaging is also different from whole-body
imaging. Therefore we have performed three simulation studies: a rat study,
a human brain study and a human whole-body study. The investigation was
limited to PET alone for two reasons. First of all, the effect of attenuation in
PET is larger in most cases. This is due to the fact that two photons need
to be detected in PET, and hence the total distance over which photons
have to travel through tissue is larger for each detection than in SPECT.
Although the linear attenuation coefficients of human tissues are larger at
the energies of the gamma photons emitted by SPECT isotopes than at
511 keV, the effect of the distance is much larger in PET. Therefore, if an
attenuation correction method is accurate enough for PET quantification, it
should also be accurate enough for SPECT quantification with most SPECT
isotopes. This does not apply for SPECT isotopes which emit very low energy
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gamma photons, such as 125I (35 keV), where the attenuation coefficient is
so much higher that the effect of distance does not dominate. Secondly, PET
simulations can be run faster than SPECT simulations. This is mainly due
to the simpler nature of PET physics, especially the absence of a collimator.
In SPECT simulations, tracking of photons through the collimator requires
significant computation time.
3.3 Simulations
All simulations were done using the GATE Monte Carlo simulation
framework[49]. As back-to-back gamma emission was simulated, positron
range and acollinearity were ignored. This was done to reduce the simulation
time. Although the digital phantoms that were used allow the simulation of
physiological motion, static simulations were performed. This was done to
avoid motion artefacts in the reconstructed images. Also, the investigation
of the effects of motion is outside the scope of this thesis.
3.3.1 Rat study
For the small animal simulation, the digital ROBY phantom was used[60].
This is a digital representation of a rat, containing all relevant organs. A
scanner model for the LabPET micro-PET system (Gamma Medica-Ideas,
Sherbrooke, Canada) was used[55], as this scanner is also available in our
lab. The axial field of view of the scanner is 76 mm. To perform a whole-
body acquisition of the ROBY phantom, 6 bed positions were simulated.
There was 50 % overlap between consecutive bed positions, yielding a total
axial field of view of 267 mm. The ROBY phantom was simulated as a
voxelized phantom in a 128 x 128 x 550 matrix with 0.5 mm isotropic voxel
dimensions. Five different tissue types were simulated: air, lung, soft tissue,
spongeous (soft) bone and cortical (hard) bone.
The activity distribution of a rat injected with 18F-FDG was simulated.
The relative activity distribution in the organs of the ROBY phantom was
obtained from human data[211]. A total activity of 74 MBq was simulated.
As quantification is best evaluated on lesions within a background, fifteen
spherical lesions with 4 mm diameter were added to the phantom. All lesions
had the same activity level, which was 8 times higher than the activity level in
muscle tissue. The lesions all had the density of soft tissue. They were placed
in the brain, lung, liver, spine, colon and femur, with different locations in
the organs, as listed in table 3.1. Fig. 3.1 shows a maximum intensity
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projection of a reconstructed image to illustrate the extent of the field of
view and the location of the lesions.
Organ Specific location
1 Brain Center
2 Brain Border - close to skull
3 Lung Center
4 Lung Apex
5 Lung Base - close to liver
6 Liver Center
7 Liver Lateral border
8 Spine Thoracic vertebra
9 Spine Lumbal vertebra
10 Spine Sacral vertebra
11 Colon Ascending part
12 Colon Transverse part
13 Colon Descending part
14 Rectosigmoid
15 Femur Neck
Table 3.1: Locations of the simulated lesions in the ROBY phantom used for the
small animal simulation.
3.3.2 Human brain study
For the human brain simulation a different phantom and a different scanner
model were used. The digital XCAT brain phantom was used[60], which pro-
vides the possibility to distinguish many small structures in the brain. We
used a scanner model for the Philips Gemini TF scanner (Philips Medical
Systems, Cleveland, USA), which has an axial field of view of 180 mm. A
single bed position was simulated. The simulated phantom matrix was 128 x
128 x 90 matrix with 2 mm isotropic voxel dimensions. The voxelized phan-
tom contained 3 different tissue types: air, soft tissue, and cortical (hard)
bone. The 18F-FDG activity distribution was obtained from [212], in which
the average uptake in different regions for two healthy volunteers is given.
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Figure 3.1: Maximum intensity projection of the a reconstructed image of the
ROBY phantom, illustrating the field of view and the location of the lesions.
No lesions were inserted in the brain phantom. Fig. 3.2 shows a transverse,
coronal and sagittal slice of a reconstructed PET image, illustrating the field
of view.
Figure 3.2: A transverse (left), coronal (middle) and sagittal (right) slice of a
PET image of the human brain study, reconstructed with the correct attenuation
map.
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3.3.3 Human whole-body study
The setup of the human whole-body simulation was similar to the small
animal simulation, using a different phantom and a different scanner model.
The XCAT whole-body phantom was used[60], representing a male subject
with a body weight of 85 kg and a height of 1.90 m. This can be considered
an average adult body constitution. The same scanner model as for the
brain study was used. 7 bed positions were simulated with 90 mm overlap
between bed positions, yielding an axial field of view of 70 cm. The simulated
phantom matrix was 350 x 350 x 400 matrix with 2 mm isotropic voxel
dimensions. The voxelized phantom contained 7 different tissue types: air,
lung, adipose tissue, soft tissue, liver, spongeous (soft) bone and cortical
(hard) bone.
The average activity distribution of a normal healthy patient injected with
18F-FDG was simulated[211]. Fifteen spherical lesions with 20 mm diameter
were placed inside the phantom to simulate clinically relevant pathologies in
the lung, liver, spine, colon, prostate and femur. As the brain was simulated
separately, no brain lesions were investigated here. All lesions had the same
density (soft tissue) and activity level, providing a contrast of 8 : 1 to the
activity in muscle tissue. Fig. 3.3 illustrates the field of view and the location
of the lesions. The specific locations of the lesions are listed in table 3.2.
3.4 Reconstruction
For all three simulation studies, reconstruction was performed with
attenuation-corrected listmode ML-EM reconstruction, as described in the
previous chapter[213]. For the rat simulation, the reconstructed matrix was
64 x 64 x 256 with 1 mm isotropic voxel size. For the human brain sim-
ulation, the matrix was 128 x 128 x 90 and the voxel dimensions were 2
mm. For the human whole-body study, a matrix of 144 x 144 x 200 was
used with 4 mm voxel size. In the human whole-body simulation, scatter
correction was performed based on scatter sinograms obtained with single
scatter simulation[36]. As the effect of scatter was deemed much smaller in
the case of small animal and human brain imaging, scattered coincidences
were removed from the data before reconstructing the images.
Geometric sensitivity correction was used in all studies. The sensitivity
map for a single bed position was generated by a single backprojection of
all available lines of response (LORs) in the scanner[22]. As only one bed
position was acquired for the human brain study, reconstructing the data
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Organ Specific location
1 Lung Center
2 Lung Apex
3 Lung Base - close to liver
4 Lung Lateral border
5 Liver Center
6 Liver Lateral border
7 Spine Thoracic vertebra lung level (T8)
8 Spine Thoracic vertebra liver level (T11)
9 Spine Lumbal vertebra (L4)
10 Colon Ascending part
11 Colon Transverse part
12 Colon Descending part
13 Rectosigmoid
14 Prostate
15 Femur Neck
Table 3.2: Locations of the simulated lesions in the XCAT phantom used for the
human simulation.
with this sensitivity map yielded a corrected image. However, the situation
is more complex for the rat and human whole-body studies, as multiple
bed positions were acquired. First, all bed positions were reconstructed
separately using the sensitivity map of a single bed position. The whole-
body image (containing all bed positions) was then obtained by summing
the individual images, all shifted 38 mm (ROBY) or 90 mm (XCAT) from
the previous one. The reconstructed value in each voxel of the whole-body
image was calculated as a weighted average of the different bed positions
contributing to that voxel. The weighing factor was obtained from the
single bed position sensitivity map. With this method, reconstructed values
acquired with a higher sensitivity (e.g. in the axial center of the scanner)
will have a larger influence on the whole-body reconstructed image than
reconstructed values acquired with a lower sensitivity (e.g. at the edge of
the axial field of view).
To investigate the effect of attenuation map errors the data was recon-
3.5 Derivation of attenuation maps 71
Figure 3.3: Maximum intensity projection of the a reconstructed image of the
XCAT phantom, illustrating the field of view and the location of the lesions.
structed using different attenuation maps. The generation of these attenua-
tion maps is discussed in the next section. All reconstructions were stopped
after 25 iterations. The number of iterations was determined from the
contrast-to-noise curve of the reconstruction with the correct attenuation
map, showing convergence after 25 iterations.
3.5 Derivation of attenuation maps
Attenuation maps for all three simulated data sets were generated in a com-
parable way. First a reference attenuation map was derived from the tissue
map of the ROBY, XCAT brain and XCAT whole-body phantoms. This
tissue map (dimensions 128 x 128 x 550, 0.5 mm, 128 x 128 x 90, 2 mm
and 350 x 350 x 400, 2 mm for ROBY, XCAT brain and XCAT whole-body
respectively) determines the tissue that is simulated by GATE inside each
voxel. The 511 keV attenuation coefficients for the simulated tissues are
listed in table 3.3. These attenuation coefficients were derived from [214]
and verified on 10 whole-body CT based attenuation maps acquired at our
hospital. As lung tissue of rats is denser than lung tissue of humans, a
different attenuation coefficient is used for lung in the ROBY simulation.
This attenuation coefficient was derived from 5 micro-CT based attenuation
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maps of rats acquired in our lab.
All derived attenuation maps had the same dimensions as the reconstruc-
tion matrix (64 x 64 x 256, 1mm, 128 x 128 x 90, 2 mm and 144 x 144 x 200,
4 mm for ROBY, XCAT brain and XCAT whole-body respectively). First a
reference attenuation map is derived. For each voxel in the reconstruction
matrix the average of the attenuation coefficients of the tissues inside the
voxel was calculated. The reference map contains a continuous range of
attenuation coefficients and can be considered the gold standard. All at-
tenuation maps described below were directly or indirectly derived from the
reference attenuation map. Table 3.4 gives an overview of the attenuation
maps that are derived.
Tissue 511 keV µ (cm−1)
Lung (human) 0.0267
Lung (rat) 0.0600
Adipose tissue 0.0927
Soft tissue 0.0968
Liver 0.0977
Spongeous (soft) bone 0.1100
Cortical (hard) bone 0.1300
Table 3.3: Attenuation coefficients of the simulated tissues.
3.5.1 Number of tissue classes
Attenuation maps segmented into different numbers of tissue classes were
derived from the reference attenuation map to investigate the effect of the
number of tissue classes considered. Based on histograms of whole body CT
images one can discriminate 7 tissue types which have clearly different at-
tenuation coefficients: air, lung, adipose tissue, soft tissue, liver, spongeous
bone and cortical bone. The regions containing these tissue types were seg-
mented using simple thresholding on the reference attenuation map. The
attenuation coefficients listed in table 3.4 were used for the segmented val-
ues. As the tissue map for the ROBY phantom did not provide separate
values for the liver or adipose tissue, it was de facto a 5-class attenuation
map. In the XCAT brain phantom only 3 tissue types are discriminated (air,
soft tissue, cortical bone), so in that case was actually a 3-class attenuation
map.
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Attenuation map Compared to
Reference (None)
1 Number of tissue classes
7 class Reference
Liver replaced by soft tissue∗† 7 class
Adipose tissue replaced by soft tissue∗† 7 class
Spongeous bone replaced by soft tissue∗† 7 class
Lungs replaced by air† 7 class
Cortical bone replaced by soft tissue 7 class
Cortical bone replaced by air∗§ 7 class
Contour map§ 7 class
2 Inter-patient variability
Lung segmented value + 1SD, 2SD∗† 4 class
Cortical bone segmented value + 1SD, 2SD∗ 4 class
3 Tissue misclassification
3.1 Random tissue misclassification
5, 10 and 20% lung => air† 4 class
5, 10 and 20% lung => soft tissue† 4 class
5, 10 and 20% lung => cortical bone† 4 class
5, 10 and 20% cortical bone => soft tissue 4 class
5, 10 and 20% cortical bone => lung 4 class
5, 10 and 20% cortical bone => air 4 class
3.2 Distance-to-interface dependent tissue misclassification
5, 10 and 20% lung => air∗† 4 class
5, 10 and 20% lung => soft tissue∗† 4 class
5, 10 and 20% lung => cortical bone∗† 4 class
5, 10 and 20% cortical bone => soft tissue∗ 4 class
5, 10 and 20% cortical bone => lung∗ 4 class
5, 10 and 20% cortical bone => air∗ 4 class
Table 3.4: Attenuation maps used for reconstruction and the attenuation map
they are compared to. The attenuation maps that were not used in the rat, human
brain and whole-body study are marked with a ∗, † and § respectively.
Eight different attenuation maps were then created. In the first all 7 tissue
types were assigned the correct attenuation coefficient. In the second the
liver was assigned the soft tissue attenuation coefficient. The third atten-
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uation map was derived by replacing the attenuation coefficient of adipose
tissue by the value for soft tissue. The attenuation coefficient of soft bone
was replaced by the soft tissue attenuation coefficient in the fourth map.
In the fifth map the attenuation coefficient of air was assigned to voxels
containing lung. In the sixth map the attenuation coefficient of cortical bone
was replaced by the value for soft tissue, in the seventh map it was replaced
by the value for air. The eight map was a contour map, i.e. a map in which
everything inside the body contour was replaced by soft tissue. The second
and third map were not derived for the rat study, as no separate tissue class
for liver and adipose tissue was available in the ROBY phantom. For similar
reasons, the second, third, fourth and fifth map were not derived for the
human brain study. The seventh map, in which cortical bone is set to air,
was only derived for the human brain study, as this is the only situation in
which air and bone occur close to each other.
3.5.2 Inter-patient variability
When segmentation is used to derive the attenuation map the same at-
tenuation coefficient will usually be assigned to a certain tissue type in all
patients. However, it is well known that there can be considerable inter-
patient variability in the attenuation coefficients of specific tissue types. We
have investigated if this inter-patient variability can also lead to significant
differences in the reconstructed PET image. For this, a quantitative measure
of the inter-patient variability is needed. We have obtained this from 20 clin-
ical whole-body CT based attenuation maps. In each data set, the cortical
bone and lungs were segmented using connected-threshold region growing.
The segmentation was verified visually. Then, the average attenuation co-
efficient in the lungs and cortical bone was calculated for each patient, as
shown in fig. 3.4. In a last step, the standard deviations of both sets of
attenuation coefficients were calculated. We found a standard deviation of
0.004 cm−1 and 0.002 cm−1 for the average attenuation coefficient of lung
and cortical bone respectively.
To evaluate the effect of using a biased attenuation coefficient in the
lung two attenuation maps were derived where the attenuation coefficient
of lung was increased by 1 and 2 inter-patient standard deviations of the
attenuation coefficient of lung. The same was done for cortical bone. As
the same data was not available for rats, these attenuation maps were not
derived for the rat study. The effect of attenuation coefficient variability on
the reconstructed images will also be much smaller for rats. The attenuation
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Figure 3.4: The average attenuation coefficient in lung and cortical bone for 20
patients, obtained from whole-body CT based attenuation maps. This data was
used to derive the inter-patient variability of the attenuation coefficients of lung
and cortical bone.
maps with a variation on the attenuation coefficient of lung were not derived
for the human brain study as there is no lung tissue in the brain.
3.5.3 Tissue misclassification
To investigate the effect of tissue misclassification, i.e. detecting the wrong
tissue class in a voxel, attenuation maps with classification errors were de-
rived. These attenuation maps were derived from an attenuation map seg-
mented into 4 tissue types: cortical bone, soft tissue, lung and air. As lung
and cortical bone are the most difficult to detect on MRI images misclassi-
fication will most likely occur in those tissues. Therefore attenuation maps
with errors in lung and cortical bone classification were derived. The attenu-
ation maps with lung misclassification were not derived for the human brain
study for obvious reasons.
The distribution of tissue classification errors throughout the attenuation
map can depend on the segmentation algorithm and the image quality of
the image that is used for segmentation. When segmenting an image with
a high noise level, the errors will be randomly distributed over the image.
This will also be the case if a clustering method is used for segmentation. If
the accuracy of the segmentation is mainly limited by the resolution of the
image, classification errors will more likely occur at the interfaces between
tissues, due to partial volume effects. This will happen if a contour-based
segmentation method is used. As the distribution of tissue classification
errors can have an effect on the reconstructed PET image, both types of
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errors were investigated.
3.5.3.1 Random tissue misclassification
Nine attenuation maps were derived with random lung misclassification.
This was done by assigning air, soft tissue and bone attenuation coef-
ficients to a fraction (5, 10 and 20 %) of voxels containing lung. The
voxels in which errors were made were distributed randomly. For random
cortical bone misclassification nine attenuation maps were derived in the
same way, replacing 5, 10 and 20 % of the attenuation coefficients of vox-
els containing bone by the attenuation coefficient of soft tissue, lung and air.
3.5.3.2 Distance-to-interface dependent tissue misclassification.
To derive attenuation maps with tissue classification errors that are dis-
tributed non-randomly, the distribution of classification errors is needed. As
described above, we assume that the probability that a classification error
occurs can depend on the distance to the tissue interface. This has not
been investigated in the past. Therefore, we have derived the error proba-
bility distribution from 5 patient data sets. For each patient a segmented
CT-based attenuation map and a segmented MRI-based attenuation map
were available. The attenuation maps contained 3 tissue types (air, soft
tissue and bone). The CT-based attenuation map was used as a reference
to determine classification errors on the MRI-based attenuation map. For
classification errors between each of these tissue types, a histogram showing
the fraction of misclassified voxels for each distance to the tissue interface
was derived. As the shape of the obtained histograms was comparable, we
assume that the error probability distribution could be derived by normaliz-
ing the histograms to a maximum value of 1 and taking the average of all
histograms. The obtained distribution is shown in fig. 3.5. It shows a strong
dependence of the error probability on the distance to the tissue interface.
Attenuation maps with distance-to-interface dependent tissue misclassifi-
cation in lung and cortical bone were then derived using this distribution.
This was done in three steps for each point. First, the distance to the
tissue interface was calculated. Then, a random number was generated. In
the last step a classification error was assigned only if the random number
was smaller than the error probability for that distance, obtained from the
distribution. The same types of classification errors as for the random classi-
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Figure 3.5: Normalized error probability distribution used to derive attenuation
maps with classification error density dependent on the distance to the tissue in-
terface.
fication errors were used. The distribution was scaled to obtain attenuation
maps in which 5, 10 and 20 % of lung or bone voxels were misclassified.
These attenuation maps were not derived for the rat study, as it can be
assumed that only minor differences with random tissue misclassification
will be observed because the organs of a rat are quite small.
3.6 Evaluation of the reconstructed images
The image reconstructed with the attenuation map using 7 tissue types (5
in the rat study, 3 in the human brain study) was compared to the image
reconstructed with the reference attenuation map. The images obtained
with the other segmented attenuation maps (using only 6 (4, 2) tissue types)
were compared to the image obtained with the 7 (5, 3) tissue map. This was
done to show the actual effect of not taking the considered tissue type into
account. For the maps with segmentation errors the images were compared
to the image reconstructed with an attenuation map segmented into bone,
soft tissue, lung and air (bone, soft tissue and air for the human brain study).
This was done because these 4 tissue types are the most important to be
discriminated, as is discussed below. All attenuation maps and the maps
they are compared to are listed in table 3.4.
For some reconstructed images visual evaluation was performed to pro-
vide insight into the location of the differences in the reconstructed images.
This was done in three steps. First a difference image was calculated by
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subtracting both reconstructed images being compared. Then the ratio of
the difference between both images to the value in the reference image was
calculated in each voxel, yielding a percent difference image. A maximum
intensity projection was then obtained by taking the percent difference with
the highest absolute value for each line in the anterior-posterior direction.
The images are depicted in color scale: red means that the modified atten-
uation map yielded an overestimation of the activity in that location, blue
indicates an underestimation.
For quantitative evaluation spherical volumes of interest (VOIs) were de-
fined. The diameter of the VOIs were 4 mm, 10 mm and 20 mm in the recon-
structed images of the ROBY, XCAT brain and XCAT whole-body phantoms
respectively. The percent difference between the activity in the VOIs in the
images reconstructed with different attenuation maps was calculated:
∆m,i (%) =
Nm,i − Nc,i
Nc,i
× 100 (3.1)
where Nm,i and Nc,i are the total number of counts in VOI i on the
image reconstructed with the attenuation map under evaluation (m) and
the attenuation map used for comparison (c) respectively. In the rat and
human whole-body studies, the VOIs were drawn on the location of the
lesions described above. In the human brain study, the VOIs were drawn in
clinically relevant regions of the brain, listed in table 3.5.
Location
1 Dorsal cortex
2 Frontal cortex
3 Lateral cortex
4 Putamen
5 Thalamus
6 White matter
Table 3.5: Locations of the VOIs defined in the brain for evaluation of the human
brain study.
As all changes to the attenuation map will lead to changes in the recon-
structed image, it is important to define what is a relevant difference. As we
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have compared the total activity in VOIs, a difference is relevant if it is larger
than the variation in the total counts in VOIs of the same size in a region
of homogeneous uptake. To determine this variation, 5 VOIs were drawn on
the image reconstructed with the reference attenuation map in a soft tissue
region with homogeneous uptake. The total counts in each of these VOIs
was calculated. The average of the total counts was then calculated:
µN =
Σ5k=1Nk
5
(3.2)
where Nk is the total counts in VOI k. The lower level of significance was
then set to:
∆sig =
√
Σ5k=1(Nk−µN)2
4
µ
(3.3)
This is the ratio of the standard deviation on the total counts to the
average total counts. For the ROBY simulation, this was 3.1 %. For the
XCAT brain and XCAT whole-body simulations, values of 4.2 % and 4.7 %
were obtained respectively. All results that have a relative difference less
than 3.1 %, 4.2 % or 4.7 % in the respective studies were therefore defined
as non-relevant.
3.7 Results
In this section, a description of the most important results obtained from
all three simulation studies is given. For clarity, the results of the different
studies are discussed separately. Not all results are described here but the
complete list of results can be found in appendix A.
3.7.1 Rat study
In the rat study, only very few relevant errors were observed. The quantita-
tive evaluation of the effect of segmenting into different numbers of tissue
classes is shown in fig. 3.6. Replacing spongeous bone with soft tissue
yielded errors smaller than 1 % and hence no results are displayed for that
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Figure 3.6: Relative errors in total activity in 4 lesions in the rat study, induced by
ignoring a certain tissue type in the segmented attenuation map: (a) lung (replaced
by air) and (b) cortical bone (replaced by soft tissue) and (c) contour attenuation
map (all tissue inside the body replaced by soft tissue).
case. The largest errors were found when lung tissue was ignored and re-
placed by air, which led to an underestimation of 8 % in the center of the
lungs. Replacing cortical bone by soft tissue did not lead to relevant errors
(2 % in the spine and femur). When a contour map is used, errors of 4 - 5
% are seen in the lungs and errors of ≈ 2 % in the spine and femur. In the
abdomen, no relevant errors were found with any of the attenuation maps.
Random tissue misclassification did not lead to any relevant errors. In
fact, even lung misclassification into cortical bone only yielded errors of
1.7 % or less. As inter-animal variability was not investigated, no results
were available. The same applies to distance-to-interface dependent tissue
misclassification.
3.7.2 Human brain study
3.7.2.1 Number of tissue classes
The quantitative effect of using different numbers of tissue classes in the
attenuation map is shown in fig. 3.7. When cortical bone is replaced by soft
tissue, underestimations of 7 % or less are seen. Larger errors are observed
if cortical bone is replaced by air: over 20 % in the dorsal cortex and the
thalamus. When a contour map is used, which replaces bone as well as air
voxels inside the head with soft tissue, the largest error is seen in the frontal
cortex, with an overestimation of 27 %. An error of almost 15 % is also
observed in the thalamus.
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Figure 3.7: Relative errors in total activity in 3 lesions induced by ignoring a
certain tissue type in the segmented attenuation map in the human brain study:
(a) cortical bone (replaced by soft tissue), (b) cortical bone (replaced by air) and
(c) contour map (all voxels inside the body set to soft tissue).
3.7.2.2 Inter-patient variability
When the attenuation coefficient of cortical bone is increased by one or two
standard deviations, no relevant errors were observed. The maximum error
was 0.6 %, which is very small.
3.7.2.3 Tissue misclassification
Misclassification of cortical bone voxels into soft tissue did not lead to rele-
vant effects, even if 20 % of bone voxels were misclassified. There was no
noticeable difference between random and distance-to-interface dependent
classification errors for those errors. When a fraction of cortical bone voxels
is classified as air, different results are observed. Random bone/air misclas-
sification of up to 10 % does not lead to relevant errors. When 20 % of
cortical bone voxels are randomly misclassified, the error in the thalamus is
borderline relevant (-4.4 %). The errors in all other VOIs are smaller.
When misclassification of cortical bone into air is not random but depends
on the distance to the bone/air interface, larger errors are observed. When
10 % of cortical bone voxels are misclassified, a relevant error can already be
observed in the thalamus (-6.7 %). When the misclassified fraction amounts
to 20 %, the error in the frontal cortex also becomes relevant (-4.6 %).
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Figure 3.8: Quantitative evaluation of the effect of bone misclassification into air
in the human brain study. The relative difference in total activity in three different
lesions is shown for 5, 10 or 20 % bone misclassification. The misclassification was
random (a) or distance-to-interface dependent (b).
3.7.3 Human whole-body study
3.7.3.1 Number of tissue classes
A visual representation of the errors induced by not taking adipose tissue,
spongeous bone, lung or cortical bone into account is shown in fig. 3.9. The
Figure 3.9: Maximum intensity projections of the relative errors induced by ignor-
ing a certain tissue type in the segmented attenuation map (human whole-body
study): (a) adipose tissue, (b) spongeous bone (both replaced by soft tissue), (c)
lung (replaced by air) and (d) cortical bone (replaced by soft tissue). Red indicates
an overestimation, blue indicates an underestimation.
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Figure 3.10: Relative errors in total activity in 5 lesions in the human whole-body
study, induced by ignoring a certain tissue type in the segmented attenuation map:
(a) adipose tissue, (b) spongeous bone (both replaced by soft tissue), (c) lung
(replaced by air) and (d) cortical bone (replaced by soft tissue).
most important quantitative results are depicted in fig. 3.10. Segmenting
into all 7 tissue classes yields very small errors compared to the reference
attenuation map (< 2 %) and hence no results are displayed for that case.
The same applies for the attenuation map where liver tissue is ignored.
Ignoring adipose tissue leads to errors of 5 - 7 % in the colon and the
prostate but no other relevant errors. Ignoring soft bone yields errors of 10
- 15 % in the spine and the femur but non-relevant differences elsewhere.
Assigning the attenuation coefficient of air to lung tissue leads to errors of
25 - 45 % in the lung but also a 17 % error in the spine at the level of the
lung. The effect of not taking cortical bone into account is smaller: 10 - 20
% in all segments of the spine and the femur. A 7 % error was also found
at the apex and lateral border of the lung. The contour map yielded very
high errors, e.g. an overestimation of more than 200 % in the lungs.
3.7.3.2 Inter-patient variability
An increase of the segmented attenuation coefficient of lung by one or two
standard deviations led to relevant effects, as visible in fig. 3.11: errors of 6
% - 12 % in the lung with a bias of one (0.004 cm−1) standard deviation.
With a bias of two standard deviations relevant errors are also seen in the
spine at the level of the lung. An increase of the segmented attenuation
coefficient of cortical bone by one or two standard deviations did not lead
to relevant differences.
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Figure 3.11: Quantitative evaluation of the effect of inter-patient variation on the
attenuation coefficient of lung (human whole-body study). The relative error in
total activity in three different lesions is shown for an overestimation of the lung
attenuation coefficient by 1 and 2 standard deviations.
3.7.3.3 Tissue misclassification
Random tissue misclassification
The effect of random lung misclassification is depicted in fig. 3.12. Lung
misclassification where lung tissue is assigned the attenuation coefficient
of air does not yield relevant errors if less than 10 % of the voxels are
misclassified. If errors are made in more voxels, a relevant underestimation
can be seen in the lung (5 - 10 %). Misclassification where the attenuation
coefficient of soft tissue is assigned to lung tissue yields relevant errors even
if there are only 5 % errors. The errors are largest at the center, lateral
border and apex of the lung, followed by the base of the lung and the part
of the spine behind the lung. Lung / cortical bone misclassification shows
results with comparable trends but the errors are even larger.
Fig. 3.13 shows the effect of random cortical bone misclassification.
Misclassification of cortical bone where the cortical bone is assigned the
attenuation coefficient of soft tissue does not lead to relevant errors, even if
20 % of bone voxels are misclassified. 10 % or more bone / lung and bone
/ air misclassification can lead to relevant errors in the thoracic and lumbar
spine. The lateral border of the lung is also affected.
Distance-to-interface dependent tissue misclassification
If the tissue classification errors are not randomly distributed, slightly dif-
ferent results can be seen for lung / soft tissue misclassification, as shown
in fig. 3.14. As expected, the error in the center of the lung is smaller,
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Figure 3.12: Quantitative evaluation of the effect of random lung misclassifica-
tion (human whole-body study). The relative difference in total activity in three
different lesions is shown for 5, 10 or 20 % lung misclassification. The effect of
misclassification where lung tissue is assigned the attenuation coefficient of air (a),
soft tissue (b) and cortical bone (c) is shown.
but the errors at the borders of the lung are increased. This still leads to
relevant errors even if only 5 % of lung voxels are misclassified. For lung /
bone errors, the difference with random misclassification is larger. In that
case, non-relevant errors are observed at the center and the bottom border
of the lung if 5 % of voxels are misclassified. The error at the apex of the
lung is increased compared to random misclassification.
Small differences with random misclassification are observed for bone clas-
Figure 3.13: Quantitative evaluation of the effect of random bone misclassifica-
tion (human whole-body study). The relative difference in total activity in three
different lesions is shown for 5, 10 or 20 % bone misclassification. The effect of
misclassification where cortical bone is assigned the attenuation coefficient of soft
tissue (a), lung (b) and air (c) is shown.
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Figure 3.14: Quantitative evaluation of the effect of lung distance-to-interface
dependent misclassification (human whole-body study). The relative difference in
total activity in three different lesions is shown for 5, 10 or 20 % lung misclassifica-
tion. The effect of misclassification where lung tissue is assigned the attenuation
coefficient of air (a), soft tissue (b) and cortical bone (c) is shown.
sification errors. Bone / soft tissue misclassification still leads to non-relevant
errors, even if 20 % of bone voxels are misclassified. Bone / lung non-random
misclassification yields slightly higher errors than random misclassification in
the apex and lateral border of the lung, leading to significant errors if 20 %
of voxels are misclassified. Bone / air non-random misclassification leads to
comparable results as bone / air random misclassification.
3.8 Discussion
3.8.1 Rat study
In the rat study, only small errors were found. This is related to the small
size of the animal under study. Although it has been shown in the past
that attenuation correction for small animal PET is necessary for accurate
quantification[182, 215], the results presented in this chapter show that
the requirements on the attenuation map are not so stringent. In fact, the
results indicate that an attenuation map that discriminates air, lung and soft
tissue is sufficient to achieve accurate results. If the lungs are not treated
as a separate tissue type, it is better to assign the attenuation coefficient of
soft tissue to them than to treat them as air. This is different from human
imaging, and is related to the higher density of rat lungs compared to human
lungs.
Spongeous bone and cortical bone can be treated as soft tissue without
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leading to relevant errors. This is also related to the size of the bone struc-
tures in a rat. To achieve the highest accuracy, they should also be treated
as separate tissue types. If the attenuation map is derived from images in
which they can be easily discriminated, such as a micro-CT, this can be done.
However, as the segmentation of cortical bone in MRI images is difficult, it
is probably not interesting to put a lot of effort into the discrimination of
cortical bone in MRI-based attenuation correction. The small size of the
bone structures also adds an extra difficulty for segmentation.
As different levels of tissue misclassification do not lead to relevant errors,
even if 20 % of bone or lung voxels are misclassified, it seems that random
tissue classification errors can be tolerated up to a certain level. This is
interesting for MRI-based attenuation correction, as it means that the noise
in the images used for segmentation can be relatively high. As small animal
imaging is usually done at high resolution, long acquisition times are needed
to achieve images with a high signal-to-noise ratio. Our results indicate
that the images that will be used for deriving the attenuation map do not
need very low noise levels. Hence, the total acquisition time can possibly be
reduced.
Only micro-PET simulations have been performed, and the effect of the
errors in the attenuation map on micro-SPECT data is therefore not clear.
However, as was explained in the introduction of this chapter, the effect of
attenuation in SPECT is smaller than in PET. Therefore, it can be expected
that an attenuation map that is sufficient for micro-PET imaging will also be
sufficient for micro-SPECT imaging. The methods derived for micro-PET
attenuation correction will therefore also be used for the micro-SPECT study
described in chapter 6.
3.8.2 Human brain study
In the human brain study, relevant errors were found when cortical bone was
replaced with a different tissue type. When it was replaced with soft tissue,
the errors were modest (≈ 7 %) but still too high to be tolerated. When
the attenuation coefficient of air is assigned to cortical bone voxels, large
underestimations are seen. The errors are largest in the dorsal cortex and
the thalamus, as both regions are located close to the skull. The contour
map, in which soft tissue is assigned to all voxels inside the body and hence
nor cortical bone nor air are discriminated, also shows large errors, especially
in the frontal cortex. This is explained by the proximity of the frontal sinus,
which is a large air structure. From these results it is clear that all three
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tissue types present in the human brain need to be discriminated to allow
accurate quantification.
20 % classification errors from cortical bone to soft tissue can be tolerated.
Random misclassification of cortical bone into air can also be tolerated, as
long as the fraction of misclassified voxels remains below 20 %. When
the misclassification is not random but depends on the proximity of the
air/cortical bone interface, larger errors are seen. This is especially the
case in the frontal cortex and the thalamus. The large difference between
the effect of random and distance-to-interface dependent misclassification
in the thalamus is related to the location of the thalamus. It is located close
to the base of the skull, where complex combinations of cortical bone and
air are present. These results are interesting when designing a segmentation
algorithm: one should keep the probability of misclassifying cortical bone as
air low, even if this means increasing the fraction of cortical bone voxels that
are misclassified as soft tissue.
3.8.3 Human whole-body study
The results of the human whole-body study show that the most important
tissue type that needs to be discriminated, apart from soft tissue and air, is
lung tissue. The large effect is mainly caused by the large volume covered
by the lungs. This implies that if a positron annihilation takes place in the
middle of this volume, the 511 keV photons will be affected by a wrong
attenuation coefficient over a long distance (at least 10 cm for the lungs),
independent of the direction in which they travel. When ignoring the atten-
uation of lung tissue, voxels containing lung tissue should be classified as
air, as the difference with soft tissue attenuation coefficients is much larger.
However, the difference between lung and air attenuation coefficients is still
substantial (0.027 cm−1). A quick calculation shows that a photon traveling
through 10 cm of lung tissue has a 24% chance of being attenuated. This
important effect is not taken into account when lung tissue is ignored.
The second most important tissue type to take into account is cortical
bone. The difference in attenuation coefficient between cortical bone and
soft tissue is comparable to the difference between lung and air (0.028 cm−1).
However, the effect is smaller compared to lung because the total volume
of cortical bone in the body is much smaller. Cortical bone is also not
concentrated in one region as is the case for lung tissue. This does make
the effect also more difficult to predict as cortical bone can be present in
many regions throughout the body. The fact that cortical bone is difficult
to visualize on MRI images, which could ideally be used to derive segmented
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attenuation maps in the context of PET-MRI, adds to the difficulty. The
most important clinical context for this is cancer that has metastasised to
the spine or other bone structures, as can be seen from the results.
Not taking spongeous bone into account leads to errors of comparable
magnitude in the bone structures. Although the difference in attenuation
coefficient between soft tissue and spongeous bone is much smaller, most
bones contain a much larger volume of spongeous bone compared to cortical
bone. When possible it should also be taken into account, as it also has a
considerable effect on the quantification of uptake in the bone. To our
knowledge, no research has been done up to this point into MRI-based
attenuation correction methods that discriminate spongeous bone.
The effect of ignoring adipose tissue will depend on patient constitution.
In this study we have modeled a patient of average size, and the effects
of adipose tissue on attenuation correction are only slightly relevant. It is
therefore more important that tissue classes discussed above are taken into
account. However, as the segmentation of adipose tissue on MRI images is
quite straightforward, we would suggest taking adipose tissue into account
when using segmented MRI images.
When a segmented attenuation map is used the same attenuation coef-
ficients will be assigned to the different tissue types for all patients. It is
well known that there is inter-patient variability on the actual attenuation
coefficient of lung or cortical bone. Our results show that the inter-patient
variability of cortical bone is not relevant for attenuation correction. The
inter-patient variability of lung tissue can produce relevant effects, even if
the attenuation coefficient only deviates from the mean by one standard
deviation. Ideally a segmented attenuation map should thus also provide a
custom lung attenuation coefficient for each patient. In MRI-based atten-
uation correction it would be interesting if the density of lung tissue could
be determined from the MRI image. Currently this possibility has not been
demonstrated. Another option would be to determine if there are other
predictors of lung density (e.g. age, constitution, smoking) that could be
used.
Segmentation algorithms can assign the wrong tissue type to a voxel. We
have shown that up to 10 % misclassification that assigns the attenuation
coefficient of air to voxels containing lung tissue can be tolerated as well as
up to 20 % misclassification that yields the attenuation coefficient of soft
tissue in bone voxels. Other errors (lung / soft tissue, lung / bone, bone
/ lung and bone / air) do lead to relevant errors and should therefore be
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avoided. This is the case when misclassified voxels are distributed randomly
over the image as well as when classification errors are more prominent
close to tissue interfaces. As mentioned in the previous section, this can be
interesting when designing a segmentation algorithm. It is better to design
the algorithm so that classification of lung to air and of bone to soft tissue
is more likely.
Apart from influencing attenuation correction, the attenuation map also
has an effect on scatter correction. As current scatter correction algorithms
use a combination of the attenuation map and a preliminary reconstructed
image to estimate the amount of scatter, it is clear that using an incorrect at-
tenuation map will lead to incorrect scatter correction. The results described
in this chapter were obtained from data containing scattered coincidences,
using the single scatter simulation algorithm to perform scatter correction.
As it is possible to remove scattered coincidences from the simulated data
prior to reconstruction, we have also performed all reconstructions described
above with scatterless data. The results were very similar to those de-
scribed above, apart from slightly smaller errors in the lungs (≈ 5 % smaller
in most cases). Therefore these additional results are not described in detail.
A final remark can be made concerning the simulated voxel size in all three
simulation studies. In the rat and human simulations, the voxel sizes of the
simulated phantoms were 0.5 mm and 2 mm respectively. These voxel sizes
were chosen because they are well below the measured resolution of the sim-
ulated scanners, which are ≈ 1.4 mm and ≈ 4.7 mm respectively[216, 217].
However, some features relevant for attenuation correction have dimensions
smaller than the chosen voxel sizes. Therefore, these features were not rep-
resented accurately in the simulation. This can, for example, be the case for
the cortical shell of some bones. The effect of errors in the attenuation map
in such small features can not be assessed from these results. However, it
is unlikely that these errors would be large, especially because of the limited
resolution of the scanners. It would also be very time consuming to perform
a Monte Carlo simulation with much smaller voxel size. Therefore, we did
not investigate this in more detail.
3.9 Conclusion
We will use the results presented in this chapter as a guideline for the re-
quirements of the algorithms that will be developed in the next chapter.
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The results indicate that for small animal attenuation correction, a method
which discriminates air, lung and soft tissue is needed. As lung tissue is not
visible on conventional MRI images, this means that a new method needs to
be developed. Discrimination of cortical bone can also be interesting, but is
not explicitly necessary.
For human brain imaging, all tissue types that are present in the head
should be discriminated: air, soft tissue and cortical bone. As classification
errors from cortical bone to soft tissue of up to 20 % can be tolerated while
this is not the case for cortical bone/air misclassification, an algorithm should
be designed which is more likely to misclassify bone voxels as soft tissue than
as air.
The results of the human whole-body study lead to much more stringent
requirements. In human whole-body imaging, at least 5 tissue types should
be discriminated: air, lung, soft tissue, spongeous bone and cortical bone.
As current methods for whole-body attenuation correction only discriminate
air, lung and soft tissue (and sometimes adipose tissue), this means that a
completely new method also needs to be derived for human imaging. Special
effort is needed to discriminate air, lung and cortical bone, as this is not
possible with conventional MRI images.
The results also indicate that classification errors in the lung should be
avoided, as even a low fraction of misclassified voxels leads to relevant errors.
Limited classification errors in cortical bone can be tolerated, at least if the
algorithm is designed so that it is more likely that cortical bone will be
misclassified as soft tissue than as air or lung. In the next chapter, the
development and testing of an algorithm that fulfills these requirements is
described.
3.10 Original contributions
The results of the human whole-body study presented in this chapter was
published in a A1 journal paper[218]. The investigation of inter-patient vari-
ability of the attenuation coefficients of lung and cortical bone was presented
at the SNM conference in 2010[219].
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Chapter 4
Derivation of attenuation
maps from ultrashort echo
time images
4.1 Introduction
In the previous chapter it was shown that, in order to achieve accurate
quantification in human whole-body imaging, 5 different tissue classes need
to be discriminated in the attenuation map: air, lung, soft tissue, spongeous
bone and cortical bone. In human brain imaging, air, soft tissue and cortical
bone are needed. In small animal studies, the discrimination of air, lung and
soft tissue is sufficient. As MRI has superior soft tissue contrast to any other
imaging modality, the segmentation of soft tissue from MRI images is not
difficult. As spongeous bone also contains a large fraction of bone marrow,
which can be considered soft tissue, the segmentation of spongeous bone
from MRI images should also be possible.
The discrimination of air, lung and cortical bone is more difficult on MRI
images. In fact, lung and cortical bone exhibit practically no MRI signal in
images acquired with conventional MRI sequences. Consequently, there is
no contrast between air, lung and cortical bone in those images. The low
signal of lung and cortical bone is caused by the low proton density and short
T2 relaxation time of these tissues. Due to these properties, the MRI signal
of these tissues disappears very quickly after RF excitation, before it can be
acquired by the scanner.
This problem can be solved by using an MRI sequence that acquires the
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signal very fast after RF excitation, before the signal has disappeared. For
this purpose, special MRI sequences called ultrashort echo time (UTE) se-
quences have been developed. In this chapter, the principles and applications
of UTE sequences are first described. Then, the MRI properties of lung and
cortical bone are investigated to assess the feasibility of using UTE sequences
to visualize them. In the last section, a method is proposed which allows the
derivation of attenuation maps from images acquired with UTE sequences.
4.2 Ultrashort echo time imaging
4.2.1 Imaging of short T2 components
4.2.1.1 Origin of short T2
As described in chapter 2, T2 is the transverse relaxation time of tissues and
is defined by the chemical environment of the protons in the tissue. In gen-
eral, protons in a highly organized chemical environment (e.g. in solids) have
extremely short T2s (≈ 1 µs), whereas protons in liquid water have very long
T2s (≈ 4000 ms). Protons in other materials can have T2s anywhere in be-
tween those values. In biological tissue, the T2 of protons strongly depends
on the organization of the protein matrix[220, 221]. The best example in
the mammalian body, and also most relevant for this thesis, is collagen[222].
Collagen molecules provide structural support in many tissues, and are es-
pecially abundant in hard tissues such as tendons, ligaments, cartilage and
cortical bone. The protons in the collagen have T2s in the order of 10 µs,
but protons in water molecules that are in the vicinity of collagen molecules
have longer T2s.
4.2.1.2 Imaging problems
The imaging of short T2 components is impeded by two specific
phenomena[223]. The first is related to the short T2 itself and involves
the RF pulses. In materials with a long T2, the T2 is much longer than the
duration of the RF pulse. Hence, transverse relaxation during application of
the RF pulse can be ignored. This means that a 90◦ RF pulse will indeed
lead to complete flipping of the magnetization vector into the transverse
plane. However, this assumption does not apply to short T2 components.
The transverse relaxation of short T2 components occurs so fast, that the
relaxation during the application of the RF pulse can not be neglected. The
longer the RF pulse, the more transverse relaxation will take place during
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application of the RF pulse and hence the smaller the obtained flip angle
will be. RF pulses therefore need to be very short to excite short T2 com-
ponents. To obtain the same flip angle in a shorter time span, the power of
the RF pulse needs to be increased, as determined by eq. 2.24. However,
the output power of the RF coils is limited by the hardware as well as safety
regulations. Also, short RF pulses will inherently have a broad bandwidth
and lead to poor slice selection. Another problem related directly to the
short T2 is that the acquisition of short T2 components also requires very
fast sampling of the signal, which relies on very fast switching from transmit
to receive mode, which is also limited by the hardware.
The second phenomenon that leads to problems in imaging of short T2
components is their broad resonance peak compared to long T2 components.
This means that they are not only affected by RF pulses exactly at the
Larmor frequency, but may also be affected by RF pulses at slightly different
frequencies. This can cause problems with fat saturation pulses, which are
applied at the resonance frequency of adipose tissue (slightly different from
water) to reduce the signal from fat in the image. Fat saturation pulses do
not affect long T2 components, but may affect short T2 components and
hence lead to a lower signal from those components.
4.2.2 Principles of UTE imaging
The goal of UTE imaging is to start the acquisition of the MRI signal as
quickly after the start of RF excitation as possible. Therefore, there are three
key differences between UTE sequences and conventional sequences[224]:
1. FID sampling: in conventional MRI sequences, the spins are refo-
cused after RF excitation by forming a gradient or spin echo. This
makes it impossible to acquire MRI signal very quickly after RF ex-
citation, as a 180◦ pulse (SE) or the application of gradients (GE) is
needed to produce the echo. In UTE sequences, the FID is sampled
instead of an echo[225]. This makes it possible to start acquiring the
signal directly after RF excitation, with only a delay from the hardware
switching time.
2. Short RF pulse: a normal 90◦ RF pulse can take up to 0.40 ms,
depending on system specifications. During this period, short T2 com-
ponents will already exhibit significant transverse relaxation. In UTE
sequences, special truncated RF pulses are used[226]. Using low flip
angles (≈ 10◦) also limits RF pulse duration. As mentioned earlier,
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truncated RF pulses have large bandwidths, leading to a broad slice
selection profile. This limits resolution in the axial direction with 2D
imaging.
3. Radial sampling of k-space: if k-space is sampled in the conven-
tional way, i.e. on a cartesian grid, the application of a gradient is
needed to move the k-space vector to the start position of a line.
This also requires time. Therefore, UTE sequences sample k-space
radially, starting in the center of k-space and moving outwards using
gradients[227]. This allows the start of acquisition without first ap-
plying any gradients. Other sampling schemes are also possible, e.g.
spiral sampling[228].
4.2.3 Philips UTE sequence
The UTE sequence used in most experiments in this thesis was available on
a Philips Achieva 3T system (Philips Medical Systems, Best, The Nether-
lands). It was developed by Rahmer et al. and is described in detail in [229].
In the following paragraphs the most important features of the sequence are
clarified. A simplified schematic overview of the sequence is shown in fig.
4.1. First of all, the RF pulse is applied. It is a hard block pulse with low
flip angle (≤ 10◦). With these properties, the RF pulse duration can be kept
much shorter than 100 µs. However, this does lead to a very broad band-
width of the pulse, which makes accurate slice selection difficult. Therefore,
no slice selection is performed: the complete imaging volume is excited. This
is called a 3D acquisition (contrary to 2D acquisitions with slice selection).
After the RF pulse, the energy stored in the RF coils must ring down to
allow tuning of the receive coils. This also leads to a delay on the start of
acquisition. If the coils are switched to receive mode too quickly while there
is still too much energy in the coil, this may destroy the coil. Ring down of
the energy only takes a few µs, but tuning of the coils can be more time
consuming. With fast coils - which are generally the simplest in design - it
is possible to be ready for acquisition within less than 100 µs from the end
of the RF pulse.
Sampling of the FID signal starts from the moment the gradients are
switched on. This means that signal is also sampled while the gradients
are ramping up to their intended strength. This also provides a few µs of
time gain. Using gradients in three dimensions, the k-space vector is moved
radially outward from the center of k-space during sampling. Each radial line
in k-space is called a spoke. By acquiring spokes with different directions,
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Figure 4.1: Schematic of a 3D UTE sequence (left), and the k-space trajectory
in the kx , ky plane (right). The kz direction is not shown for simplicity, but the
sequence does acquire in 3 dimensions. The RF pulse is very short, with flip angle
well below 90◦. Acquisition of the FID starts as quickly as possible after the RF
pulse. The gradients are used to traverse k-space from the center outward. The
data is acquired on the red line. To acquire the gradient echo image, the gradients
are inverted and data is acquired while traveling along the green line. Note that
twice as much data is sampled for the gradient echo.
a spherical sampling pattern of k-space is obtained. As the sampling time
is usually in the order of several hundred µs, this is the main limitation on
the T2 of tissues that can be visualized. Rahmer et al. have investigated in
their paper that, in order to have an optimal signal-to-noise ratio (SNR) for
tissues with a specific T2, the following equation should be used to define
the sampling time:
Ts = 0.69 T2 (4.1)
where Ts is the sampling time and T2 is the transverse relaxation time
of the tissue that needs to be visualized. This shows that the sampling
time is shorter than T2, leading to a very short sampling time for short T2
components. This requires high gradient strengths, and fast sampling. The
latter inherently leads to a large bandwidth for the sampled data and more
noise in the data.
The FID image will contain signal from short T2 components, but also
from long T2 components. To provide contrast between short and long T2
components, a second image is acquired using the UTE sequence. This is
a normal gradient echo image, for which the echo time can be set. The
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data for this image is also sampled radially, and each spoke is sampled after
the sampling of the FID. The difference with the FID sampling is that the
sampling of the gradient echo is done from the end of the spoke reached by
FID sampling, over the origin of k-space, towards the other end of the spoke.
This means that the double amount of data is sampled for the gradient echo
image. This will lead to better image quality in the gradient echo image.
4.3 MRI properties of relevant tissues
UTE sequences have mainly been used in clinical practice to study tendons,
ligaments, menisci, etc. However, for attenuation correction, we want to
specifically visualize lung and cortical bone using a UTE sequence. As these
tissues are generally considered to have even shorter T2s than the tissues
currently visualized with UTE sequences, it is uncertain if it is possible to
acquire signal in lung and cortical bone using a UTE sequence. In this
section, we therefore investigate the MRI properties of lung and cortical
bone.
4.3.1 Lung
4.3.1.1 Origin of short T2
The parenchyma of mammalian lungs is composed of millions of alveoli,
which can be seen as small spheres of tissue filled with air (fig. 4.2). Al-
though the tissue itself does not have an especially short T2 (≈ 35 ms),
the complex structure of the lungs does lead to an apparent short T ∗2 [225].
This is caused by susceptibility effects, which appear at the border between
tissue and air. The magnetic susceptibility χν of a material, e.g. a biologi-
cal tissue, describes its response to an applied magnetic field. It defines the
magnetization of the material when it is placed in an external magnetic field:
~M = χν ~H (4.2)
where ~M is the magnetization of the material and ~H is the external mag-
netic field. The magnetization can be interpreted as the magnetic field that
is produced by the material itself in response to an applied field. Diamag-
netic materials will produce a magnetic field that is opposed to the external
field (χν < 0), whereas paramagnetic materials will produce a magnetic field
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Figure 4.2: Schematic illustration of a lung alveolus. Reproduced from the Wiki-
media Commons library (http://commons.wikimedia.org/wiki/File:Alveolus_ dia-
gram.svg).
that has the same direction as the external magnetic field (χν < 0). The
total local magnetic field ~B is then given by the equation:
~B = µ0(~H + ~M) = µ0(1 + χν)~H (4.3)
The interface between two materials with different susceptibilities, e.g.
tissue and air, is therefore also an interface between two local magnetic field
strengths. At this interface, there exists a small magnetic field gradient.
This gradient will accelerate the dephasing of the spins at the interface, and
lead to faster relaxation[230]. Susceptibility effects are larger if the applied
field is larger, as the magnetization of the material is proportionate to the
external magnetic field. As the lungs can be seen as a collection of many
tissue/air interfaces, the susceptibility effects in the lungs have a very large
effect on the apparent T ∗2 [231].
Apart from the low T ∗2 due to susceptibility effects, lung tissue also has a
much lower proton density than other tissues, as a large fraction is occupied
by air. The proton density in lung tissue has been shown to be approximately
20 % of the proton density of soft tissue[232]. This is also the reason for the
lower density of lungs on CT and the lower attenuation coefficient of lungs.
As a lower proton density means that less MRI signal is available, this adds
an extra difficulty to the MRI imaging of lung tissue.
As the low signal in lung tissue is mainly a T ∗2 effect, it should be possible
to visualize lung tissue with UTE sequences. In fact, several authors have
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demonstrated the feasibility of lung imaging with MRI. Lung imaging with
UTE sequences has been shown[225], as well as imaging with normal gradient
echo sequences[233, 232], as long as the echo time is kept low. We have
investigated the UTE imaging properties of lung tissue below, to obtain
insight into the optimal sequence settings.
4.3.1.2 Methods
The ideal method for determining the MRI properties of a material is by
NMR relaxometry, as will be done in the next section for cortical bone.
This requires a number of small samples of the material that needs to be
investigated. For lung tissue, this would require performing relaxometry of
small pieces of lung. However, a lung is kept open in the body by the
negative pressure inside the chest cavity. When a lung is removed from the
chest cavity, it collapses immediately under the normal atmospheric pressure.
As a consequence, it is impossible to obtain a small sample of lung tissue in
the same state as when inside the body. Hence, relaxometry of lung tissue is
not possible. The MRI properties of lung tissue were therefore investigated
by acquiring MRI images of healthy volunteers.
UTE-MRI images of 3 healthy volunteers were acquired on a Magnetom
Trio 3T system (Siemens Healthcare, Erlangen, Germany), with a 3D ra-
dial UTE sequence comparable to the Philips sequence. Two images were
obtained by this sequence: a FID at 0.08 ms and a gradient echo at 2.3
ms. To investigate the effect of resolution on the available MRI signal in
the lungs, data was acquired at three different isotropic resolutions: 2 mm,
4 mm and 6 mm. The acquisition times were approximately 6 min, 2 min
and 1 min. Coronal slices of one of the data sets are shown in fig. 4.3. For
each volunteer five spherical volumes of interest (VOIs) with a diameter of
20 mm were drawn on the lungs. The volunteers stayed on the bed between
different acquisitions. Therefore, we assume that all images of a volunteer
were registered to each other and the same VOIs could be used for the 2
mm, 4 mm and 6 mm images. For each patient and resolution, the average
amplitude over all 5 lung VOIs was calculated for the FID and gradient echo
image and compared to each other. As MRI image intensity as such is not
a quantitative measure, and there is no guarantee that the MRI receiver
settings did not change between the different scans, the image intensities at
different resolutions can not be compared directly. Therefore, all intensities
were normalized to the noise level of the image. The noise level was calcu-
lated as the average intensity in five spherical VOIs drawn outside the body.
The normalized intensity is then calculated as:
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Figure 4.3: Coronal slice through the FID images of a healthy volunteer acquired
at 2 mm (left), 4 mm (middle) and 6 mm (right) resolution.
IL,N =
IL
IA
(4.4)
where IL,N is the normalized amplitude in the lungs and IL and IA are the
average image intensities measured in lungs and air respectively.
4.3.1.3 Results
Fig. 4.4 depicts the normalized signal amplitude in the lungs in the FID
image for different resolutions. It shows that the relative amplitude in lung
parenchyma is always higher than unity. This means that the UTE sequence
enables the acquisition of a signal higher than the noise level from lung tissue.
Fig. 4.4 also shows that the normalized amplitude is considerably higher in
images acquired at 4 mm and 6 mm resolution than at 2 mm resolution. This
is explained by the fact that SNR increases with voxel size[234]. Acquisition
at a resolution of 4 mm or more should therefore be preferred, or longer
acquisition times should be used to achieve a higher SNR.
The relation between image intensity in the FID and gradient echo images
is depicted in fig. 4.5. For 2 mm resolution, the signal in both images
is comparable. For a resolution of 4 mm, the gradient echo image shows
considerably less signal than the FID image. With 6 mm resolution, the
difference in signal intensity between the gradient echo image and the FID
image is further increased. It is not entirely clear what the explanation
is for this dependence of the lung signal in the gradient echo image on
resolution. It could be explained using the theory of susceptibility effects
described above. If images are acquired at a high resolution (e.g. 2 mm),
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Figure 4.4: Normalized signal amplitude in the lungs in the FID image acquired
with a UTE sequence for three volunteers and three different resolutions. The
different symbols represent three different volunteers.
there are much less tissue/air interfaces per voxel than at low resolution
(e.g. 6 mm). Therefore, the susceptibility effects within the same voxel are
much lower at a higher resolution. This could lead to a longer apparent T ∗2
when imaging at a higher resolution. However, as the alveoli in human lungs
have average diameters of approximately 150 µm[235], there are already
over 1000 alveoli in a single 2 x 2 x 2 mm voxel. It seems unlikely that an
increase of this number will still lead to larger effects.
These results show that, at high resolution, the imaging of lung tissue with
normal gradient echo sequences is therefore possible. However, the SNR in
images acquired at a high resolution is relatively low. This could be solved by
acquiring for a longer time, but this should be avoided as the imaging time
used to derive the attenuation map should be limited to allow enough time
for other MRI acquisitions. Therefore, these results indicate that acquisition
of UTE images at a resolution of 4 mm would be the best option to visualize
lung tissue.
4.3.2 Cortical bone
4.3.2.1 Origin of short T2
Cortical bone has a short T2 because of the highly organized matrix it con-
sists of. Cortical bone has three main components: hydroxyapatite, collagen
and water. Hydroxyapatite is a mineral form of calcium, with chemical for-
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Figure 4.5: Relative image intensity acquired with a UTE sequence in lung tissue
for three volunteers and three different resolutions. The image intensity in the FID
image (acquired at 0.08 ms) is compared to the image intensity in the gradient
echo image (acquired at 2.3 ms).
mula Ca5(PO4)3(OH). It is organized in a hexagonal crystal system, and
constitutes approximately 50 % of cortical bone. Therefore, it is also called
bone mineral. The calcium atoms in hydroxyapatite are the cause of the
high density of cortical bone.
Collagen is a structural protein and forms the main component of mam-
malian connective tissue. There are different types of collagen, and up
to now 24 different collagen genes have been identified. In cortical bone,
collagen I is predominant and accounts for 30 % of the tissue. Collagen
macromolecules are made up of smaller collagen molecules, which are all
formed by three polypeptide strands wound around each other to produce a
triple helix (fig. 4.6). Assembly of the macromolecules leads to a structural
matrix, which is then mineralized with hydroxyapatite. The third component
of cortical bone, water, is located throughout the collagen matrix as water
molecules bound more or less closely to the collagen.
The protons in hydroxyapatite and collagen have extremely short T2s, due
to their immobility and the strong dipolar interactions between atoms in such
organized structures. They can therefore most likely not be visualized with
MRI[224]. However, the protons in the water molecules that are distributed
throughout the collagen matrix will have longer T2s. Due to the presence
of the collagen matrix they are also relatively immobile. Hence, the T2
of these protons will still be much shorter than the T2 of protons in free
water[236]. Nevertheless, it may be possible to visualize these protons using
UTE sequences. As only 20 % of cortical bone consists of water, the proton
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Figure 4.6: A collagen molecule is a triple helix of three polypeptide strands.
Reproduced from the Wikimedia Commons library under the Creative Commons
- Share Alike license (http://commons.wikimedia.org/wiki/File:Collagen triplehe-
lix.png).
density of cortical bone is also much lower than that of soft tissue. This
may also cause problems for visualization.
4.3.2.2 Methods
To investigate the MRI properties of cortical bone relaxometry measurements
were performed on samples of bovine cortical bone. 5 samples were taken
from the shaft of a bovine femur bone obtained from a local slaughterhouse.
The bovine femur bone was chosen because it has a very thick cortical shell so
that large sample sizes could be obtained. The samples are shown in fig. 4.7.
The samples were analyzed with a Bruker 0.5 T relaxometer (Minispec mq20,
Bruker Optics, Ettlingen, Germany). The proton density was quantified
as a value relative to the proton density of water. The signal amplitude
170 µs after RF excitation of different volumes of water was measured.
Subsequently the signal amplitude of the bone samples was measured with
the same receiver gain settings. The volume of the samples was derived from
a micro-CT scan.
The T2 relaxation time of each sample was measured with an in-house
developed multi spin-echo sequence with Carr-Purcell-Meiboom-Gill phase
alternation[237]. With this sequence 50 consecutive echoes are acquired
after excitation with a 90◦ RF pulse, yielding 50 data points on the transverse
relaxation curve. By fitting an exponential decay function (exp(− tT2 )) to the
acquired data points, the sample averaged transverse relaxation time T2 is
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Figure 4.7: 5 cortical bone samples, taken from a bovine femur bone and used to
evaluate the MRI properties of cortical bone.
determined. The inter-echo time spacing was 170 µs.
4.3.2.3 Results
Fig. 4.8 shows measured signal amplitude versus volume of the cortical bone
samples and 5 samples of distilled water. Linear regression was performed
on both sets, yielding approximate expressions for the signal intensity I as a
function of the sample volume V:
Iwater ≈ 0.175 Vwater (4.5)
Ibone ≈ 0.051 Vbone (4.6)
A unit volume of cortical bone will thus provide approximately 29% ( =
Figure 4.8: Measured signal amplitude versus volume of 5 samples of bovine
cortical bone and 5 samples of distilled water. A linear fit on both data sets is also
shown.
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Figure 4.9: Transverse relaxation curve of one of the bovine cortical bone samples.
0.051
0.175 ) of the signal intensity of a unit volume of water. The signal intensity
in cortical bone is significantly lower than in water, but it should still be
detectable.
A T2 relaxation curve of one of the samples is shown in fig. 4.9. The
T2 values measured in the samples were in the range of 1.37 − 1.70 ms,
with an average over 5 samples of 1.51 ms. This is much shorter than soft
tissue, but with current UTE sequences echo times below 0.1 ms can easily
be reached. These results therefore indicate that the visualization of cortical
bone with UTE sequences should be possible.
4.4 Proposed method
In the previous sections of this chapter, we have introduced UTE sequences
and shown that it is feasible to visualize lung tissue and cortical bone with
those sequences. The question is now how an attenuation map can be
derived from the images acquired with a UTE sequence. In this section,
a method to achieve this is introduced. In the next chapters, the method
for deriving the attenuation map will be slightly modified for each specific
study. For example, the method will be different for human brain studies
than for rat whole-body studies. Therefore, only the basic features that all
investigations in the next chapters have in common are introduced here.
The different steps that have led to the development of our method are
described and illustrated using UTE images of a segment of bovine femur
bone. A segment of bovine femur bone was chosen because it has a very
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Figure 4.10: Slice through the FID (left) and gradient echo (right) image of the
bovine femur bone.
thick cortical shell, which limits interference of partial volume effects. The
center of the bone was yellow bone marrow, which is spongeous bone with
a very low bone content, and hence comparable to soft tissue. As no lung
tissue was present in the bone segment, the method is not evaluated on lung
tissue in this section. However, the method presented here can be easily
extended to segmentation of lung tissue, as is described in the next chapter.
The segment of bovine femur bone was obtained from a local slaugh-
terhouse. It was approximately 8 cm long with a diameter of 5 cm and
a cortical shell with 1 cm thickness. UTE-MRI images were acquired on
a Philips Achieva 3T system (Philips Medical Systems, Best, The Nether-
lands), using the UTE sequence described in section 4.2.3. A standard head
coil was used, and the echo times for the FID and gradient echo images
were 0.09 ms and 1.7 ms respectively. TR was 4.8 ms and the total ac-
quisition time was approximately 4 minutes. The resolution was 1 mm in
a reconstructed matrix of 152 x 152 x 152. As CT is currently the best
method to discriminate tissue density, the images were compared to a CT
of the same segment of bone. The CT was acquired on a Philips Gemini
PET-CT system (Philips Medical Systems, Cleveland, USA). The standard
protocol used for CT-based attenuation correction was used: 50 mAs, 120
kVp. The CT data set was coregistered to the MRI data set using rigid
mutual-information based registration and resampled to the same matrix as
the MRI. A slice through the FID and gradient echo is shown in fig. 4.10.
The same slice through the CT and segmented CT based attenuation map
is depicted in fig. 4.11.
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Figure 4.11: Slice through the CT (left) and segmented CT based attenuation
map (right) of the bovine femur bone.
4.4.1 Image intensity-based segmentation
The simplest method for segmenting the UTE images into air, soft tissue
and cortical bone is by segmentation using a combination of thresholds on
the FID and gradient echo images. Due to the T2s of cortical bone and soft
tissue, cortical bone will have a medium to high image intensity in the FID
image and a low image intensity on the gradient echo image, whereas soft
tissue will have a high signal on both images. Therefore, segmentation can
be done using table 4.1:
Gradient echo
Low High
FID
Low Air (Impossible)
High Cortical bone Soft tissue
Table 4.1: Segmentation matrix for segmentation based on image intensities of
the FID and gradient echo images.
Fig. 4.12 shows the result of segmentation based on the image intensities
in the FID and gradient echo images. The resemblance with the segmented
CT based attenuation map in fig. 4.11 is very good.
4.4.2 Derivation of the R2-map
Although segmentation based on image intensities is possible, as shown
above, this is not a very practical method in MRI. The reason for this is that
the image intensities in MRI are not a quantitative measure, and can vary
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Figure 4.12: Slice through the attenuation map derived from the FID and gradient
echo images using thresholding on the image intensities.
greatly between different acquisitions. This is mainly caused by changes
in the receiver gain settings, which are automatically adapted to the water
content of the object in the scanner. As the user has no control over these
settings, this means that for image intensity based segmentation, the thresh-
olds would have to be set for each acquisition separately. This could be
done manually or automatically based on the histograms. However, another
problem with image intensity based segmentation is that inhomogeneities in
the images could lead to segmentation errors. This can not be solved by
adapting the thresholds for each acquisition. Therefore, it would be better
to use a quantitative parameter as a base for segmentation.
In this work we propose the use of the quantitative parameter R2, the
transverse relaxation rate. It is the inverse of the transverse relaxation time
T2. Recall the transverse relaxation equation, described in section 2.3.2.6:
~Mtr (t) = ~Mtre
−t
T2 (4.7)
Suppose two images are acquired at TE1 and TE2 with the same receiver
gain settings, then the transverse magnetization vector in each of these
images is defined by the T2 of the tissue and the echo times:
~Mtr (TE1) = ~Mtre
−TE1
T2 (4.8)
~Mtr (TE2) = ~Mtre
−TE2
T2 (4.9)
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If the MRI signal only depends on T2 relaxation, which can be assumed
for short echo times, the image intensity in a voxel will be proportional
to the transverse magnetization defined in this equation. An image which
represents the transverse relaxation rate, called the R2-map, can then be
derived from both images by a voxel-by-voxel calculation:
R2 =
ln(I1)− ln(I2)
TE2 − TE1 (4.10)
where I1 and I2 are the image intensities in both images. As the FID and
gradient echo images obtained from the UTE sequence are acquired with the
same receiver gain settings, we can derive the R2-map from those images.
The first image is then the FID image and the second image is the gradient
echo image.
R2 does not depend on receiver gain, and should not be affected by image
inhomogeneity. It can therefore be used as a quantitative parameter for
segmentation. In the R2-map, we expect tissues with a long T2 to have a
low value and tissues with a short T2 to have a high value. This means that
cortical bone will have a higher value than soft tissue in the R2-map.
Fig 4.13 shows the R2-map obtained from the segment of bovine femur
bone, showing high intensity in cortical bone and low intensity in soft tissue.
However, voxels outside the piece of bone, which contain air, exhibit low
as well as high R2 values. The joint histogram of the R2-map and the CT
image is shown in fig. 4.14. This shows that, although cortical bone and
soft tissue can be perfectly separated, air voxels can not be discriminated
from cortical bone or soft tissue based on R2 alone. This is explained by the
logarithms used in the definition of R2 in eq. 4.10 and the low quality of the
FID image. The numerator of eq. 4.10 is equal to:
ln I1 − ln I2 = ln I1
I2
(4.11)
when the denominator of the argument of the logarithm is small, a small
absolute change in the value of the numerator will have a large effect. This
is the case in voxels containing air, where the image intensity is very low in
the gradient echo image. However, due to its lower quality the FID image
contains more noise. Therefore, there will be a larger variation in I1 than in
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Figure 4.13: Slice through the uncorrected R2-map of the bovine femur bone.
I2. This leads to a large variation in R2 for voxels containing air, as shown
in fig. 4.14. This causes problems for segmentation, as voxels containing air
could be segmented as soft tissue or cortical bone. In the next paragraph, a
solution to this problem will be proposed.
4.4.3 Air mask
To allow direct segmentation from the R2-map into air, soft tissue and cor-
tical bone, a step is needed in which R2 in voxels containing air is corrected.
This would allow perfect separation of these tissue types. In our method,
Figure 4.14: Joint histogram of the uncorrected R2-map and the CT of the bovine
femur bone.
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Figure 4.15: Slice through the corrected R2-map (left) and attenuation map
derived from the corrected R2-map (right) of the bovine femur bone.
this is done by multiplying the R2-map with a binary mask, in which all
voxels containing air are set to zero and all other voxels are set to 1. As
there is almost no contrast between air and cortical bone in the gradient
echo image, this mask can only be derived from the FID image.
The mask is derived in two steps. First a region-growing approach is used
to determine the outer contour of the patient (or phantom). Eight seeds
are used, placed at the outer corners of the image. Starting from these
seeds all neighboring voxels which have an intensity below a certain value
(outer threshold intensity, Ith,o) are set to 0. Next all voxels which have an
intensity below a different threshold (inner threshold intensity, Ith,i ) but are
not necessarily connected to the region that was grown in the first step are
also set to 0. All remaining voxels are set to 1. The mask is derived in two
steps because the high intensity of the border of the patient, mainly caused
by fat in the skin, allows for a higher threshold outside than inside the patient.
Fig. 4.15 shows the corrected R2-map and fig. 4.16 shows the joint
histogram of the corrected R2-map and the CT. As all air voxels are set to
zero in the R2-map, perfect separation of air, soft tissue and cortical bone
is now possible based solely on the corrected R2-map. The derivation of
the attenuation map from the corrected R2-map can now be done using a
simple mapping:
µ(R2) = 0 cm−1 R2 = 0 ms−1 (air)
= 0.097 cm−1 0 ms−1 < R2 < 0.5 ms−1 (soft tissue)
= 0.13 cm−1 R2 ≥ 0.5 ms−1 (bone)
The threshold value 0.5 ms was obtained from the measurement of the
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Figure 4.16: Joint histogram of the corrected R2-map and the CT of the bovine
femur bone.
T2 of cortical bone, described above. Fig. 4.15 shows the segmented atten-
uation map derived from the corrected R2-map. It resembles the CT-based
attenuation map in fig. 4.11 very well.
4.5 Conclusion
In this chapter, UTE sequences were introduced as a possibility to visualize
lung and cortical bone using MRI. The feasibility of acquiring measurable
signal was evaluated for lung and cortical bone separately. For lung, the
results indicate that lung tissue is best imaged using a UTE sequence with
moderate resolution (≈ 4 mm). The proton density and T2 of cortical
bone was investigated using relaxometry. Although the proton density of
cortical bone is significantly lower and its T2 much shorter than most tissues,
visualization using UTE sequences should be possible.
In the last section of this chapter, a method was proposed which allows the
discrimination of air, soft tissue and cortical bone based on images acquired
with a UTE sequence. As image intensities can vary between different MRI
studies, the quantitative parameter R2 was used for segmentation. The R2-
map, which is derived from the FID and gradient echo images, needs to
be corrected to set all voxels containing air to zero. From this corrected
R2-map, an attenuation map can be derived using a simple mapping. This
basic method will be modified in the next chapters to allow the derivation of
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attenuation maps in different situations. For example, it will be modified to
discriminate lung as well for studies where lung tissue is present in the field
of view.
4.6 Original contributions
The evaluation of the MRI properties of cortical bone was presented at the
IEEE NSS/MIC conference in 2008[238] and was also included in a A1 journal
paper[239]. The UTE-MRI-based method using the corrected R2-map was
first presented at the ISMRM conference in 2009[240]. A patent application
was also submitted for that method[241].
Chapter 5
Phantom experiments
5.1 Introduction
In the previous chapter a method was proposed to derive the attenuation
map from MRI images acquired with a UTE sequence. The feasibility of
generating contrast between air and bone was shown using a very simple
object, i.e. part of bovine femur bone. However, the method is intended to
be used to derive the attenuation map for animals and humans, which are
far more complex structures. Therefore, the question can be posed if the
method will also work on more realistic objects. Before testing our method
on real animal (chapter 6) and real human (chapter 7) data, it is tested on
different phantoms in this chapter.
In medical imaging, phantoms are often used to evaluate the performance
of scanners. There are a number of advantages to using phantoms instead
of real patients for this. Most importantly, phantom experiments are repro-
ducible. This allows comparing different scanners or different scanner set-
tings while imaging exactly the same object. Second, phantoms themselves
can also be reproduced. This enables the possibility of using comparable
phantoms in different locations, allowing comparison of results obtained by
different groups. Third, phantoms are rigid structures. This allows easy
coregistration, contrary to patient imaging where small registration errors
are unavoidable. Phantom experiments are also simple to organize and per-
form. Finally, there is also the advantage that the radiation dose delivered
to the phantom is of no concern. When imaging with modalities that use
ionizing radiation, such as CT, PET or SPECT, this means that phantom
experiments can be repeated as much as needed.
Phantoms can consist of mathematical shapes, such as cylinders and
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Figure 5.1: The Alderson phantom, a good example of an antropomorphic phan-
tom used in PET, SPECT and CT.
spheres. These phantoms are mostly used to evaluate image quality prop-
erties, such as contrast, noise, uniformity, etc. In emission tomography,
the Jaszczak phantom is used very often. More realistic phantoms can also
be made, which are intended to resemble the human or animal body. The
Alderson phantom, depicted in fig. 5.1, is a good example. It can be used
for CT, PET and SPECT. As it is shaped like the human body, it is called
an antropomorphic phantom. Such an antropomorphic phantom allows a
more realistic evaluation of how the scanner will perform in a real imaging
situation.
Phantoms are usually constructed of synthetic material, such as different
kinds of plastics, and filled with water to resemble the human body. For
CT, PET and SPECT, other structures such as bone or lung can be mim-
icked by inserting materials with different densities into the phantom. In
an MRI phantom, different tissues or pathological processes can be simu-
lated by doping water with specific compounds that change the relaxation
properties[242]. However, as far as we know, there are currently no materials
that mimic the behavior of protons in tissues with special relaxation proper-
ties, such as lung and cortical bone. Rubber has a short T2 and can be used
to evaluate the performance of UTE sequences[229]. The origin of the short
T2 of rubber lies in its molecular structure, and the mechanism is therefore
comparable to the fast relaxation of cortical bone. However, the specific
relaxation behavior of protons in the lung, mostly due to the inhomogeneous
structure of the lung, can not be modeled with rubber. As cortical bone
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and lung are two important tissues in attenuation correction, this poses a
problem for our investigation. Also, there is the added difficulty that we are
working in a multi-modal setting, and a phantom therefore needs to appear
realistic on MRI, CT and PET or SPECT. There are currently no phantoms
available that are realistic on all modalities. There are even no materials
available that mimic cortical bone or lung realistically.
Therefore, we have designed different multimodality phantoms to evalu-
ate our method. Due to the lack of realistic synthetic materials, biological
materials were used in these phantoms. First, the head of a pig is used as
a phantom for human brain imaging. Afterwards a human thorax phantom
is presented. For both phantoms, the description of the design of the phan-
tom is followed by the evaluation of the performance of our method on the
phantom.
5.2 Human brain imaging: pig head phantom
5.2.1 Materials and methods
5.2.1.1 Phantom construction
The human head contains mostly soft tissue, but also bone structures (skull,
facial bones) and air cavities (sinuses, nasal cavity). A realistic phantom for
human brain imaging should therefore contain air, soft tissue and bone. The
head of a pig was chosen for this, as it contains all three tissue types and
has a complexity that is roughly comparable to that of the human head. It
is also rigid, as is the human head. The pig head was obtained from a local
slaughterhouse, and stored in the freezer in between acquisitions to prevent
decomposition. As freezing can alter MRI signal, it was always defrosted
before a MRI acquisition. A sagittal slice of a MRI image of the pig head is
shown in fig. 5.2 to illustrate its structure. As the pig head is completely
filled with tissue, no activity can be added to the phantom. For this reason,
no PET or SPECT images were acquired but only CT and MRI images.
5.2.1.2 CT and MRI acquisitions
MRI acquisitions were done on an Achieva 3T system (Philips Medical Sys-
tems, Best, The Netherlands). The UTE sequence described in section 4.2.3
was used. A combination of Philips Flex coils was used to achieve a field-
of-view large enough to cover the entire phantom. The flex coils are very
simple coils, which allow very fast switching to receive mode, and hence
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Figure 5.2: Sagittal slice of a gradient echo MRI image of the pig head phantom.
yield a very short echo time for the FID. For the FID, the shortest possible
echo time was used (0.072 ms). The echo time for the gradient echo was
1.747 ms. The repetition time was chosen as short as possible (TR = 4 ms)
to reduce total image acquisition time. The images were reconstructed to a
176 x 176 x 176 voxel matrix with 1.875 mm isotropic voxel dimension. This
resulted in a field of view covering a sphere with 165 mm radius. CLEAR
(Constant LEvel AppeaRance) coil sensitivity correction was used to correct
for the highly non-uniform sensitivity of the Flex coils. The total imaging
time was approximately 3.5 minutes.
A CT scan of the pighead phantom was acquired on a Philips Gemini
TF PET-CT scanner (Philips Medical Systems, Cleveland, USA) using the
following parameters: 120 kVp, 200 mAs and 1.5 mm slice thickness. The
in-plane resolution was 1.17 mm. The size of the reconstructed matrix was
512 x 512 x 264 voxels.
5.2.1.3 Derivation of attenuation maps
Before the attenuation maps were derived from the CT and MRI images,
the CT images were registered to the MRI images. This was done using
rigid 3D registration based on an optimization of the mutual information
metric, as implemented in the Insight Toolkit[243]. The CT images were
then resampled to the matrix of the MRI images. Two attenuation maps
were derived: CT-based and UTE-MRI-based. As no activity can be injected
into the phantom, the performance of the algorithm can only be evaluated
by assessing the ability of the algorithm to discriminate air, soft tissue and
bone. Therefore, segmented attenuation maps were used. The segmented
CT-based attenuation map was obtained by mapping CT Hounsfield units
(HU) to linear attenuation coefficients at 511 keV:
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µ (cm−1) = 0 HU ≤ −800 (air)
= 0.097 −800 < HU ≤ 200 (soft tissue)
= 0.13 HU > 200 (bone)
(5.1)
For the UTE-MRI-based attenuation map, the corrected R2-map was first
derived using the algorithm described in section 4.4. The attenuation map
was then derived from the corrected R2-map by mapping R2 to linear atten-
uation coefficients:
µ (cm−1) = 0 R2 = 0 (air)
= 0.097 0 < R2 ≤ 0.5 (soft tissue)
= 0.13 R2 > 0.5 (bone)
(5.2)
This yields an attenuation map in which air, soft tissue and bone are
discriminated.
5.2.1.4 Analysis
The accuracy of the UTE-MRI-based attenuation map was evaluated by per-
forming a voxel-by-voxel comparison to the segmented CT-based attenuation
map. For each tissue class on the CT-based attenuation map, the percent-
age of voxels that was assigned to the correct and incorrect tissue classes
was calculated. A region of interest was chosen inside the head to avoid
deterioration of the results by the oversegmentation of skin, as explained
below.
5.2.2 Results
Transverse slices of the FID and gradient echo image are shown in fig. 5.3.
In areas of cortical bone (the jawbone is indicated) the signal intensity is
medium to high in the first echo image and much lower in the second echo
image. Soft tissue has a medium to high signal content in both images,
whereas air has a low signal intensity in both images. These observations
agree with the expectations. The quality of the first echo image is not
very good, showing a lot of artefacts. The reasons for this are described
in chapter 4. The uncorrected R2-map is shown in fig. 5.4A. The high R2
value of cortical bone is clear, but cavities containing air also show voxels
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Figure 5.3: Transverse slice of the FID (A) and gradient echo (B) image of the
pig head phantom.
with a high R2. The corrected R2-map shown in fig. 5.4B shows distinctive
intensity values in bone, soft tissue and air regions.
The same transverse slice of the segmented UTE-MRI is shown in fig. 5.5A
together with the segmented CT (fig. 5.5B). The results of the quantitative
evaluation of the classification accuracy of our method are depicted in fig.
5.6. A large majority of the voxels is assigned to the correct tissue class:
89 % for bone, 91 % for soft tissue and 82 % for air. The discrimination
between tissue (either soft or bone) and air is correct in 97 % of the voxels.
5.2.3 Discussion
In the UTE-MRI-based attenuation map it is clear that major bone structures
such as the jawbones are correctly segmented. The air cavity in the middle is
also detected. Some segmentation errors are visible, mainly an overdetection
Figure 5.4: Transverse slice of the uncorrected (A) and corrected (B) R2-map of
the pig head phantom.
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Figure 5.5: Transverse slice of the segmented UTE-MRI-based (A) and segmented
CT-based (B) attenuation map of the pig head phantom. Air is depicted in black,
soft tissue in grey and bone in white.
of bone in the central part of the phantom and in the skin. The latter is
possibly in part related to the high collagen content and thick constitution
of porcine skin. Collagen is also present in cortical bone and is in part
responsible for the short T2 of cortical bone. Although the human skin also
contains a lot of collagen, it is thinner so it is expected not to cause the
same amount of error. This will also be shown in the clinical brain images
in chapter 7.
The quantitative results show that our method is quite accurate in dis-
Figure 5.6: Results of the voxel-by-voxel comparison of the segmented UTE-MRI
and segmented CT.
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criminating air, soft tissue and bone. The tissue/air discrimination is very
accurate, which is most important. As was shown in the simulation study
in chapter 3, a segmentation algorithm should be designed so that bone
is more likely to be misclassified as soft tissue rather than as air. This is
clearly the case with our algorithm. As no PET images are available it is
not possible to say what the effect of these errors on the reconstructed PET
images would be. However, with an overall segmentation accuracy of around
90 % for bone and soft tissue and around 80 % for air, the results from the
simulation study indicate that it should be possible to obtain quantitatively
accurate images.
5.3 Human thorax phantom
5.3.1 Materials and methods
5.3.1.1 Phantom construction
The human thorax contains air, lung, soft tissue, spongeous bone and cortical
bone. Hence, a good thorax phantom should contain these tissue types.
Water is a good equivalent for soft tissue on PET, CT and MRI. For lung and
bone, it is more difficult to find a simple equivalent. Therefore, biological
tissue was used. To allow evaluation of the effect of attenuation on the
reconstructed PET or SPECT images, a fillable phantom is needed.
For the lung part of the phantom, a lobe of a pig lung was used. It
was obtained from an adult female pig sacrificed after a cardiac surgery
experiment. As the lung was maintained open inside the body by the negative
pressure within the chest cavity, it collapsed once it was exposed to normal
atmospheric air pressure. Therefore it had to be reinflated mechanically. A
cannula was inserted into the main bronchus of the lobe and fixed air-tight.
The lung was inflated using a positive pressure ventilator available in the lab
(fig. 5.7). Once the lung was inflated the cannula was sealed air-tight and
the lung was submersed in 4 % formaldehyde solution for 48 hours to allow
fixation. This is necessary to allow long-term storage of biological tissue.
For the bone part of the phantom, only cortical bone was modeled. Spon-
geous bone was not taken into account, as it is usually visible on conventional
MRI sequences and hence it is not needed to evaluate the accuracy of our
method. A section of a bovine femur bone was used, comparable to the one
used in the previous chapter. A bovine femur bone was obtained from a local
slaughterhouse. A piece from the middle of the shaft was cut out. The bone
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Figure 5.7: The collapsed (left) and reinflated (right) lobe of pig lung.
has a thick cortical layer (≈ 10 mm) and a center filled with yellow bone
marrow, which can be considered adipose tissue. The marrow was removed
from the cylinder as it is not relevant for this experiment. This yielded a
piece of cortical bone approximately cylindrically shaped with inner radius
≈ 10 mm, outer radius ≈ 20 mm and height ≈ 80 mm. The cylindrical
shape of the bone allows it to be used as a rough model for the spine, which
is the most important bone in thoracic imaging. It was also stored in 4 %
formaldehyde solution.
The container of a Jacszak phantom was used as a base for the phan-
tom. This is a PMMA cylinder with height 200 mm and diameter 220 mm.
4 CT-MRI markers were attached to the surface of the cylinder to allow
coregistration between CT and MRI. The bone was screwed to the floor of
the cylinder with a plastic screw. The lung was fixed to three plastic rods
inserted in the floor of the cylinder using suture wire. Two hot spheres with
10 mm radius were filled with 18F-FDG and inserted. A cold sphere was also
inserted. The phantom was then filled with water containing a lower activity
concentration of 18F-FDG. The ratio of the activity concentration in the hot
spheres to the background was 8:1. The total activity inside the phantom
was approximately 2 mCi. There was no activity in the lung. Fig. 5.8 shows
a picture of the assembled phantom, before it was filled. The color of the
lung has changed from pink in fig. 5.7 to grey-brown in fig. 5.8. This is due
to the fixation with formaldehyde.
5.3.1.2 Acquisitions
CT, PET and MRI images of the phantom were obtained. First a standard
low-dose CT (50 mAs, 120 kVp), usually used to derive the attenuation map
in clinical studies, was acquired on a Gemini TF system (Philips Medical Sys-
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Figure 5.8: The assembled thorax phantom, containing a segment of bovine
cortical bone and a lobe of pig lung.
tems, Cleveland, USA). The slice thickness was 5 mm with 1.18 mm in-plane
resolution. The reconstructed matrix was 512 x 512 x 36. Subsequently, a
PET was acquired on the same system. The acquisition time for the PET
was 5 minutes.
The phantom was then moved to the MRI facility. A UTE-MRI scan was
acquired on a Siemens Magnetom 3T system (Siemens, Erlangen, Germany).
The UTE sequence was comparable to the one described in section 4.2.3.
FID and gradient echo times were 0.08 ms and 3.2 ms respectively. The
images were reconstructed to a 122 x 122 x 32 matrix with 4 mm isotropic
voxel size. The MRI acquisition time was approximately 2 minutes.
5.3.1.3 Derivation of attenuation maps
UTE-MRI images were coregistered to the CT images with AMIDE by using
the 4 CT-MRI markers as fiducial markers[244]. As the PET and CT im-
ages were acquired on the same bed, the UTE-MRI images are automatically
coregistered to the PET images. CT-based and UTE-MRI-based attenua-
tion maps were derived. The CT-based attenuation map was derived using
bilinear scaling of CT Hounsfield units to linear attenuation coefficients at
511 keV, as is the gold standard in human whole-body imaging[198]:
µ (cm−1) = 0.097 HU+10001000 HU ≤ 0
= 0.097 + 0.057 HU1000 HU > 0
(5.3)
5.3 Human thorax phantom 125
The derivation of the UTE-MRI-based attenuation map can be done using
a method comparable to the one presented in the previous section, modified
to discriminate lung tissue as well. This can be done based on the R2 as well.
First the corrected R2-map is derived as described in section 4.4. Then, a
mapping from R2 to µ is performed:
µ (cm−1) = 0 R2 = 0 (air)
= 0.097 0 < R2 ≤ 0.5 (soft tissue)
= 0.03 0.5 < R2 ≤ 0.9 (lung)
= 0.13 R2 > 0.9 (bone)
(5.4)
This yields an attenuation map which discriminates air, lung, soft tissue
and bone.
5.3.1.4 PET reconstruction
The PET images were reconstructed with the CT-based and UTE-MRI-
based attenuation map. This was done using the ML-EM algorithm and
based on the raw PET data obtained directly from the scanner. Apart from
attenuation correction, geometric sensitivity correction was performed using
the same method as described in section 3.4. Scatter correction was not
implemented as the phantom was relatively small. Random coincidences
were not corrected as the total activity in the phantom was low so the
random fraction should be limited.
5.3.1.5 Analysis
A spherical volume of interest (VOI) with 10 mm radius was drawn in the
lung and in the bone. The average values inside these VOIs on the CT and
the R2-map were calculated to verify if the materials in the phantom have
realistic values on both modalities. To evaluate the quantitative accuracy of
the PET images reconstructed with the UTE-MRI-based attenuation map, 3
VOIs with 10 mm radius were drawn over the hot and cold spheres. The total
activities in the spheres with UTE-MRI-based attenuation correction were
compared to the total activities in the spheres with CT-based attenuation
correction.
5.3.2 Results
A sagittal slice of the CT image is shown in fig. 5.9. The same slice of the
FID and gradient echo images is depicted in fig. 5.10. The density of the
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Figure 5.9: A sagittal slice of the CT image of the thorax phantom.
lung and bone on the CT image is comparable to what is seen in clinical
data sets. The average values of lung and bone were -630 HU and 1300
HU respectively. The corrected and uncorrected R2-maps are shown in fig.
5.11. The average R2 value of lung and bone was 0.70 ms−1 and 1.05 ms−1
respectively.
Fig. 5.12 shows the attenuation maps used for PET reconstruction. A
transverse slice through both reconstructed PET images at the location of
the spheres is shown in fig. 5.13. A coronal slice is also shown in fig. 5.14.
Quantitative evaluation showed that there was an average underestimation
of the activity in the hot spots of 2 % using the UTE-MRI-based attenuation
correction. In the cold spot there was also an underestimation of 2 %.
5.3.3 Discussion
The average HU and R2 values that are found in the lung are comparable to
what is seen in clinical data sets. This shows that the pig lung used in the
phantom is a realistic representation of human lung. The values observed
in cortical bone are also realistic. The phantom can therefore be used to
evaluate the performance of our method, in particular to determine if our
method can discriminate air, lung, soft tissue and bone based on UTE-MRI
signal alone. Although the bone and lung are realistic, the phantom does
not model the composition of the human body accurately. For example,
a real thorax contains two lungs and contains a spine that runs along the
complete axial length. Because of this limitation, the phantom can not
Figure 5.10: A sagittal slice of the FID (left) and gradient echo (right) image of
the thorax phantom.
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Figure 5.11: A sagittal slice of the uncorrected (left) and corrected (right) R2-map
of the thorax phantom.
Figure 5.12: A sagittal slice of the CT-based (left) and UTE-MRI-based (right)
attenuation map used for reconstructing the PET images of the thorax phantom.
Figure 5.13: A transverse slice of the PET image of the thorax phantom recon-
structed with CT-based (left) and UTE-MRI-based (right) attenuation correction.
Figure 5.14: A coronal slice of the PET image of the thorax phantom recon-
structed with CT-based (left) and UTE-MRI-based (right) attenuation correction.
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be used to test methods that rely on assumptions about patient anatomy.
All current methods that have been proposed for whole-body MRI-based
attenuation correction methods fall into this category. Designing a phantom
that is more antropomorphic would allow evaluation of those methods as
well, enabling comparison of the performance of different methods.
The UTE-MRI images show that there is signal in the bone and the lung
in the FID image. In the gradient echo image, most of this signal has
disappeared, as was expected. The signal in the water is comparable in
both images. The R2-maps show that the bone and lung have very high
R2 compared to the water. The uncorrected R2-map also shows a high R2
outside the phantom, due to the noise in the air surrounding the phantom.
This is fixed in the corrected R2-map.
Comparison of both attenuation maps shows that our method can discrim-
inate air, lung, soft tissue and bone quite well. There are a few segmentation
errors in the bone, which lead to bone being segmented as lung tissue, but
these are limited. This happens because the R2 in some voxels is just below
the threshold for bone. These voxels are segmented as lung tissue in the
attenuation map. Both reconstructed PET images are comparable, and no
visual differences can be seen. The quantitative evaluation also reflects this,
as only a very small deviation in total counts in the spheres is found.
These results indicate that our method could be used to derive an atten-
uation map which discriminates air, lung, soft tissue and bone. Although
small classification errors are made, these have only a minor effect on the
reconstructed PET images. However, one should keep in mind that these
results only prove that these tissue types can be discriminated in an ideal sit-
uation. In a real imaging situation, there will be different effects which may
pose extra problems. First of all there can be physiological motion of the
heart and lungs in the thorax. Second, the field of view in clinical imaging
will be larger, which will increase acquisition time. A last remark is that the
bone structures in a real body are much more complex and usually smaller
than the segment of bone that was used here. Bone may therefore be much
more difficult to discriminate in a real data set.
5.4 Conclusion
In this chapter our method was tested on two phantoms. The data obtained
with the pig head phantom, used as a model for human brain imaging, show
that classification of UTE-MRI images into air, soft tissue and bone can be
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done with our method. Limited classification errors are made, but mostly
between bone and soft tissue. This is much better than classification errors
between air and tissue (either soft tissue or bone). As it was not possible to
fill the pig head phantom with activity, we could not evaluate the effect of
reconstructing with the UTE-MRI-based attenuation map on a reconstructed
PET image. However, from the data of the simulation study we expect that
the effect of the classification errors will be limited.
A thorax phantom was presented in the second part of this chapter. It con-
tains bovine bone and pig lung to model bone and lung realistically on PET,
CT and MRI. The results indicate that our method enables the discrimina-
tion of air, lung, soft tissue and bone based solely on MRI data. Because the
phantom could be filled with activity, the effect of the limited errors in the
UTE-MRI-based attenuation map on the reconstructed PET images could
be tested. The results indicate that the errors cause only small quantitative
differences. However, the thorax phantom is structured much simpler than
a real human thorax, and does not exhibit any motion. Application of our
method to real animal and human data may therefore be more difficult. This
will be investigated in the next chapters.
5.5 Original contributions
The use of a pig head as a phantom for evaluation the performance of MRI-
based attenuation correction was first presented at the IEEE NSS/MIC con-
ference in 2008[238] and also at the annual meeting of the ISMRM Benelux
chapter[245]. The evaluation of the classification accuracy of our method on
the pig head phantom was included in a A1 journal paper[239]. The design
of the thorax PET-CT-MRI phantom was accepted for presentation at the
IEEE NSS/MIC conference in 2011[246].
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Chapter 6
Preclinical imaging
experiments
6.1 Introduction
In the previous chapter our UTE-MRI-based attenuation correction method
was tested on phantom data. The eventual goal of developing a MRI-based
attenuation correction method is to use this method to perform attenuation
correction in real emission tomography studies. As was described in chapter
2, micro-PET and micro-SPECT are important tools in current preclinical
research, and attenuation correction is also necessary for quantitative small
animal imaging. As micro-PET inserts for MRI scanners are already avail-
able and micro-SPECT-MRI is being developed, a MRI-based attenuation
correction method for small animal studies is also needed.
The current gold standard for attenuation correction in small animal imag-
ing is micro-CT-based attenuation correction. As was already described,
the derivation of an attenuation map from CT images is straightforward.
However, there are two specific disadvantages to the use of micro-CT for
attenuation correction in preclinical imaging. First, micro-CT delivers soft
tissue contrast which is even poorer than clinical CT. For vessel imaging,
this can be solved by using large amounts of contrast agent. This leads
to problems in the attenuation map, as the attenuation coefficients of the
contrast agents can not be rescaled in the same way as biological tissue.
Bonta et al.[247] have shown that this leads to significant errors in the
reconstructed image for clinical SPECT studies, but the effect on preclinical
imaging has not been studied. It should be noted that high doses of con-
trast agent can also be toxic for the animals. Second, the dose delivered to
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the animal can be quite high (> 0.1 Gy). It has been proposed that this
could effect study outcome in longitudinal studies which use many micro-CT
scans[112, 113, 248, 249]. The dose could have an effect on e.g. tumor
metabolism or on the immune system of the animal. These two reasons
provide additional motivation to develop a MRI-based attenuation correction
method for small animal imaging.
In this chapter the feasibility of MRI-based attenuation correction for emis-
sion tomography of small animals is investigated. This is done for micro-
SPECT as well as for micro-PET. First a large micro-SPECT study, com-
prising a total of 18 rats, is described. Four different tracers, each tar-
geting a different organ, were used to evaluate the effect of MRI-based
attenuation correction throughout the complete body of the rat. The im-
ages reconstructed with different MRI-based attenuation correction methods
are compared to the images reconstructed with micro-CT-based attenuation
correction. A smaller micro-PET study was also performed, to illustrate the
applicability of the method to micro-PET. For that study 3 dead rats were
used, and artificial lesions were implanted in different regions of the rat body.
6.2 Rat micro-SPECT-MRI
6.2.1 Materials and Methods
6.2.1.1 Acquisitions
Animal preparation
18 Hsd:Wistar rats were imaged in total. All rats weighed approximately
300 g and were no older than 8 weeks. Different radiotracers were used for
micro-SPECT imaging. All radiotracers were administered via the tail vein.
For the brain study, five rats were injected with 330 MBq of 99mTc-labeled
hexamethylpropyleneamine oxime (HMPAO). A total of 13 rats were imaged
for the body studies. Five rats were injected with 110 MBq of 99mTc-labeled
dimercaptosuccinic acid (DMSA, kidney tracer), five rats were injected with
300 MBq of 99mTc-labeled colloids (liver and spleen tracer) and five rats
were injected with 150 MBq of 99mTc-labeled macro-aggregated albumin
(MAA, lung tracer). Of the rats injected with colloids two died before the
MRI acquisition could be finished, so results from only 3 colloid scans will be
presented here. The rats were anesthetized with an intraperitoneal dose of
115 µl pentobarbital per 100 g body weight. This dose was slightly higher
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than the normal dose (100 µl per 100g body weight) to keep the animals
anesthetized long enough to perform all acquisitions.
Micro-SPECT and micro-CT acquisitions
Micro-SPECT imaging was done on a dual-head Siemens e.cam clinical
gamma camera (Siemens Medical Systems, Erlangen, Germany) using two
multipinhole collimators. Each collimator had three pinholes with 1.5 mm
knife-edge pinhole apertures. The total micro-SPECT acquisition time was
30 minutes. The system is described in more detail in [250]. The rats were
then moved to the micro-CT scanner in the adjacent room while remaining
on the same bed. A micro-CT was acquired on a SkyScan 1178 high-
throughput in vivo micro-CT system (Skyscan, Kontich, Belgium). The CT
settings were 50 kV and 615 µA. The acquisition time for the micro-CT
was 2 min. The images were reconstructed with the software provided by
the scanner manufacturer into a 1024 x 1024 x 1024 matrix with 0.083 mm
isotropic voxel size.
MRI acquisitions
MRI acquisitions were performed on a clinical MRI system (Achieva 3T,
Philips Medical Systems, Best, The Netherlands). A standard wrist coil was
used for the brain scans. A standard knee coil was used for the body scans.
Images were acquired with the UTE sequence described in section 4.2.3. For
the brain scans, UTE-MRI images were acquired at an isotropic resolution
of 0.5 mm and with FID and gradient echo times (TE1 and TE2) set to
0.15 and 2.4 ms respectively. Two averages were acquired to improve signal
to noise, yielding a total acquisition time of 35 minutes for a field of view
of 75 mm x 75 mm x 75 mm. For the body scans the resolution was 0.7
mm and a larger field of view was acquired to include almost the complete
body of the rat ( 75 mm x 75 mm x 177 mm ). To allow acquisition of a
non-spherical FOV, a modified version of the UTE sequence was used which
performs non-isotropic radial sampling[251]. Only one average was used to
keep the acquisition time acceptable (40 minutes).
6.2.1.2 Registration
Micro-SPECT, micro-CT and MRI images were registered using rigid regis-
tration methods. To restrict movement when moving the rats between dif-
ferent scanners, the rats were placed inside a plastic tube before the start of
the experiment. Two small syringes filled with water were also placed inside
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Figure 6.1: Illustration of the fiducial markers used for coregistration of the MRI
images to the micro-CT images for the micro-SPECT brain studies. Three anatom-
ical markers were used: the tip of the nose and the entrances of the left and right
ear canal. The markers (yellow +) are illustrated on transverse and sagittal slices
of a micro-CT (left) and MRI (right) image.
the plastic tube to help with the registration. The registration of micro-
SPECT and micro-CT images was done using two circular discs placed on
the bed used for both modalities. Each disc contained three 3.7 MBq 57Co
point sources. The method is described and validated in [252].
As the 57Co point sources are not visible on MRI images, the same method
could not be used to for the MRI images. The MRI images were regis-
tered to the micro-CT images using A Medical Image and Data Examiner
(AMIDE)[244] by selecting fiducial markers on both CT and MRI images
and applying the implemented alignment wizard. Different fiducial markers
were used for the brain scans and the body scans. For the brain scans 3
anatomical fiducial markers were used: the tip of the nose and the entrances
of the left and right ear canal, as shown in fig. 6.1. Four fiducial markers
were used for registration of the body scans: both ends of the water syringes
placed inside the plastic tube, depicted in fig. 6.2. After registration the
micro-CT and MRI images were resampled to the same matrix as the micro-
SPECT images. This was a matrix of 128 x 128 x 128 voxels with isotropic
voxel size of 0.5 mm for the brain scans and a matrix of 128 x 128 x 256
with the same isotropic voxel size for the body scans.
6.2.1.3 Attenuation maps
The goal of this study is to evaluate the performance of different methods
of MRI-based attenuation correction, compared to the currently used atten-
uation correction on the system (micro-CT-based attenuation correction).
Therefore different attenuation maps were derived. All attenuation maps
described in this section, derived for one of the DMSA (kidney) scans, are
shown in fig. 6.5C-F. As all micro-SPECT imaging was done with 99mTc,
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Figure 6.2: Illustration of the fiducial markers used for coregistration of the MRI
images to the micro-CT images for the micro-SPECT body studies. Four markers
were used: both endpoints of two syringes filled with water. The two endpoints of
one syringe are shown on a sagittal slice of a micro-CT (left) and a MRI (right).
attenuation coefficients for 140 keV photons were used. First of all, the
micro-CT-based attenuation map is derived. As micro-CT-based attenuation
correction is currently the best available method for attenuation correction
in micro-SPECT imaging, we can consider this attenuation map as the ref-
erence. The micro-CT image is first downsampled to the resolution of the
micro-SPECT image by summing several neighbouring voxels together. This
also acts as a smoothing operator and reduces noise in the micro-CT. The
attenuation map is then derived from the micro-CT image by rescaling the
micro-CT value in each voxel according to the formula:
µ (cm−1) = 0.15
I
Iwater
(6.1)
where I is the micro-CT value in the voxel and Iwater is the micro-CT value
of water, which is calibrated daily. The micro-CT values obtained from the
scanner are positive values with air = 0 and increase with measured tissue
density. As 0.15 cm−1 is the linear attenuation coefficient of water at 140
keV, this formula yields a linear scaling from the attenuation measured by CT
to the attenuation coefficient for 140 keV photons. A linear scale was used
rather than a bilinear scale (used e.g. in CT-based attenuation correction
for clinical PET) as Brown et al. showed that the relationship between CT
values and attenuation coefficients is linear to a good approximation for low
energies up to 140 keV[253].
Three attenuation maps were derived from the MRI images, each using
a different segmentation approach. Two of them can be derived from a
conventional (non-UTE) MRI image. In our study the second (gradient
echo) image of the UTE acquisition was used for this, as it is a normal
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Figure 6.3: Image processing steps used to derive an attenuation map from UTE-
MRI images of a rat.
T1-weighted MRI image. A uniform (contour) attenuation map was derived
by using region growing to determine the contour of the animal and set-
ting the attenuation coefficient inside the contour to 0.15 cm−1. A second
attenuation map discriminating only soft tissue and air was extracted from
the gradient echo image by simple thresholding. As there is no signal in the
lungs in this image, this means that voxels in the lungs will be assigned air
attenuation coefficients (0 cm−1). Theoretically this should also happen in
voxels containing bone, but this was not the case as is discussed in section
6.2.3. The second attenuation map was not derived for the brain scans,
as there is no lung tissue in the head. Consequently, this attenuation map
would be identical to the contour attenuation map.
In the small animal simulation study described in chapter 3, it was shown
that air, lung and soft tissue should be discriminated in the attenuation
map in rat studies. Discrimination of bone is not strictly necessary, but can
provide even more accurate results. As described in chapter 4, information
about bone and lungs can be extracted from the UTE images. An extra
attenuation map which discriminates air, lung, soft tissue and bone was
therefore also derived. This was done in three steps, which are summarized
in Fig. 6.3. The first two steps consist of the derivation of the R2-map
and multiplication with the air mask, as described in section 4.4. This
yields a corrected R2-map. In this corrected R2-map different tissues are
discriminated based on their R2 value. Lung has the highest R2, followed by
bone. Soft tissue has a low R2 and the R2 in air is set to 0 by the binary
mask. The UTE-MRI-based attenuation map was derived from the corrected
R2-map by applying a mapping to the R2 values:
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µ (cm−1) = 0 R2 = 0 (air)
= 0.15 0 < R2 ≤ 0.5 (soft tissue)
= 0.15 + (0.25− 0.15)R2−0.50.1 0.5 < R2 ≤ 0.6 (bone)
= 0.08 R2 > 0.6 (lung)
(6.2)
The attenuation coefficient for voxels containing lung tissue was set to
the average attenuation coefficient of lung tissue in the micro-CT-based
attenuation maps. The R2 thresholds of bone and lung were determined
empirically. With this mapping, the highest R2 values are segmented as
lung whereas the R2 of bone is assumed to be lower. This is different from
the mapping used for the thorax phantom described in section 5.3, where
bone has the highest R2. This was done because we observed that the
R2 of the bone structures of the rats appeared to be lower than the R2 of
lung. This can be explained by considering the size of the bones of the rats.
These bones are much smaller than the bone used in the thorax phantom.
Consequently, the cortical shell of these bones is also very thin and far below
the resolution of the system. Hence, voxels that contain cortical bone also
always contain soft tissue or spongeous bone. As the protons in those tissues
relax much slower than the protons in cortical bone, partial volume effects
lead to a lower R2 in such voxels. In fact, the R2 is so much lower that it is
even below the R2 of lung tissue.
In eq. 6.2, voxels which have an R2 value between lung and soft tissue are
not just assigned a single bone attenuation coefficient. This is done for two
reasons. First, due to the mechanism described above, the contrast between
(partial) bone voxels and soft tissue voxels is not always high enough to
clearly discriminate both tissue types. Second, not all voxels containing
bone have the same attenuation coefficient: on the micro-CT a large range
of values can be seen in bone. To compensate for both effects the R2
values between 0.5 and 0.6 are rescaled to the range of values between
the attenuation coefficient of soft tissue (0.15 cm−1) and the maximum
attenuation coefficient of bone on the micro-CT-based attenuation maps
(0.25 cm−1). The linear scale that is used is a working assumption and has
not been verified experimentally.
The bed used for micro-CT and micro-SPECT and the plastic tube used
to fixate the animals also cause some attenuation. As the bed is not MRI-
compatible it was not used for the MRI scans and hence not visible on the
MRI images. The plastic tube was used in the MRI scans but was also
not visible on the MRI images as it provides no MRI signal. Therefore, an
138 Preclinical imaging experiments
attenuation template was made of the bed and tube from a micro-CT scan
of the bed and tube without an animal. The template was then included in
every MRI-derived attenuation map.
6.2.1.4 Micro-SPECT reconstruction
The SPECT projections were reconstructed using an iterative reconstruction
algorithm based on the Ordered Subsets Expectation Maximization (OSEM)
algorithm[250, 254], which is a modified version of the ML-EM algorithm
described in section 2.2.4.2. The reconstructed matrix was 128 x 128 x
256 with an isotropic reconstructed voxel size of 0.5 mm. The algorithm
models the system geometry as accurately as possible, taking into account
the pinhole geometry, the collimator response, the angular variation of the
sensitivity for each pinhole aperture, the intrinsic spatial resolution of the
gamma camera, attenuation and scatter. It is described in detail in [252].
The non-uniform attenuation correction was implemented in the iterative
reconstruction as proposed by Gullberg et al. [255]. A triple energy window
(TEW) scatter correction was used. The SPECT images were reconstructed
with four different attenuation maps: micro-CT-based, MRI uniform (con-
tour) map, MRI map with air and soft tissue and a UTE-MRI map with
air, lung, bone and soft tissue. A fifth reconstruction with no attenuation
correction was also done.
6.2.1.5 Analysis
It has been shown that the reconstruction algorithm yields absolutely quan-
titative results when using a non-uniform micro-CT based attenuation map
in [252]. Therefore the micro-SPECT images reconstructed with micro-CT
based attenuation map can be considered the reference. In this study, we
have thus compared the images reconstructed with the micro-CT based at-
tenuation correction and the other images to prove that quantification is
also possible with MRI-based attenuation correction. This was done in two
ways. First the average percent difference ∆X in a volume of interest (VOI)
was calculated:
∆X (%) = 100
1
N
∑
i
|SX ,i − SCT ,i |
SCT ,i
(6.3)
where i is the voxel index, SCT ,i and SX ,i are the reconstructed SPECT
activity concentrations in the image corrected with the micro-CT based at-
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tenuation map and other image respectively and N is the total number of
voxels in the VOI. For the body scans the VOI was automatically defined by
thresholding on the micro-SPECT image reconstructed with the micro-CT
based attenuation map, taking into account only voxels that have a signif-
icant SPECT image intensity. This was done to avoid corruption of the
results by voxels that have only very low tracer uptake. The threshold was
set to 10 % of the maximum micro-SPECT value. This was not done for the
brain scans as HMPAO is a less specific tracer than the others. For the brain
scans the VOI was manually defined by a box which contained the complete
brain.
Second, the average activity concentrations in the VOIs in the different
micro-SPECT images reconstructed with MRI-based attenuation maps were
compared to the images reconstructed with micro-CT based attenuation
map. The significance of the difference between the average activity con-
centrations was tested using a paired Student’s t-test. The same VOI’s as
above were used for the evaluation. A significant difference was defined as
a p-value smaller than 0.05.
6.2.2 Results
6.2.2.1 Attenuation maps
Fig. 6.4 shows images of one of the brain scans. The UTE-MRI images
(FID and gradient echo), the micro-CT-based attenuation map, the uniform
MRI-based attenuation map and the UTE-MRI-based attenuation map are
depicted. Fig. 6.5 shows the same images for one of the DMSA (kidney)
scans, but also includes the MRI-based (non-UTE) attenuation map which
discriminates only air and soft tissue. The uniform MRI-based attenuation
maps (Fig. 6.4D, 6.5D) are easy to derive and the contour of the body is
correctly defined. The same applies to the non-UTE-MRI map where lung
tissue is assigned air attenuation coefficients (Fig. 6.5E). The bones in this
image are segmented as soft tissue, because of the issues discussed below.
The UTE-MRI map of the brain shows resemblance to the micro-CT-
based attenuation map. Although the segmentation is not perfect, the large
bone structures are discriminated in this attenuation map. The skull, jaw
and spine can be seen. The attenuation map derived from the body UTE-
MRI image shows good resemblance to the micro-CT in the lungs and soft
tissue. The segmentation of the bones is more difficult. Although bone is
detected in the ribs, the detected volume of bone is much smaller than on
the micro-CT.
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Figure 6.4: FID image (A), gradient echo image (B), micro-CT-based attenuation
map (C), uniform MRI-based attenuation map (D) and UTE-MRI-based attenua-
tion map (E) for one of the brain micro-SPECT-MRI scans.
6.2.2.2 Reconstructed micro-SPECT images
For each type of scan a slice of all micro-SPECT images of a single rat
reconstructed with different attenuation maps is shown in Fig. 6.6. The
greyscale window was the same within each scan type. Only very small visual
differences can be seen between the micro-SPECT images reconstructed with
the different attenuation maps. The quantitative comparison in fig. 6.7
shows more differences. The results for the brain scans should be interpreted
separately from the body scans, as the setting is clearly different. In the brain
scans, the UTE-MRI-based attenuation correction performs best in all rats,
yielding an average error in all rats of 5 - 8 %. Uniform attenuation correction
gives slightly larger errors, leading to errors above 10 % in two subjects. No
attenuation correction gives errors of around 15 %. In the body scans the
average errors are much smaller. All UTE-MRI-based attenuation maps have
an average percent difference of 3 % or less. The non-UTE-MRI maps have
an average percent difference of at most 6 %. Large average errors between
Figure 6.5: FID image (A), gradient echo image (B), micro-CT-based attenuation
map (C), uniform MRI-based attenuation map (D), MRI-based attenuation map
discriminating air and soft tissue (E) and UTE-MRI-based attenuation map discrim-
inating air, lung, soft tissue and bone (F) for one of the body micro-SPECT-MRI
scans.
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Figure 6.6: Micro-SPECT images from different tracers reconstructed with dif-
ferent attenuation maps. Tracers from top to bottom: HMPAO (brain), DMSA
(kidney), colloids (liver and spleen), macro-aggregated albumin (lung). Attenu-
ation map from left to right: micro-CT-based, uniform MRI-based, NON UTE
MRI-based (air and soft tissue), UTE MRI-based (air, lung, soft tissue and bone).
The third attenuation map was not available for the brain scans.
25 % and 45 % are found when no attenuation correction is done.
The average difference in activity concentration between the different MRI-
based attenuation correction methods and the micro-CT-based attenuation
correction is shown in table 6.1. For the brain scans, all MRI-based atten-
uation correction methods yield significant differences. For the body scans,
the UTE-MRI-based attenuation correction yields a non-significant difference
for all different tracers. The non-uniform non-UTE-MRI-based attenuation
correction shows significant errors for all tracers. The uniform MR-based
attenuation correction leads to significant differences for all tracers except
colloids.
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35% 
40% 
HMPAO  DMSA  COLLOID  MAA 
UTE‐MRI  non‐UTE‐MRI  Contour  None 
* * * * 
Figure 6.7: Average percent difference with micro-CT-based attenuation cor-
rection in the reconstructed micro-SPECT images, per scan type. The different
attenuation maps are color-coded (* = non-significant difference).
6.2.3 Discussion
When looking at both UTE images it is clear that the FID image is of lower
general quality than the gradient echo. Especially the FID body image (Fig.
6.5A) looks more blurred and exhibits more noise. This can be seen clearly
around the edges of the body. The reasons for the lower quality of the FID
image are discussed in chapter 4. As with the phantom images, these images
also show why applying the binary mask is necessary. If the R2-map would
be used in its uncorrected form, there would be a lot of voxels with a high
R2 surrounding the body. By applying the binary mask, these voxels are set
to 0 in the corrected R2-map.
The UTE acquisition provides signal in bone and lung as the image inten-
sity in the FID image in these tissues is well above the noise level. This is
in clear contrast with the gradient echo image. The image intensity in the
lungs in Fig. 6.5B is almost zero. In the brain image (Fig. 6.4B) the drop
in signal is also apparent in the bones of the skull, spine and jaw. This will
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UTE MRI Non-UTE MRI Uniform MRI None
DMSA 0.59 % ∗ 2.23 % 1.55 % 32.32 %
Colloids 0.61 % ∗ 1.75 % 1.08 % ∗ 26.56 %
MAA 0.60 % ∗ 4.34 % 2.34 % 22.79 %
HMPAO 6.34 % 9.60 % 17.66 %
Table 6.1: Average difference between activity concentration yielded by differ-
ent MR-based attenuation correction methods and micro-CT based attenuation
correction (∗ = difference is non-significant).
lead to high R2 values. There is also a signal drop in bone in the body image
(Fig. 6.5B), but it is much smaller than in the brain image. This is because
the bones are smaller than the MRI resolution, which was explained above.
As this leads to a lower R2, close to the R2 of soft tissue, bone will thus be
segmented as soft tissue from these images. For the attenuation correction
this is much better than segmenting bone as air as the attenuation coeffi-
cient of bone is much closer to soft tissue than to air. Bone is also detected
in regions where no bone is present. The most obvious is the contour of
the lungs. Partial volume effects comparable to what happens with bone
and soft tissue will lead to lower R2 values at the border of the lungs, where
lung and soft tissue are contained in the same voxel. This leads to R2-values
between lung and soft tissue, comparable to the R2 of voxels which contain
bone.
These partial volume effects demonstrate that, to obtain a very accurate
MRI-based attenuation map, UTE-MRI based images with a higher resolu-
tion should be acquired. In fact, the resolution of the acquired UTE-MRI
images should be high enough to resolve the smallest structures with a dif-
ference in attenuation coefficient, which are probably the cortical shells of
the bones. This is necessary because there is no direct correlation between
MRI signal intensity and attenuation. Therefore, if a voxel contains tissues
with different attenuation coefficients, the signal that is measured is the av-
erage of the MRI signals of these tissues. The calculated R2 in the voxel
will not necessarily be the R2 that is expected from a tissue which has an
attenuation coefficient equal to the average attenuation coefficient of the
tissues in the voxel. Unfortunately, acquiring at such a high resolution would
lead to unacceptably high acquisition times. We have also shown in the rat
simulation study in chapter 3 that the discrimination of cortical bone is not
strictly necessary to achieve accurate quantification.
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In the non-uniform body MRI images (Fig. 6.5E, 6.5F) an air bubble can
be seen in the abdomen. In the UTE-MRI-based R2-map, a very high R2 is
in general seen in these bubbles. This is probably caused by fast relaxation
within the bubbles because of susceptibility effects, comparable to what
happens in the lungs. It leads to the segmentation of the air bubbles as
lung tissue. In the gradient echo the image intensity is low in these bubbles,
leading to segmentation as air. In the uniform attenuation map the bubble
can not be seen as it is assigned the attenuation coefficient of soft tissue.
The effect of air in the abdomen is very difficult to evaluate, as the air can
shift to a different position. This can happen not only between different
modalities but also within the same scan. It is therefore unclear which of
the three attenuation maps is more correct at the moment of micro-SPECT
acquisition. Only truly simultaneous micro-SPECT-MRI could compensate
accurately for this.
These results indicate that attenuation correction should be performed
in all situations. The statistically significant errors of over 25 % that are
seen in the uncorrected reconstruction of the body images are unacceptable
for quantitative studies.These figures were also found by other authors[181,
252]. As the head is smaller than the body the overall attenuation is lower
and the effect of attenuation correction is smaller. However, the effect is
still significant and attenuation correction should still be included in the
reconstruction to keep the average error below 10 %.
In the colloid scans, the uniform attenuation map performs only slightly
worse than the UTE-MRI-based map. Both maps yield a non-significant
difference in activity concentration from micro-CT based attenuation correc-
tion. This can be understood as the spleen and liver are large homogeneous
soft tissue structures and are not surrounded by many bones, so the effect of
bone and lung attenuation will be very small. The attenuation of the lungs
will have a small effect on the top part of the liver, but the liver is such
a big structure that this does not significantly influence the average activ-
ity concentration. For the DMSA scans the uniform attenuation correction
yields slightly larger errors, which are significant. This can be explained by
the fact that the kidneys are smaller in size and close to the spine and ribs.
This leads to a slightly larger effect of ignoring bone in the attenuation map,
and so only the UTE-based attenuation map leads to non-significant errors.
In the lung scans (MAA) the errors between the different MRI-maps are
larger than in the other body scans. This is conceivable as the attenuation
of the lungs is only implemented correctly in the UTE-MRI map. In four out
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of five rats the non-UTE MRI map discriminating air and soft tissue per-
forms worst. The uniform map, where the lungs have soft tissue attenuation
coefficients, performs better. This is explained by the fact that the attenu-
ation coefficient of the lung tissue of the rats was closer to the attenuation
coefficient of soft tissue than to air. However, only the UTE-MRI-based
attenuation correction leads to a non-significant difference with micro-CT
based attenuation correction.
In the brain the average differences with micro-CT based attenuation
correction are larger. The difference between non-UTE and UTE-based
attenuation correction is also larger. The head contains a lot of bone struc-
tures (skull, jaw, part of the spine) which are quite large compared to the
total volume of the head. This is different in the body, where in most areas
there is relatively little bone present. This leads to higher effect of not
taking bone into account in the brain. It also leads to a higher effect of
small errors in the attenuation map on the measured activity concentration.
This explains why none of the MRI-based attenuation maps yield a non-
significant difference with the micro-CT based attenuation correction.
Overall most of these results agree with what was derived in chapter 3,
although those results were only directly applicable to micro-PET. If air,
lung and soft tissue would be discriminated, errors of 3 % or less would be
obtained in the body scans. This would be qualified as a non-relevant error
in the simulation study. In the study presented in this chapter, the statistical
significance of the errors was also evaluated. This leads to the requirement
of a complete UTE-MRI-based attenuation map, which also discriminates
bone. As described above, this will only be necessary if the quantification
needs to be very accurate, e.g. within 1 %.
The results for the brain studies differ somewhat from the results obtained
in the micro-PET simulation study. This could be related to the difference
between micro-PET and micro-SPECT. In micro-PET, the attenuation co-
efficient of cortical bone is approximately 30 % higher than the attenuation
coefficient of soft tissue (0.13 cm−1 versus 0.097 cm−1), whereas in micro-
SPECT the attenuation coefficient of cortical bone is up to 65 % higher
(0.25 cm−1 versus 0.15 cm−1). This may lead to a larger effect of ignoring
the skull in the brain micro-SPECT scans.
From these results it seems that uniform (contour) attenuation correction
can be used in most micro-SPECT studies. It can always be used for liver
studies. For brain, lung and kidney studies it can be used if the quantification
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criteria are not too stringent. This has a number of advantages. The biggest
advantage is that no time is lost with the relatively slow UTE acquisition.
The MRI scan time is often limited for different reasons: the animal can not
be anesthetized for too long, limited experimental availability of the MRI
system, etc. This means that the available MRI time should be used as
good as possible to acquire interesting MRI images, e.g. images with high
contrast in the organ under study. Apart from providing signal in bone and
lung the UTE sequence does not provide interesting contrast. Therefore it is
only acquired to derive the attenuation map and if that can be derived from
the other MRI images, this is a more efficient use of scan time. Another
advantage is the stability of the uniform attenuation map: apart from the
anticipated errors in the lungs and bone the attenuation map is correct.
The derivation of the attenuation map can also be done fast and is easy to
implement. The only parameter that needs to be tuned is the threshold for
the contour detection.
In brain, lung and kidney scans the UTE-MRI-based attenuation correction
performs better. It should be preferred if absolute quantification is impor-
tant, as it is the only MRI-based method that leads to non-significant errors
(for lung and kidney scans). It is the best approximation of micro-CT-based
attenuation correction. However, there are some downsides to using UTE-
MRI-based attenuation correction. First of all, there is the long acquisition
time of the UTE sequence as discussed above. Second, the UTE images
can be difficult to acquire and sufficient care should be taken to assure the
highest possible quality. Finally, the UTE-MRI-based attenuation correction
is much more difficult to implement and requires a lot more parameters to
be tuned. This can lead to errors if the image quality is lower than normal
or the parameters are not tuned well. These errors can be larger than the
benefit that is achieved by taking bone and lung into account. All of this
should be kept in mind when making the trade-off between uniform and
UTE-MRI-based attenuation correction.
All micro-SPECT scans in this study were performed using 99mTc-labeled
tracers. In micro-SPECT many other isotopes can be used. If imaging
is done with a lower-energy isotope, such as 125I the effect of attenuation
correction will be larger. This has been demonstrated in phantom studies
by Hwang et al[181], showing that the quantitative error can be up to 50
% if no attenuation correction is performed. In this context, attenuation
correction is even more important.
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6.3 Rat micro-PET-MRI
In this section a smaller micro-PET study, using only 3 rats, is described.
It was not possible to perform a large study, such as the micro-SPECT
study described above. This was in part due to the limited availability of the
micro-PET scanner. Also, such a large study comes with a considerable cost.
Therefore, the idea of the micro-PET study described here was to demon-
strate that the performance of our method in micro-PET is comparable to
the performance in micro-SPECT.
6.3.1 Materials and methods
6.3.1.1 Acquisitions
Animal preparation
Spherical artificial lesions were created for the experiment. This was done
by submersing small spheres in a 18F-FDG solution. The spheres were 10
Å carbon molecular sieves, with a diameter of approximately 2 mm. After
leaving the spheres in the 18F-FDG solution for approximately 15 minutes,
they were placed on a hard surface to dry for 5 minutes. Subsequently they
were coated with plastic glue, to prevent leaking of the activity. A total of
24 artificial lesions were created, with activities ranging from 1 to 3 MBq.
Three rats that were sacrificed after previous experiments and stored in
the lab freezer were used. All rats weighed approximately 300 g. The
rats were taken out of the freezer the day before the experiment. In each
rat, 8 spherical lesions were implanted in different locations: mouth, neck,
shoulder, lung, kidney, abdomen, bladder, lumbar spine.
Micro-PET and micro-CT acquisitions
All acquisitions were done on a Triumph (Gamma Medica-Ideas, Sher-
brooke, Canada) system. This tri-modality system consists of a micro-PET
(LabPET), micro-CT (X-O) and micro-SPECT (X-SPECT) scanner. The
LabPET scanner is an APD-based scanner with 50 % LYSO and 50 % LGSO
crystals (2 x 2 x 13 mm)[256]. It is made up of modules of 4 (tangential)
by 2 (axial) crystals. There are 48 modules in the tangential direction and
16 modules in the axial direction. There are gaps between the modules (≈
2.5 mm and ≈ 0.8 mm tangential and axial respectively). A model for the
LabPET scanner was also used in the rat simulation study in chapter 3.
The X-O is a micro-CT scanner with adjustable magnification, which can be
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achieved by moving the source closer or further away from the animal. The
X-SPECT scanner was not used for this study.
First a micro-CT scan was performed by acquiring 256 projections into a
1184 x 1120 matrix with 50 µm pixel size and magnification 1.3. The CT
settings were 75 kVp and 140 µA. The micro-CT acquisition time per bed
position was approximately 2 minutes. Three bed positions were acquired
for each rat, with 50 % overlap. The total axial field of view (FOV) was
approximately 220 mm. The micro-CT images were reconstructed with the
software provided by the scanner manufacturer. The reconstructed matrix for
a single bed position was 512 x 512 x 512 with 0.25 mm isotropic voxel size.
All three bed positions were joined to obtain a CT image of the complete
rat. This image was then downsampled to 1 mm isotropic resolution by
summing together neighboring voxels. This acts as a smoothing operator
and also reduces noise.
Five micro-PET bed positions were needed to cover the complete rat.
All bed positions were acquired with 50 % overlap, yielding a total axial
FOV of 228 mm. Ten minutes were acquired per bed position, leading
to a total PET acquisition time of 50 minutes. The reconstruction of the
micro-PET images was not done with the software provided by the scanner
manufacturer but is described below.
MRI acquisitions
MRI acquisitions were performed on a clinical MRI system (Magnetom Trio
3T, Siemens Healthcare, Erlangen, Germany). A standard knee coil was
used, and images were acquired with a UTE sequence comparable to the
one described in section 4.2.3. The echo times for the FID and gradient
echo images were set to 0.08 and 2.3 ms respectively. The reconstructed
matrix was 224 x 224 x 224 with 1 mm isotropic voxel size, covering the
complete rat. The MRI acquisition time was approximately 25 minutes.
6.3.1.2 Registration
As the micro-CT and micro-PET images were acquired on the same scanner
using the same bed, no coregistation was needed to align those data sets.
However, the MRI images were acquired on a clinical system in a different
building. Coregistration of the MRI images to the micro-CT images was
done using a comparable method as for the micro-SPECT study described
in section 6.2. To restrict movement, the rats were placed inside a plastic
tube before the start of the experiment. For coregistration between MRI and
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micro-CT, two small syringes filled with water were also placed inside the
plastic tube. After the micro-CT and micro-PET acquisitions, the plastic
tube with the rat inside was moved to the MRI scanner. Afterwards, the
MRI images were coregistered to the micro-CT images with the implemented
alignment wizard of AMIDE, using both ends of the water syringes as fiducial
markers.
6.3.1.3 Attenuation maps
As in the micro-SPECT study described above, the goal of this study is to
compare the performance of MRI-based attenuation correction to micro-CT-
based attenuation correction. The same attenuation maps as in the micro-
SPECT study were therefore derived from the micro-CT and MRI images.
However, as a positron emitter was used rather than 99mTc, different absolute
values for the attenuation coefficients were used. Bilinear scaling was also
used to derive the attenuation map from the micro-CT, as this is the most
accurate method for 511 keV photons. The attenuation coefficient in each
voxel using the following equation:
µ (cm−1) = 0.097 IIwater I ≤ Iwater
= 0.097 + 0.096 I−IwaterIwater I > Iwater
(6.4)
where I is the micro-CT value in the voxel and Iwater is the micro-CT value
for a voxel containing water. This equation was obtained from [198].
The three MRI-based attenuation maps were derived using the same
method as in the micro-SPECT study. The uniform MRI-based attenua-
tion map and the non-UTE MRI-based attenuation map discriminating air
and soft tissue were obtained from the gradient echo image. The correct
511 keV attenuation coefficient for soft tissue was assigned (0.097 cm−1).
For the UTE-MRI-based attenuation map the method illustrated in fig. 6.3
was also used. The mapping from R2 to µ was changed to apply to 511 keV
photons:
µ (cm−1) = 0 R2 = 0 (air)
= 0.097 0 < R2 ≤ 0.5 (soft tissue)
= 0.097 + (0.13− 0.097)R2−0.50.1 0.5 < R2 ≤ 0.6 (bone)
= 0.06 R2 > 0.6 (lung)
(6.5)
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Figure 6.8: Illustration of the gap correction for a single module of the LabPET
scanner. The actual crystal surface is depicted in blue. The position on the crystal
surface is randomly sampled from the red + blue region. This yields a scanner with
virtually no gaps.
6.3.1.4 Micro-PET reconstruction
The reconstruction software available from the scanner manufacturer is a 2D
MLEM algorithm with single slice rebinning (SSRB). It is well known that
SSRB generates artefacts for points that are not in the transaxial center. The
manufacturer software also does not include attenuation correction. There-
fore we developed our own 3D MLEM reconstruction algorithm including
corrections for the gaps between modules, geometric sensitivity and attenu-
ation. Attenuation correction was implemented into the forward projection
of the algorithm. Scatter correction was not implemented as it was deemed
to have a small effect in micro-PET.
The reconstruction is LOR histogram based. A LOR histogram contains
the number of measured counts for each crystal pair. For each histogram
bin the three-dimensional position of each of the crystals is calculated. To
avoid sampling artefacts, random sampling on the crystal surface is used to
calculate the position inside the crystal. As the gaps between the modules
are quite large relative to the module dimensions, a gap correction is needed
to avoid artefacts in the reconstructed images. This was done by performing
random sampling on a region larger than the crystal surface, as shown in
fig. 6.8. As the crystals at the tangential border of a module are made
virtually larger than the others with this method, the number of counts in
these crystals were multiplied with a correction factor. This method is a
form of nearest neighbor interpolation of the data that was lost inside the
gaps. The calculated points are then used to forward- and backproject the
number of counts in the LOR.
Although the gaps are corrected for, correction for geometric sensitivity
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is still necessary, as the solid angle coverage of the scanner will still vary
between points inside the field of view. A geometric sensitivity map was
calculated by performing a single backprojection of all available LORs. This
method is comparable to the sensitivity correction described in section 3.4,
except that crystals which are defective and are not measuring at the time
of the scan are not backprojected and hence do not contribute to the cal-
culated sensitivity. This is necessary as a real scanner is used rather than
a simulation, and some crystals may be defective. The active crystals were
determined from a normalization scan with a 68Ge rod source performing a
full rotation close to the crystal surfaces.
Using this reconstruction algorithm all bed positions were reconstructed
separately with the different attenuation maps. The reconstructed matrix
for each bed position was 100 x 100 x 64 with 1 mm isotropic voxel dimen-
sions. The reconstruction was stopped after 50 iterations. The bed positions
were then merged by calculating the reconstructed value in each voxel as a
weighted average of the different reconstructed images contributing to that
voxel. The weighing factor was obtained from the geometric sensitivity map,
comparable to what was done in section 3.4.
6.3.1.5 Analysis
To evaluate the accuracy of MRI-based attenuation correction, the rela-
tive difference between the activity in the lesions in the micro-PET images
reconstructed with micro-CT-based attenuation correction and MRI-based
attenuation correction was calculated. This was done by drawing 8 spherical
VOIs on the artificial lesions. The diameter of the spherical VOIs was 10 mm.
The relative difference was then calculated using the following equation:
∆X ,k (%) = 100
∑
i
(PX ,i − PCT ,i )∑
i
PCT ,i
(6.6)
where ∆X ,k is the relative difference in VOI k , PX ,i and PCT ,i are the
micro-PET values in voxel i reconstructed with MRI-based attenuation map
X and micro-CT-based attenuation map respectively. The sums are taken
over all voxels i in the VOI.
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Figure 6.9: Average percent difference with micro-CT-based attenuation correc-
tion in the reconstructed micro-PET images, per lesion location. The different
attenuation maps are color-coded.
6.3.2 Results
As the attenuation maps obtained from the rats in this study were compa-
rable to the attenuation maps obtained in the micro-SPECT study, they are
not depicted separately. The relative differences in all VOIs, averaged over all
3 rats, are shown in fig. 6.9. All results in fig. 6.9 are also listed in table 6.2.
Large underestimations of 25 - 40 % are seen in all lesions when no atten-
uation correction is performed. Uniform MRI-based attenuation correction
yields errors smaller than 2 % in most lesions, except for overestimations in
the lung (3.5 %) and abdomen (2 %) and an underestimation in the mouth.
Non-uniform non-UTE MRI-based attenuation correction, which discrimi-
nates air and soft tissue inside the body, leads to larger errors. Especially
the underestimations in the abdomen, kidney, mouth and lung (3.7 - 8.1 %)
are high. UTE-MRI based attenuation correction yields errors of less than 2
%, except for the lesion in the mouth, which is underestimated by 3 %.
6.3.3 Discussion
The results from the micro-PET study also show that attenuation correction
should be performed at all times. In all lesions, the relative error made
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UTE MRI Non-UTE MRI Uniform MRI None
Mouth -3.0 % -5.8 % -2.0 % -28.6 %
Neck -1.1 % -3.0 % -0.3 % -30.6 %
Shoulder -0.9 % -2.5 % -0.3 % -30.4 %
Lung -1.0 % -3.7 % 3.5 % -35.8 %
Kidney -1.7 % -7.8 % 0.4 % -37.5 %
Abdomen -0.7 % -8.1 % 2.0 % -39.4 %
Bladder 0.7 % -1.6 % 1.7 % -37.0 %
Back -0.2 % -1.9 % 0.5 % -28.3 %
Table 6.2: Average relative difference between the total activity in the lesions in the
micro-PET images reconstructed with different MRI-based attenuation correction
methods and micro-CT based attenuation correction.
by ignoring attenuation is much too high to allow quantitative micro-PET
studies. The errors in the mouth, neck, shoulder and back are slightly smaller
than in the lung, kidney, abdomen and bladder. This is related to the depth
at which the lesions were implanted. In the latter the lesions were implanted
deeper into the body, leading to a higher effect of attenuation.
When performing MRI-based attenuation correction, the results of the
micro-PET study indicate that a uniform attenuation map leads to small
errors in general. Errors are specifically small in soft tissues, such as the
kidney. The quantification error in the liver will also be small with this
method. This was also observed in the rat simulation study discussed in
chapter 3, as well as in the micro-SPECT study. A slightly larger error is
seen in the lungs, which is due to the fact that this method ignores the
difference between the attenuation coefficients of lung and soft tissue.
A non-uniform non-UTE-MRI-based attenuation correction method, where
lung and air inside the body are given the attenuation coefficient of air,
should not be used. It leads to underestimations of up to 3.7 % in the lungs
and up to 8.1 % in the abdomen. The relatively large error in the abdomen
is probably caused by air bubbles, as discussed already in the micro-SPECT
study. If these bubbles actually contain a certain amount of water or food,
but have a low MRI signal in a gradient echo image because of susceptibility
effects, the attenuation coefficient of air will be assigned to them.
Overall, a non-uniform UTE-MRI-based attenuation correction performs
the best. An underestimation of 3 % in the mouth is the largest error that is
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observed. All other errors are small, most even below 1 %. This attenuation
correction method is also the only method that leads to a small error in the
lungs, as it is the only method that takes the real attenuation coefficient
of lung tissue into account. It will also assign the attenuation coefficient of
lung tissue to air bubbles in the abdomen, which is a better approximation
of the real attenuation coefficient than soft tissue (in the uniform map) or
air (in the non-uniform non-UTE map).
As with the results obtained from the micro-SPECT study described above,
these results support the conclusion that a uniform MRI-based attenuation
correction is generally sufficient for rat micro-PET studies. Especially if soft
tissue studies are performed this is the case. When the focus of a study is in
the lung or close to the lungs, a UTE-MRI-based attenuation correction can
be considered. This is, however, far more challenging and time-consuming,
and only leads to small improvements. The same remarks as above therefore
apply to micro-PET studies. The results also agree quite well with the results
obtained in the rat simulation study. The errors in the mouth are smaller
than those observed in the brain in the micro-SPECT study and resemble
the simulated errors in the brain closer. However, as this is not exactly the
same location, it is uncertain if the error in a brain lesion would not be larger
in the real micro-PET study.
As a last remark, one could question how realistic this study is. There
are two main limitations. First of all, the animals are dead. Therefore,
there are no additional image-degrading effects such as physiological motion.
However, the effect of physiological motion in rats is probably small. This
is supported by the fact that no motion effects were observed in the micro-
SPECT study, where the animals were alive during imaging. Secondly, only
small spherical lesions were imaged, without a background. This is a different
situation than a whole-body scan of an animal injected with 18F-FDG. This is
partly compensated by the dispersion of the lesions throughout the complete
body. If a large error would be made in a specific part of the body, this would
lead to errors in one or more of the lesions. In a real imaging situation, partial
volume effects would also play an important role. The lesions used here had
a diameter of 2 mm. This is quite close to the resolution of the scanner
(≈ 1.4 mm). Therefore, if the lesions would be imaged with background
activity, it would be more difficult to discriminate them.
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6.4 Conclusion
In this chapter, the feasibility of MRI-based attenuation correction for micro-
SPECT and micro-PET studies of rats was demonstrated. For micro-
SPECT, scans of the brain, kidneys, spleen, liver and lungs were evaluated.
For micro-PET, artificial lesions were implanted into the body of the rat in
8 locations: mouth, neck, shoulder, lung, kidney, abdomen, bladder, back.
The different study types cover most areas of the rat body. In most cases
uniform attenuation correction can be applied. This leads to errors of less
than 5 % in the body and less than 12 % in the brain for micro-SPECT,
and errors of less than 4 % for micro-PET. It can be implemented quickly,
provides stable results and the attenuation map can be derived from different
types of MRI images.
When accurate quantification is important a UTE-MRI-based attenuation
correction should be applied in the brain and lungs, and perhaps also in soft
tissues close to bone structures such as the kidneys. This technique dis-
criminates air, lung, soft tissue and bone and yields the best performance.
However, it is much more difficult to implement and requires a long acquisi-
tion time on the MRI system. In many cases the small improvement obtained
with UTE-MRI-based attenuation correction will not justify the additional
effort that is needed.
6.5 Original contributions
The results of the micro-SPECT study were presented at the WMIC con-
ferences in 2009 and 2010[257, 258]. A paper with these results has also
been accepted for publication in a A1 journal[259]. The validation of the
reconstruction that was implemented for the LabPET scanner was accepted
for presentation at the IEEE NSS/MIC conference in 2011[260].
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Chapter 7
Clinical imaging
experiments
7.1 Introduction
As the first clinical PET-MRI systems are now available, a MRI-based atten-
uation correction method for human imaging is also needed. The fact that
attenuation correction has a much larger effect in human studies than in
small animal studies has already been discussed in the introductory chapter.
It has also been shown in the simulation studies described in chapter 3. We
have demonstrated that there are more stringent requirements for a human
MRI-based attenuation correction method, as more tissue types need to be
discriminated to allow accurate quantification. The field of view in human
imaging is also a lot larger. This may lead to an increase in imaging time.
The application context in human imaging is different from that of small
animal imaging. It can be expected that current clinical PET-MRI systems
will be used almost exclusively for research. This means that quantification
can be important, comparable to small animal imaging. It also means that
many different situations may be encountered, e.g. different regions of the
body can be imaged. A method should be able to adapt to that. On the
other side, a research context also allows closer follow-up of a new method,
and does not necessarily require full automation. Although imaging time for
the acquisition of the attenuation map should always be kept short, research
protocols are usually lengthy so a few extra minutes for the acquisition of
the attenuation map may not pose a big problem.
Over the next few years, it is likely that PET-MRI scanners will also evolve
158 Clinical imaging experiments
into clinical practice. In that case, different requirements will apply. In clin-
ical practice, standard protocols are used. Full automation of MRI-based
attenuation correction will therefore be necessary. Quantification is used
more and more in clinical situations, and this would require a very accurate
attenuation correction method. Nevertheless, the most important require-
ment of a clinical MRI-based attenuation correction will be its robustness.
In a clinical situation it is more acceptable to make small errors that can
be predicted and accounted for, than having the possibility of a large error
which can not be predicted. The best example is lesion detection: if a
clinical MRI-based attenuation correction can lead to the disappearance of
a lesion on the reconstructed PET image, this is completely unacceptable.
The same applies when an artificial lesion is created. As throughput is
also very important in a clinical situation, the imaging time used for the
acquisition of the attenuation map should be kept as low as possible.
After testing our method on phantoms and small animals, it will be tested
on human data in this chapter. In human imaging, the effect of attenuation
and the requirements for the attenuation map depend on the region that is
being imaged. As was discussed before, the most important future applica-
tions for PET-MRI are probably neurology, cardiology and oncology. In the
first part of this chapter a clinical brain study with 5 patients is described.
In the second part a method is proposed for use in thoracic imaging, such
as cardiac imaging. This method is evaluated on a single data set, and the
limitations and difficulties in thoracic imaging are extensively discussed. The
thorax was chosen because it contains the lungs, which are very important
for human body attenuation correction, as described in chapter 3. To test
our method in the context of oncological studies, whole-body data sets would
be needed. No whole-body data is presented in this thesis for two reasons.
First, we did not have the possibility to acquire these data sets. Second, the
application of UTE-MRI-based attenuation correction to clinical whole-body
imaging may not be feasible. The reasons for this and other considerations
regarding to whole-body MRI-based attenuation correction are discussed in
the third part of this chapter.
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7.2 Brain
7.2.1 Materials and methods
7.2.1.1 Acquisitions
Five epilepsy patients who were planned to receive a brain PET-CT and
MRI exam also received a UTE-MRI scan. The PET-CT was acquired on a
Philips Gemini TF PET-CT (Philips Medical Systems, Cleveland, USA). A
low-dose CT suitable for attenuation correction was acquired with standard
settings (50 mAs, 120 kVp). The slice thickness was 5 mm. The in-plane
resolution was 1.17 mm. The reconstructed matrix was 512x512x40 voxels.
18F-FDG PET images were acquired with the standard brain PET protocol.
The acquisition time was 7 minutes. The images were reconstructed to a 128
x 128 x 90 matrix with 2 mm isotropic voxel dimension. After the PET-CT
exam the patient was transferred to the MRI department.
UTE images were acquired with a Philips 8-channel SENSE head coil. The
FID echo time was set to the minimum achievable echo time, i.e. 0.140 ms.
The gradient echo time was 1.8 ms. TR was 4 ms. This yielded a total
acquisition time of 6 minutes. The images were reconstructed to a 224 x
224 x 224 matrix with 1.3 mm isotropic voxel dimension. The field-of-view
was a sphere with 145.6 mm radius.
7.2.1.2 Derivation of attenuation maps
A comparable method as described in section 5.2 was used for the derivation
of the attenuation maps. First, a segmented CT-based attenuation map was
derived from the CT data sets. This was done by mapping CT Hounsfield
units (HU) to linear attenuation coefficients at 511 keV:
µ (cm−1) = 0 HU ≤ −800 (air)
= 0.097 −800 < HU ≤ 200 (soft tissue)
= 0.13 HU > 200 (bone)
(7.1)
The different steps used in the derivation of the attenuation map from the
UTE-MRI images are shown in fig. 7.1. First, the corrected R2-map was
first derived from the FID and gradient echo image, as described in section
4.4. The attenuation map was then derived from the corrected R2-map, by
the same mapping from R2 to µ as described in section 5.2:
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Figure 7.1: Image processing workflow used for the clinical brain PET study. The
uncorrected R2-map is calculated from the UTE FID and gradient echo images.
The R2-map is masked with the air mask derived from the first echo image to yield
the corrected R2-map. The corrected R2-map can be segmented into bone, soft
tissue and air.
µ (cm−1) = 0 R2 = 0 (air)
= 0.097 0 < R2 ≤ 0.5 (soft tissue)
= 0.13 R2 > 0.5 (bone)
(7.2)
This yields CT-based and UTE-MRI-based attenuation maps for each pa-
tient, which are then resampled to the matrix of the PET acquisition: 128 x
128 x 90 voxels with 2 mm isotropic voxel dimensions. As the CT and PET
were acquired on the same system, those images were automatically coreg-
istered. However, coregistration of the MRI images to the PET-CT data set
was needed. This was done in two steps: first approximate coregistration
was done manually using visual guidance. In a second step, optimization
of the coregistration was done using automatic rigid 3D registration with a
mutual information metric. The mutual information metric was calculated
on the CT image and the corrected R2-map, as the corrected R2 map has 0
image intensity in air, medium intensity in soft tissue and high intensity in
bone, comparable to the CT.
7.2.1.3 PET simulation
As described below, the classification accuracy of our method will be evalu-
ated against the segmented CT, showing the amount of voxels of different
tissue types that are misclassified. However, this does not allow intuitive
derivation of the effect of these misclassified voxels on the reconstructed
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PET image, as an error in the attenuation map will not only have an effect
locally, but will also affect all voxels on LORs that are passing through the
error. The ideal method for evaluating the performance of a MRI-based
attenuation correction method on clinical data sets is to reconstruct the
original raw PET data with a CT-based and a MRI-based attenuation map.
Unfortunately, the raw PET data was not available for all patient data sets.
Therefore, a simplified simulation of the PET acquisition/reconstruction pro-
cess was done to evaluate our method.
For each patient, the PET data set was first forward projected along all
LORs in a clinical PET scanner. As the data was acquired on a Philips
Gemini TF scanner, a model for this scanner was used. For each LOR, the
projected data was attenuated by the total attenuation factor for that LOR
in the CT-based attenuation map. This yields a LOR histogram, comparable
to the data format of the LabPET systems described in section 6.3. The
data in this histogram represent the data that would be obtained by a perfect
acquisition of the activity distribution in the PET data set, without randoms,
scatter or noise. Attenuation is taken into account, with the assumption that
the CT-based attenuation map represents the exact attenuation coefficient
distribution of the patient.
The reconstruction was then performed twice: once using the CT-based
and once using the UTE-MRI-based attenuation map. An attenuation cor-
rected ML-EM algorithm was used and the reconstruction was stopped after
20 iterations. As the simulation process depends on the geometry of the
scanner, geometric sensitivity correction was needed. This was implemented
as described in section 3.4. The differences between the simulated PET
images reconstructed with the CT-based and UTE-MRI-based attenuation
will be similar to the differences that would be obtained if the real PET
data was reconstructed with both data sets. In fact, as attenuation is the
only image-degrading effect that is modeled, the errors introduced by the
UTE-MRI-based attenuation correction will be the only errors present in the
reconstructed images. This allows evaluation of the effect of attenuation by
itself.
7.2.1.4 Analysis
The evaluation of the classification accuracy of the UTE-MRI-based atten-
uation map was evaluated by performing a voxel-by-voxel comparison with
the segmented CT-based attenuation map. For each tissue class on the seg-
mented CT, the fraction of voxels that were assigned to the correct tissue
class in the UTE-MRI-based attenuation map and the fractions that were
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assigned to the other tissue classes was determined.
The effect of the UTE-MRI-based attenuation map on the reconstructed
PET images was also evaluated. This was done by calculating the relative
difference between the images reconstructed with the CT-based and UTE-
MRI-based attenuation maps in 12 volumes of interest. The VOIs were
spherical with 10 mm diameter and were located in the left and right dorsal
cortex, frontal cortex, lateral cortex, putamen, thalamus and white matter.
The relative difference was calculated in each VOI:
∆k (%) = 100
∑
i
(PMRI ,i − PCT ,i )∑
i
PCT ,i
(7.3)
where ∆k is the relative difference and PMRI ,i and PCT ,i are the image
intensities in voxel i in the PET images reconstructed with UTE-MRI-based
and CT-based attenuation correction respectively. The sum is taken over all
voxels in the VOI. To give a visual impression of the location of the errors
in the reconstructed images, a percent difference image was also generated.
This was done by calculating the relative difference in each voxel, and as-
signing a color intensity proportional to the percent difference to that voxel.
Red was used for underestimation, blue for overestimation.
7.2.2 Results
Fig. 7.2 shows transverse slices of the FID and gradient echo images through
the eye sockets of one subject. This region was chosen because it contains
complex bone structures as well as air cavities (the ethmoidal sinuses) and
hence is the most challenging for the classification algorithm. As was already
observed in UTE images shown in the previous chapters, there is signal in
the bone in the FID image. In the gradient echo image, this signal has
practically disappeared. In the air cavities, there is no signal in the FID or
in the gradient echo image.
The same transverse slice of the uncorrected and corrected R2-maps are
shown in fig. 7.3. The segmented UTE-MRI-based and CT-based attenu-
ation maps are depicted in fig. 7.4. The voxel-by-voxel comparison of the
segmented MRI and segmented CT yielded an overall accuracy of between
85 % and 95 % for all subjects. The tissue/air discrimination was at least
95 % in all cases. Approximately 95 % of air voxels are classified correctly.
There are significantly more classification errors in voxels containing bone or
soft tissue: up to 25 % of bone voxels are assigned the attenuation coeffi-
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Figure 7.2: Transverse slices of the FID (A) and gradient echo (B) images of one
of the data sets of the brain study.
cient of soft tissue. Approximately 20 % of soft tissue voxels are classified
as bone. Fig. 7.5 shows a summary of the results per tissue type, averaged
over all patients. Fig. 7.6 shows a summary per individual patient.
The same transverse slice as in fig. 7.2 is shown for the simulated PET
images reconstructed with UTE-MRI-based and CT-based attenuation cor-
rection in fig. 7.7. A summary of the quantitative evaluation is shown in fig.
7.8. The average relative error over all VOIs was 3 %. Most VOIs showed
relative errors between 0 and 5 %. The largest error in a single VOI was 9
%. Fig. 7.9 shows a transverse (A) and a sagittal (B) slice of the percent
difference map of that subject. The largest deviation in a single voxel in the
complete brain of this patient was an overestimation of 34 % in the border
of the right eyesocket. Maximum deviations in other data sets were also
between 20 and 40 %.
Figure 7.3: Transverse slices of the uncorrected (A) and corrected (B) R2-maps
of one of the data sets of the brain study.
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Figure 7.4: Transverse slices of the UTE-MRI-based (A) and CT-based (B) at-
tenuation maps of one of the data sets of the brain study.
7.2.3 Discussion
As was observed in the previous chapters, the uncorrected R2-map shows
significant artefacts and can not be used to derive the attenuation map
directly. The R2 in the air surrounding the head is especially high. However,
the corrected version shows a much better image. The ethmoidal sinuses are
detected, showing that air inside the head can be discriminated from bone. It
shows contrast between bone and soft tissue. However, this contrast seems
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Figure 7.5: Evaluation of the classification accuracy of the UTE-MRI-based at-
tenuation map (overview per tissue type). For each tissue type on the CT images,
the fraction of voxels that were assigned to the correct and other tissue types were
determined per patient. The average of these fractions was then taken and shown
in this graph.
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Figure 7.6: Evaluation of the classification accuracy of the UTE-MRI-based at-
tenuation map (overview per patient). For each patient, the fraction of voxels that
is assigned to the correct tissue class is shown, as well as the fraction of voxels that
are misclassified from bone to soft tissue or vice versa (tissue/air correct) and the
fraction of voxels that are misclassified from tissue (bone or soft tissue) to air.
lower than in the R2-map of the pig head phantom, discussed in section
5.2. Several reasons can be proposed for this. First of all, the FID time was
shorter in the phantom acquisitions (0.08 versus 0.14 ms). This may lead
to more relaxation in the bone before acquisition, and hence less signal in
the FID image. However, as R2 is a quantitative measure which should not
be influenced by the echo times, this should not have an effect. A lower R2
can also be caused by partial volume effects. As explained before, the R2 in
voxels which contain bone as well as soft tissue will be lower than the R2 in
Figure 7.7: Transverse slices of the simulated PET images reconstructed with
UTE-MRI-based (A) and CT-based (B) attenuation correction of one of the data
sets of the brain study.
166 Clinical imaging experiments
0% 
2% 
4% 
6% 
8% 
Dorsal 
cortex 
Frontal 
cortex 
Lateral 
cortex 
Putamen  Thalamus  White 
ma<er 
Re
la
%
ve
 e
rr
or
 
Figure 7.8: Average relative error in different VOIs between PET images recon-
structed with CT-based and UTE-MRI-based attenuation correction. For each VOI
location, the average was taken over the left and right side and the 5 patients. The
error bars show the standard deviation on the error.
voxels which contain only bone. However, as the skull is quite thick, and the
reconstructed resolution was quite high, this will probably only have minor
effects on the brain UTE images. It is therefore not clear what is causing
this lower contrast.
Even with a lower contrast between bone and soft tissue, an attenuation
map discriminating air, soft tissue and bone can still be derived from the
corrected R2-map. The segmented UTE-MRI-based attenuation map shows
that the same large bone structures as in the CT-based attenuation map are
Figure 7.9: Transverse (A) and sagittal (B) slice of the percent difference image
between PET images reconstructed with CT- and UTE-MRI-based attenuation
correction.
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detected. In the depicted slice, the skull is the most important. Some differ-
ences can be seen between both attenuation maps. The most obvious is that
the skull seems thicker in the CT-based attenuation map. In part, this could
be caused by the coarse axial resolution of the CT (slice thickness 5 mm)
compared to the MRI. This can also explain the fact that some structures
are only seen on the MRI-based attenuation map, such as the bony back of
the eye sockets. As the ethmoidal sinuses also consist of bone structure with
air cavities, it is possible that the UTE-MRI-based attenuation map, which
shows bone near the sinuses, is actually a more accurate representation than
the CT-based attenuation map. There are also some voxels that are clearly
misclassified in the MRI-based attenuation map. Most obvious are the bone
voxels in the center of the brain, which are definitely errors. There are also
some segmentation errors at the border of the head, where bone is detected.
The quantitative evaluation of the classification accuracy shows very good
tissue/air discrimination. The discrimination between bone and soft tissue
is less accurate. However, as shown in the simulation studies in chapter 3, it
is much better to confuse bone with soft tissue than bone or soft tissue with
air. Overall, the fraction of classification errors between tissue and air is less
than 5 %. The classification errors between bone and soft tissue amount
to 20 - 25 %. In the simulation study, classification errors between bone
and soft tissue of up to 20 % did not cause any relevant errors. We there-
fore expect that no large errors will be seen in the reconstructed PET images.
The comparison between PET images reconstructed with CT-based and
UTE-MRI-based attenuation correction suggest that the segmentation errors
do not cause large errors in the resulting PET image. Visual comparison of
the PET images did not show large differences. Evaluation of the quantita-
tive difference in different clinically relevant VOIs showed only small differ-
ences. The largest errors in the VOIs are found in the frontal cortex, which
is explained by the presence of the frontal sinus. Although the frontal sinus
was detected in all data sets, there may be some classification errors there,
which lead to a slightly larger error. These results agree with the results
obtained from the human brain simulation study in chapter 3.
The percent difference image shows that most errors in the reconstructed
image can be found at the borders of the skull, which is where segmentation
is most difficult. Nevertheless, these errors mostly remain below 15 %.
Higher errors are seen in the vicinity of the ethmoidal sinuses and the eye
sockets. However, this is compared to the CT-based attenuation map. As
described above, the UTE-MRI images were acquired at higher resolution
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than the CT images. It is therefore possible that the bone in the region of
the eye sockets and the ethmoidal sinuses is more accurately classified in the
UTE-MRI-based attenuation map.
Nevertheless, one should always be careful when looking at the recon-
structed PET images in the vicinity of bone. Overestimation or underesti-
mation of bone content could respectively cause artificial hotspots or cause
tumors to become invisible in extreme cases. This is important in a clinical
situation, as this may lead to under- or overdiagnosis and hence to incorrect
patient treatment. None of the evaluated clinical data sets exhibited artifac-
tual hot or cold spots. This is also visible in the reconstructed PET images:
the 34 % difference in the vicinity of the orbits did not yield artifactual
appearances on the PET images reconstructed with the UTE-MRI-based
attenuation map.
These results therefore indicate that our method can be used for atten-
uation correction of human brain PET studies. As the derivation of the
attenuation map is done without intervention of the operator, it can be fully
automated. This would allow use of our method within a standardized clin-
ical protocol, which is executed by a radiological technician. In the 5 data
sets that were evaluated, no large errors were seen. However, this does not
suffice to conclude that the method is robust, as 5 data sets can only be
regarded as an extended proof of concept. To demonstrate clinical robust-
ness, a larger study should be done, which also involves radiologists which
evaluate the clinical interpretation of the images.
For implementation into a clinical protocol, the imaging time should also
be as short as possible. In the described study UTE-MRI imaging time was 6
minutes. Considering that the total scanning time of a clinical MRI protocol
is mostly between 30 and 60 minutes, this can be considered borderline
acceptable. There are different options to reduce imaging time. First of
all, the images could be acquired at a coarser resolution. However, this is
difficult in the brain where many small bone structures and air cavities are
present. A different option would be to reduce the number of spokes sam-
pled in k-space. This will lead to a lower quality images, with more noise,
which will probably not be tolerated as the FID image already has a low
quality. As a last option, the acquisition scheme of the sequence could also
be improved. As MRI sequence development is not the focus of this thesis,
we have not investigated this. However, after this study was performed,
a new UTE-MRI sequence, designed for Siemens systems, was installed at
our hospital. It allows acquisition of UTE images with the same quality as
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shown here in an acquisition time of 3 minutes. This would definitely be
acceptable for clinical practice.
7.3 Thorax
7.3.1 Materials and methods
7.3.1.1 Acquisitions
A SPECT-CT of a single patient was acquired on a Symbia S SPECT-CT
system (Siemens Medical Solutions, Malvern, USA). The patient had been
treated with 131I radio-ablation therapy for thyroid cancer. As the SPECT
images showed only a very small region with uptake, they were not usable
for evaluation of attenuation correction. The CT was a low-dose CT used
for attenuation correction, acquired with settings 130 kVp, 70 mAs. The
slice thickness was 5 mm. The reconstructed matrix was 512 x 512 x 73,
with 1 mm in-plane resolution.
UTE-MRI images were acquired on a Philips Achieva 3T system with a
Torso XL chest coil. The UTE sequence described in section 4.2.3 was used.
The FID and gradient echo times were 0.14 ms and 2.3 ms respectively.
The reconstructed matrix was 125 x 125 x 100, with 4 mm isotropic voxel
dimensions. This yielded a field of view of 500 x 500 x 400 mm, which
comprised the complete chest and part of the neck axially. Transaxially, part
of the arms were outside the maximum field of view of the MRI scanner and
hence not visible. The total acquisition time was 2 minutes.
7.3.1.2 Derivation of attenuation maps
Registration of the MRI images to the CT images was done manually with
AMIDE[244]. Different attenuation maps were then derived. First, the
reference CT-based attenuation map was derived. As bilinear scaling is
currently the gold standard for derivation of the attenuation map in whole-
body PET-CT studies, this method was used. The CT Hounsfield units (HU)
were scaled to linear attenuation coefficients at 511 keV using the following
equations:
µ (cm−1) = 0.097 HU+10001000 HU ≤ 0
= 0.097 + 0.057 HU1000 HU > 0
(7.4)
170 Clinical imaging experiments
This equation is comparable to the one used in section 6.3, but a different
scaling factor is used as different CT settings apply for this study. The basic
equation was obtained from [198].
Three MRI-based attenuation maps were derived from the UTE-MRI im-
ages. As was demonstrated in the simulation studies in chapter 3, accurate
thoracic imaging requires the discrimination of 5 tissue types: air, lung,
soft tissue, spongeous bone and cortical bone. Ideally, an attenuation map
should therefore be obtained which accurately discriminates these 5 tissue
types. However, cortical bone can not be discriminated accurately with a
resolution of 4 mm. As the cortical shell of the spine vertebrae and the
ribs is only 1 - 2 mm thick, partial volume effects make it impossible to
discriminate cortical bone from the surrounding soft tissue and spongeous
bone. Therefore we will not aim to discriminate cortical bone, but aim
to discriminate 4 tissue types: air, lung, soft tissue and bone, the latter
representing a combination of cortical and spongeous bone.
Threshold-based UTE-MRI attenuation map
The first UTE-MRI-based attenuation map was derived with a method com-
parable to the one used in the rat micro-PET and micro-SPECT studies
described in chapter 6. The first two steps comprise the calculation of the
R2-map and the correction with an air mask, as described in section 4.4. The
attenuation map was then derived using a mapping of R2 values to linear
attenuation coefficients at 511 keV as follows:
µ (cm−1) = 0 R2 = 0 (air)
= 0.097 0 < R2 ≤ 0.5 (soft tissue)
= 0.097 + (0.13− 0.097)R2−0.50.1 0.5 < R2 ≤ 0.6 (bone)
= 0.03 R2 > 0.6 (lung)
(7.5)
where air, lung, soft tissue and bone are discriminated. As simple thresh-
olds on the R2-map are used to discriminate different tissue types, this
attenuation map is called the threshold-based map in what follows.
Theoretically, this should yield an accurate attenuation map. Unfortu-
nately, the image quality of UTE images is not optimal. This will lead to
two problems in the attenuation maps:
1. Large local variations in the apparent R2 of lung tissue. This yields
highly inhomogeneous lungs in the R2-map, and difficulties segmenting
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the lungs based on the R2 value of a single voxel. It will lead to the
segmentation of voxels in the lungs as bone and soft tissue.
2. Significant inhomogeneity of the images, especially at the outer parts
of the FID image. This will lead to changes in the apparent R2, which
make segmentation of the complete image with the same R2 thresholds
difficult. It will lead to errors between bone and soft tissue in the outer
parts of the image.
Possible explanations for these problems are discussed in section 7.3.3. A
solution to these problems needs to be found in order to derive a more ac-
curate attenuation map. The solution consists of employing more advanced
segmentation methods than simple thresholding, and is described below.
MRF-based UTE-MRI attenuation map
Both issues that lead to problems in the threshold-based attenuation map are
solved by modifying the derivation of the attenuation map from the R2-map
in two ways. First, the segmentation of the lungs can be improved by using a
segmentation algorithm that performs classification of voxels not only based
on the value in the current voxel, but also on the values of the surrounding
voxels. This can be done using Markov random field (MRF) segmentation
with a Gibbs prior. The extensive description of MRF segmentation is outside
the scope of this thesis. We have used the MRF segmentation method that
is implemented in the Insight Toolkit[243]. It suffices here to say that MRF
segmentation attempts to classify each voxel into the tissue class to which
the voxel has the smallest distance. The distance is calculated based on local
(the value of the current voxel) and regional (the values of the neighboring
voxels) information. MRF classification will allow segmentation of the lungs
as a homogeneous structure, as local variations will be compensated by
regional information.
MRF segmentation can not be used for the bones, as they are too small
to allow taking regional information into account. Therefore, a different
method is needed for this. Due to the global inhomogeneity of the R2-map,
it is difficult to derive a classification method which will correctly classify
bone in all regions of the thorax. However, if a region is homogeneous in it-
self, simple classification method will work there. Therefore, we modified our
method so that bone is only detected in a single region. In all other regions,
only air, lung and soft tissue are detected. As one of the possible applications
of PET-MRI is cardiac imaging, we decided to focus on bone segmentation
in the spine. This was done because the spine is the most important bone
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Figure 7.10: Modified algorithm for the derivation of the attenuation map from
UTE-MRI images, using Markov random field segmentation to classify lung voxels.
structure close to the heart. Attenuation of the other bones in the thorax
has a smaller effect on cardiac imaging as they are either further removed
from the heart (such as the arm bones) or smaller than the spine (such as
the ribs). The spine also has the advantage that it is quite easy to locate,
as it is concentrated in a cylinder parallel to the longitudinal axis of the body.
To include these modifications, the algorithm was changed as shown in
fig. 7.10. The first steps comprise the derivation of the corrected R2-map as
described already and are not shown in the image. Then, two operations are
performed on the corrected R2-map. The first is a MRF segmentation, which
classifies the voxels in the image into air, lung or soft tissue. The second
is a modified version of the mapping described in eq. 7.5. In a cylinder
paralell to the longitudinal axis of the body, which contains the spine, the
same mapping as in eq. 7.5 is used. This means that air, lung, soft tissue
and bone are discriminated in that region. In all other regions of the body,
bone tissue is not discriminated and the following mapping is used:
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µ (cm−1) = 0 R2 = 0 (air)
= 0.097 0 < R2 ≤ 0.6 (soft tissue)
= 0.03 R2 > 0.6 (lung)
(7.6)
Then, both derived images were combined into the UTE-MRI-based at-
tenuation map in a final step. In each voxel, the tissue class obtained with
the MRF segmentation was determined. If the voxel was classified as lung
or air, the attenuation coefficient of lung or air was assigned in the final
attenuation map. If the voxel was classified as soft tissue by the MRF seg-
mentation, the value of the voxel in the final attenuation map was set to
the value in the second derived image. This can then be the attenuation
coefficient of soft tissue or bone. To evaluate the effect of the regional bone
segmentation separately, an attenuation map which does not contain bone
was also derived, directly from the segmented MRF attenuation map.
7.3.1.3 PET simulation
As the SPECT images were not useable for the evaluation of attenuation
correction, a simulated PET was generated. This was done with the same
method as in the brain study described above. However, as the field of view
in this study was larger than in the brain study, the axial field of view of the
scanner was doubled by simulating a scanner with twice as many rings. The
simulated activity distribution was obtained by segmenting the CT into air,
lung, soft tissue and bone and assigning the activity distribution of a healthy
patient injected with 18F-FDG[211]. The images were then reconstructed
with 4 attenuation maps:
• CT-based,
• threshold-based UTE-MRI attenuation map,
• MRF-based UTE-MRI attenuation map with discrimination of bone in
the spine,
• MRF-based UTE-MRI attenuation map without discrimination of
bone.
7.3.1.4 Analysis
The reconstructed PET images were compared quantitatively by calculating
the total counts in volumes of interests in different organs. 10 VOIs were
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drawn in the lungs (5 left, 5 right), 5 in the heart and 4 in the spine. The
VOIs were spherical with a diameter of 20 mm. In each VOI, the relative
difference in total counts with the CT-based reconstruction was calculated:
∆X ,k (%) = 100
∑
i
(PX ,i − PCT ,i )∑
i
PCT ,i
(7.7)
where ∆X ,k is the relative difference in VOI k , PX ,i and PCT ,i are the
reconstructed PET values in voxel i reconstructed with MRI-based attenua-
tion map X and CT-based attenuation map respectively. The sums are taken
over all voxels i in the VOI. For each organ, the average absolute relative
difference was calculated:
∆X ,O (%) =
1
NO
∑
k∈O
|∆X ,k | (7.8)
where O is the organ and NO is the number of VOIs in the organ.
7.3.2 Results
Fig. 7.11 shows coronal and sagittal slices of the FID and gradient echo
images acquired. The uncorrected and corrected R2-maps are shown in fig.
7.12, and the attenuation maps that were used are depicted in fig. 7.13.
The UTE-MRI-based attenuation map derived by simple mapping from R2
to µ shows that the general contour of the lungs is segmented correctly.
The structure of the spine and parts of the shoulder bones can also be
seen. However, many differences with the CT-based attenuation map can
be observed. Especially the oversegmentation of bone on one side of the
body, and detection of bone voxels inside the lungs and at the border of the
lungs are seen.
The third attenuation map, which was derived with the modified algo-
rithm and determines the lungs using MRF segmentation and only detects
bone in the spine region, shows a better image. The segmentation of the
lungs by the MRF method is accurate, except for the large bronchi in the
middle of the lungs, which are classified as soft tissue. The detection of the
structure of the spine is also adequate. Obviously, other bones such as the
shoulder bones are not detected. Small soft tissue structures in the lungs,
such as the vessels, are also not detected. The last attenuation map shows
a comparable image but without the spine.
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(a) FID
(b) Gradient echo
Figure 7.11: Coronal (left) and sagittal (right) slices of the FID (a) and gradient
echo (b) images acquired in the thorax study.
The reconstructed PET images are shown in fig. 7.14. Reconstruction
with the CT-based attenuation map shows uniform activity distributions in
the lungs, soft tissue and bones. Reconstructing with the first, threshold-
based UTE-MRI attenuation map shows many differences with the CT-based
reconstruction. Especially remarkable are the artificial hot spots that are cre-
ated in the lungs. The acivity distribution in the rest of the body is also not
uniform. Less artefacts are seen when reconstructing with the attenuation
maps derived using MRF segmentation. In the map that discriminates air,
lung, soft tissue and bone, the activity in the lungs is quite uniform, with
the exception of small underestimations at the border of the heart and a
significant overestimation in the region where the large bronchi are normally
found. The activity distribution in soft tissue and the lower part of the spine
is also quite uniform, but clear underestimations are observed in the upper
part of the spine and in the other bones. Reconstruction with the last at-
tenuation map shows comparable images, but with larger underestimations
in the spine.
The quantitative evaluation of the differences between the PET images
reconstructed with the CT-based and the three UTE-MRI-based attenuation
maps is depicted in fig. 7.15. The threshold-based UTE-MRI attenuation
map shows errors of over 10 % in the lung and spine VOIs. In the heart the
average error remains below 5 %. The MRF-based UTE-MRI attenuation
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(a) Uncorrected R2-map
(b) Corrected R2-map
Figure 7.12: Coronal (left) and sagittal (right) slices of the uncorrected (a) and
corrected (b) R2-map of the thorax study.
map with bone discrimination yields average errors of less than 5 % in the
lung, spine and heart. The MRF-based map without bone shows comparable
results in the lung and heart but leads to much larger errors (≈ 26 %) in
the spine.
7.3.3 Discussion
Although the threshold-based UTE-MRI attenuation map shows that most
of the lung tissue is detected and large bone structures are also detected, it
also displays many local errors. The bone/soft tissue segmentation errors in
one side of the body are mainly caused by inhomogeneity in the FID image.
This leads to a higher apparent R2 in the voxels in that region, which is
comparable to the R2 of bone in other regions of the image. It is unclear
how the inhomogeneity could be corrected, especially since it mostly affects
the FID image. Homogeneity corrections such as CLEAR (Constant LEvel
AppeaRance) can be used, but they will affect the FID and gradient echo
image comparably, and will therefore most probably not fix this problem.
The errors in the lung, where local variations in the R2 values lead to
misclassification of some lung voxels into bone and soft tissue, are even
more problematic. These can be caused by different effects. One possibility
is high noise due to the low signal in the lungs, but the UTE sequence is
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(a) CT-based
(b) Threshold-based UTE-MRI
(c) MRF-based UTE-MRI with bone
(d) MRF-based UTE-MRI without bone
Figure 7.13: Coronal (left) and sagittal (right) slices of the attenuation maps used
in the thorax study. The CT-based (a) and three UTE-MRI-based (b-d) attenuation
maps are shown.
used to obtain higher signal in the lungs so this should not be a problem.
Secondly, there is also a lot of motion in the lungs, which may lead to
complex effects. A third possible reason is that the lungs have a highly
inhomogeneous structure, composed of a combination of alveoli, air ducts
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(a) CT-based
(b) Threshold-based UTE-MRI
(c) MRF-based UTE-MRI with bone
(d) MRF-based UTE-MRI without bone
Figure 7.14: Simulated PET images of the thorax study, reconstructed with dif-
ferent attenuation maps (a-d). Coronal (left) and sagittal (right) slices are shown.
and small vessels. This in itself may also lead to inhomogeneity, and even
more so when motion is added. The inhomogeneous R2 in the lungs is
probably caused by a combination of these factors.
Another difference between the CT-based and threshold-based UTE-MRI
attenuation map can be observed. In the CT-based attenuation map, some
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Figure 7.15: Average relative error in the VOIs in the lung, spine and heart in the
PET images reconstructed with three different UTE-MRI-based attenuation maps.
4-class = air, lung, soft tissue, bone and 3-class = air, lung, soft tissue.
vessels can be seen, especially close to the heart. In the MRI images, these
vessels are very difficult to visualize. This can be related to flow artefacts,
which are caused by the flow of blood through the vessels. The protons
in the blood are moving through the imaging volume instead of remaining
at the same location as other protons. Therefore, they are influenced by
the RF pulses and gradient fields in a different way, rendering them difficult
to visualize. Breathing motion can also have an effect. As the acquisition
time of the MRI is much longer than the CT, the MRI image is acquired
over multiple breaths. Therefore, the vessels also move during the MRI
acquisition and their signal is smoothed over different voxels.
The different errors in this attenuation map lead to many errors in the
reconstructed PET image. Especially the creation of artificial hot spots
in the lungs is a big problem for interpretation of the images. If only a
MRI image and a PET image with so many artefacts are available, it is
not possible for the radiologist to decide if a pathological process, such
as a lung tumor, is present or if the hot spots are caused by errors in the
attenuation map. The inhomogeneity in the lateral parts of the body can
also cause problems for the same reasons. The main problem is that this
method leads to unpredictable errors, which may be present in one image
but not in another. This may lead to an incorrect clinical diagnosis. This
can be either a diagnosis of a tumor if none is present, which may lead to
unnecessary medical or surgical therapy, or a tumor that is missed, which
leads to undertreatment. Both situations are unacceptable in clinical prac-
tice. The quantitative evaluation also shows errors that are too large, which
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can be expected when looking at the images qualitatively.
The MRF-based UTE-MRI attenuation map, derived with the modified
algorithm in which the lungs are segmented using MRF segmentation and
bone is only detected in the spine region, is much better. The general contour
of the lungs is accurately detected, and the spine is also discriminated. No
other bone is detected, as intended. This causes an error in itself, but also
has the advantage that no erroneous bone voxels are assigned in other parts
of the body. For example, there is no bone/soft tissue misclassification on
one side of the body. We can also see that the entire content of the lungs is
homogeneous, without bone or soft tissue voxels. This shows that the MRF
method works well and enables classification of voxels not only based on their
own value but also on the values of neighboring voxels. There is a downside
to MRF segmentation of the lungs, as it also leads to small structures being
ignored. Two examples are seen in the lung region. First, none of the lung
vessels are detected. However, as already discussed, the long acquisition time
of the MRI images probably makes it impossible to visualize these vessels
anyway, due to motion. Second, the large bronchi, which are situated just
above the heart, are classified as soft tissue whereas they should actually be
classified as air. This does cause problems, as discussed below.
The PET images reconstructed with this attenuation map are much better
than with the first UTE-MRI-based attenuation map. The lungs and the soft
tissue regions show relatively homogeneous activity uptake, as in the images
reconstructed with the CT-based attenuation map. The heart also shows
uniform uptake. Underestimation of activity is seen in the periferal bones,
which were not detected by the algorithm. However, this is a predictable
effect, which will be present in all images and can be taken into account
by the radiologist when interpreting the images. Limited underestimation
is also seen in the part of the lungs close to the mediastinum, where lung
vessels are seen on the CT but not on the MRI. However, this does not
lead to real cold spots. The segmentation error at the large bronchi, which
leads to segmentation as soft tissue instead of air, do lead to a big problem.
A clear artificial hot spot is created, which may cause problems in clinical
interpretation.
The quantitative evaluation of this method in VOIs in the lung, heart
and spine shows good results. As all average errors are below 5 %, this
seems acceptable for quantification. This was also the limit that was used
for evaluation of the simulation study in chapter 3. Evaluation of the last
attenuation map, in which the spine is not discriminated, shows that it is
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useful to detect bone in the spine. Indeed, an average error of over 25
% is seen in the spine, which is far too high to allow quantification. As
quantification in the spine is accurate in the reconstruction where bone is
discriminated, we can conclude that merging cortical bone and spongeous
bone into a single class does not cause any problems. As the thickness of
the cortical bone layers is mostly smaller than the scanner resolution, this
is understandable. In this way, the recommendations derived in chapter 3
are partially fulfilled: only 4 tissue classes are distinguished, but the fourth
tissue class actually comprises a combination of spongeous and cortical bone.
Overall these results indicate that our method could be used for attenua-
tion correction of thorax PET images, but with caution. There is probably
no problem for cardiac imaging, which is an important possible application
of PET-MRI, as the heart and lungs are segmented accurately. However,
there is still the possibility of important classification errors, as was shown
with the artificial hotspot in the large bronchi in these results. Also, we have
only evaluated our method in a data set from a single patient here. In order
to claim feasibility, a more extensive study should be done, comparable to
the brain study presented in the first part of this chapter. However, this was
not done, in part for the reasons described in the next section.
7.4 Whole-body
As already mentioned in the introduction to this chapter, no evaluation of
our method for whole-body imaging was done. The motivation for this
is discussed here, together with other considerations regarding whole-body
MRI-based attenuation correction. There are several reasons why the appli-
cation of UTE-MRI-based attenuation correction to whole-body imaging will
be very difficult. First of all, there is the intrinsic difficulty of discriminating
all five tissue types that are important for attenuation correction based on
the MRI image alone. This was shown in the previous section, and leads
to various problems. First, the discrimination of cortical bone is impossible
with limited resolution, as cortical bone is too thin. Therefore a compound
tissue class, containing cortical and spongeous bone, was created. Second,
a very inhomogeneous R2 was observed in the lungs. Therefore, MRF seg-
mentation was used to determine the contour of the lungs. And third, the
inhomogeneity of the images can cause large problems and requires different
segmentation thresholds for different regions of the body. This was solved
by only detecting bone in the spine region, which was defined as a cylinder
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parallel to the axis of the body. However, these last two methods already
take into account some anatomical information and determine the attenua-
tion map not solely from the MRI image anymore. This partly counteracts
the primary reason for using UTE sequences.
A second reason why UTE-MRI-based attenuation correction for whole-
body studies will be difficult, is the long acquisition time of the UTE images.
For the single data set presented in the previous section, MRI acquisition
time was 2 minutes. This can be acceptable for a cardiac study, where
the complete attenuation map may be acquired with a single bed position.
However, in a whole-body study multiple bed positions of the attenuation
map will need to be acquired. For a normal adult at least 5 bed positions
will be needed, yielding a MRI acquisition time of 10 minutes or more for
acquisition of the attenuation map alone. This can be considered quite long.
The acquisition time for the UTE-MRI could be reduced by acquiring at a
coarser resolution, but this would lead to even more segmentation difficulties.
Thirdly, motion is not compensated in the UTE sequence at the moment.
Therefore, it is unclear what the effect of motion is, especially in the thorax.
It will definitely lead to blurring of the heart and lung borders. However, one
can argue that this is not a problem for PET attenuation correction, as PET
images are also acquired over many cardiac and respiratory periods. In fact,
as was discussed in chapter 2, one of the issues with CT-based attenuation
correction is that the CT is acquired much faster and hence shows only part of
the respiratory period. This can lead to reconstruction artefacts in the PET
image, such as a cold liver dome. Nevertheless, it is not sure if the effect of
motion on the PET and MRI images is the same. Therefore, the acquisition
of a static attenuation map would be interesting. By implementing cardiac
and respiratory gating into the UTE sequence, this could be done. However,
this would again lead to an increase of the acquisition time, which is already
too long as it is.
A fourth problem is that, for whole-body imaging, the method must be
tested and validated in different regions of the body. For example, for tho-
racic imaging the segmentation of the spine is probably most important.
However, for other parts of the body, different bones should be taken into
account. In the pelvis, e.g. for prostate imaging, the hip and sacral bones
will have a much larger effect than the spine. In the legs and arms, other
bones will also be more influential. Implementing a region-based segmenta-
tion for all these bones can be possible, but will lead to many assumptions
on patient anatomy which we want to avoid. Derivation of the attenuation
map in the abdomen will also require a different focus. In that part of the
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body, discrimination of adipose tissue may be important.
All these considerations lead to the conclusion that our UTE-MRI-based
method for deriving the attenuation map is currently not applicable to
whole-body PET-MRI imaging. To allow this in the future, different im-
provements need to be made. The most important improvement can be
made by optimizing the UTE sequence, possibly improving image quality and
shortening acquisition time. Furthermore, investigations need to be done
into different regions of the body. When the feasibility of UTE-MRI-based
attenuation correction has been shown on all body regions separately, an
algorithm could be derived which combines different methods to obtain a
whole-body UTE-MRI-based attenuation map.
Apart from the issues that are specific to UTE-MRI-based attenuation cor-
rection, there are also other difficulties in whole-body MRI-based attenuation
correction in general. First, there is the problem of field-of-view truncation
in MRI. In general, the field of view of the MRI scanner will not contain the
complete body in the transaxial plane. Usually, the arms are not completely
included in the image. However, PET attenuation is not limited to the FOV
as it is a physical effect. Therefore, the attenuation map also needs to in-
clude the arms. This problem could also be avoided by asking the patient to
place the arms behind the head. Unfortunately this is quite uncomfortable
for a long PET-MRI exam.
Another problem in whole-body MRI-based attenuation correction is
caused by the MRI coils. These coils are usually developed to be invisi-
ble on MRI images, but do cause attenuation. Coil attenuation may even
be quite high, as they often contain metal parts. Therefore, coils need to
be included in the attenuation map. For rigid coils, such as brain coils, this
is not a big problem: a template can be derived and added to the attenua-
tion map, comparable to what was done for the bed and plastic tube in the
micro-PET and micro-SPECT studies described in chapter 6. However, in
whole-body imaging, flexible coils are often used, such as the torso coil that
was used in the thorax study. As these coils usually have a different location
and orientation for each patient, inclusion in the attenuation map is more
difficult. If the location and orientation of the coil could be determined, this
could be solved. It may be possible to do this using UTE sequences, as they
allow visualization of the plastic of the coils.
A last remark can be made about the usability of the MRI images acquired
to derive the attenuation map for other purposes than attenuation correction.
In PET-CT, the CT is not only acquired to obtain the attenuation map but
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also serves as an anatomical reference. If the MRI images that are used for
attenuation correction could also serve as a general anatomical reference,
this would be interesting. This would also place a less severe constraint on
the acquisition time that can be used to acquire the attenuation map. Some
authors have proposed the use of Dixon-based methods for the derivation
of the attenuation map[207]. This involves a whole-body acquisition with
a Dixon sequence, which yields images that can also be used as a general
anatomic reference.
7.5 Conclusion
In this chapter, we have demonstrated the feasibility of applying our UTE-
MRI-based attenuation correction method to human brain imaging. This was
done by testing the method on 5 patients, and evaluating the classification
accuracy of the attenuation map as well as the quantitative accuracy of the
reconstructed PET images. The distinction between tissue (bone or soft
tissue) and air showed an accuracy of 95 % or more in all patients. The
average quantitative error in different clinically relevant VOIs was 3 %. The
maximum error observed in a VOI was 9 %. These numbers are acceptable
for clinical imaging. Most importantly, no artificial hot spots or cold spots
were observed in the images.
We also evaluated our method on one single human thorax data set. It
was shown that derivation of the attenuation map for thoracic imaging is a
lot more cumbersome. While no such assumptions were made in all other
studies presented in this thesis, limited assumptions on patient anatomy
were needed to obtain a relatively accurate attenuation map from the UTE
images. Visual evaluation showed mostly limited differences with the PET
images reconstructed with CT-based attenuation correction, but a single
artificial hot spot was created. Therefore, this method can only be used in a
clinical context with caution. The attenuation correction is probably accurate
enough to allow quantitative cardiac imaging, which is one of the possible
applications of PET-MRI. However, a more extensive validation should be
done to reliably evaluate feasibility.
The application of UTE-MRI-based attenuation correction to whole-body
imaging was not evaluated. In our opinion, there are still a lot of limitations
that need to be overcome in order to allow application of our method to
whole-body imaging. Most importantly these limitations include the image
quality of the UTE images and the total acquisition time needed to acquire
a whole-body attenuation map. Also, different algorithms may be needed in
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different regions of the body, such as the thorax, abdomen, or pelvis.
7.6 Original contributions
The clinical brain study, presented in the first part of this chapter, was
published in a A1 journal paper[239]. It was also presented at the second
PET-MR workshop in Juelich, Germany in 2010[261]. The evaluation of our
method on a single thorax data set was presented at the EANM conference
in 2010[262].
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Chapter 8
General conclusions
In this chapter, a general overview of the work presented in this thesis is
given. For each chapter, the most important results are summarized together
with the conclusions that can be drawn from them. Afterwards, an overall
conclusion is presented.
8.1 Summary
In chapter 2, a number of concepts and methods that are used through-
out this work were introduced. In the first part, emission tomography was
discussed. Emission tomography is based on the tracer principle, in which
a radioactive isotope is linked to a tracer molecule and the radiation emit-
ted by the isotope is recorded by a scanner. Two types of isotopes are
used: positron emitters (used in PET) and single photon emitters (used in
SPECT). The imaging principles of PET and SPECT were explained, starting
from the gamma detector invented by Anger in 1957. Next, a brief overview
of reconstruction methods was given. Special attention was devoted to the
ML-EM iterative reconstruction algorithm, which was extensively used in this
thesis. In PET and SPECT there are different physical effects that degrade
image quality, such as sensitivity, resolution, attenuation and scatter. These
effects and the correction methods that are mostly used to correct for them
were also described. Subsequently the basics of Monte Carlo simulation in
emission tomography were explained. In the last section on emission to-
mography, the clinical and preclinical applications of PET and SPECT were
discussed.
In the second part of chapter 2, magnetic resonance imaging was intro-
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duced. After describing the principles of spin physics and nuclear magnetic
resonance, the imaging principles were discussed. Particular attention was
given to the k-space theorem and the principles of spin echo and gradient
echo sequences. A brief description of MRI hardware was also given. Finally,
the most important current clinical and preclinical applications of MRI were
discussed.
Multimodality imaging was introduced in the third part of the introductory
chapter. The advantages of combining information from different medical
imaging modalities were explained. The design of PET-MRI and SPECT-
MRI systems raises quite a few difficulties, which were also discussed. Sub-
sequently, an overview was given of the different PET-MRI and SPECT-MRI
systems that have been designed, from the first prototype systems to the
currently available human scanners.
As this thesis concerns MRI-based attenuation correction, the last part
of chapter 2 was devoted to this topic. First an overview was given of
the results that have been presented on the effect of attenuation on the
reconstructed images. Next, the implementation of attenuation correction
into the reconstruction algorithm was explained. Subsequently, the different
methods that have been used historically to derive the attenuation map
were discussed. In the last section, the challenges of MRI-based attenuation
correction are explained, along with the current methods that have been
proposed and their limitations. The goal of our work was also introduced:
to develop a method which allows the derivation of the attenuation map
based on MRI image intensity alone.
Before designing a new MRI-based attenuation correction method, it is
important to determine how accurate this method needs to be. This was
done using simulations in chapter 3. As the effect of attenuation depends
on the size and constitution of the object under study, it will be different in
small animal imaging, human brain imaging and human whole-body imaging.
Therefore, 3 simulation studies were done with the ROBY, XCAT brain and
XCAT whole-body phantom respectively. The GATE simulation toolkit was
used. The simulated PET data was reconstructed with different attenuation
maps, to evaluate the effect of different errors in the attenuation map on
the reconstructed PET images. Attenuation maps were derived to determine
the effects of ignoring different tissue classes, the effect of inter-patient
variability, and the effect of tissue classification errors. The quantitative
difference in VOIs between the images reconstructed with the correct and
the modified attenuation maps were calculated.
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The results indicated that discriminating air, lung and soft tissue is suf-
ficient in small animal studies. Cortical bone can also be discriminated for
a higher accuracy, but is not explicitly necessary. Tissue classification also
does not need to be extremely accurate: tissue classification errors in bone
and lung of up to 20 % did not show relevant changes in the quantitative
accuracy of the reconstructed PET images.
In human brain studies, the three tissue classes present in the head should
be included to allow quantitative imaging: air, soft tissue and cortical bone.
Classification errors from cortical bone to soft tissue did not lead to relevant
effects even if 20 % of voxels were misclassified. More care should be taken
with classification errors from cortical bone to air. They may lead to sig-
nificant effects, even if only 10 % of voxels are misclassified. A MRI-based
attenuation correction method for human brain imaging should therefore be
designed so that it is more likely that cortical bone will be misclassified as
soft tissue than as air.
For human whole-body imaging, even more stringent requirements were
derived from the simulation results. Five tissue types need to be discrim-
inated to allow accurate quantification: air, lung, soft tissue, spongeous
bone and cortical bone. Additionally, adipose tissue may also be included
when possible. Although the effect of the inter-patient variability of the
attenuation coefficient of cortical bone was negligible, this was not the case
for lung. Therefore, it would be interesting if the attenuation coefficient of
lung tissue of a specific patient could be derived from the MRI images of
that patient. Misclassification of lung to air was tolerable if 10 % or less of
the lung voxels were misclassified. If lung is misclassified to soft tissue or
cortical bone, even 5 % errors lead to relevant effects. Classification errors
of cortical bone to soft tissue were acceptable, even if 20 % of cortical bone
voxels were set to soft tissue. Classifying cortical bone as air or lung was not
acceptable. Therefore, a whole-body attenuation correction method should
be designed so that lung is more likely to be misclassified as air, and cortical
bone is more likely to be misclassified as soft tissue.
In chapter 4, UTE sequences were introduced. UTE sequences are used
in MRI imaging to visualize tissues with very short T2, such as tendons and
ligaments, which can not be visualized with conventional MRI sequences.
Lung and cortical bone, two tissue types which are important for attenuation,
also have a very short T2. Therefore, we propose using UTE sequences for
derivation of the attenuation map. The principles of UTE imaging were first
introduced, along with the properties of the Philips UTE sequence that is
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used for most experiments in this thesis. This sequence acquires two images:
one of the FID, which is acquired as shortly as possible after RF excitation,
and one normal gradient echo image. The MRI properties of lung and cortical
bone were investigated in the next section. The results indicated that it was
possible to visualize lung and cortical bone using UTE sequences.
In the last section of chapter 4, the development of the basic method that
was used throughout this thesis was described and tested on a segment of
bovine femur bone. It was shown that UTE sequences allow the visualization
of cortical bone. MRI image intensity is not a quantitative parameter and
depends on receiver gain settings. Therefore, it can not be used reliably for
automatic segmentation. We introduced the R2-map, which represents the
transverse relaxation rate in each voxel, and can be calculated from both
images acquired by the UTE sequence. As voxels containing air may have a
high R2 due to artefacts in the FID image, the images need to be masked
with a binary mask to set all voxels containing air to zero. This yields the
corrected R2-map, which shows distinctive intensities in air, soft tissue and
cortical bone.
Before moving on to real animal or human imaging, we tested our method
on phantom data in chapter 5. As no phantoms are currently available
that have a realistic appearance on PET, CT and MRI, new phantoms were
designed. There are also no synthetic materials available that realistically
mimic lung or cortical bone on all three modalities. Therefore, biological
tissue was used in the phantoms. The first phantom was a pig head, ob-
tained from a local slaughterhouse. It was used as a model for human brain
imaging, as it contains the same tissue types (air, soft tissue and bone) and
has a comparable complexity. The classification accuracy of the segmented
UTE-MRI-based attenuation map was compared to the segmented CT-based
attenuation map. The accuracy was approximately 90 % for cortical bone
and soft tissue and 80 % for air. The results from the simulation study
indicated that this was sufficient for accurate quantification.
A human thorax phantom was also created, to evaluate the feasibility
of discriminating air, lung, soft tissue and cortical bone with our method.
For the bone part of the phantom a segment of bovine femur bone was
used. For the lung part a lobe of pig lung was used, obtained from a pig
sacrificed after a cardiac surgery experiment. The phantom was assembled
in a PMMA cylinder and filled with water with 18F-FDG. Two hot spheres
and one cold sphere were also inserted. A CT-based and UTE-MRI-based
attenuation map were derived, and the PET images reconstructed with both
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attenuation maps were compared. The difference in reconstructed activity
between both images was small (≈ 2 %), demonstrating the feasibility of
discriminating lung with our method. However, the thorax phantom was a
simplification of the human thorax. Therefore, these results do not prove
that our method will also be applicable to in-vivo human thoracic imaging.
The applicability of our method to preclinical small animal imaging was
tested in chapter 6. First a large micro-SPECT study was presented, includ-
ing a total of 18 rats. Different 99mTc-labeled tracers were used to target
the brain, lung, kidney, liver and spleen. UTE-MRI images of the rats were
acquired. The reconstruction with different MRI-based attenuation maps
was compared with the current gold standard, micro-CT-based attenuation
correction. For the brain images, errors of 5 - 8 % were found when re-
constructing with the UTE-MRI-based attenuation map. For the images of
other organs, UTE-MRI-based attenuation correction yielded errors of 3 %
or less. This demonstrates the feasibility of using UTE-MRI-based atten-
uation correction for micro-SPECT imaging. However, performing uniform
MRI-based attenuation correction leads to only slightly higher errors, and is
much easier to implement. Therefore, it can be used in most studies.
A smaller micro-PET study was also performed. In that study, artifi-
cial 18F-FDG lesions were implanted in 3 dead rats in specific locations:
mouth, neck, shoulder, lung, kidney, abdomen, bladder and lumbar spine.
Micro-PET images were reconstructed with different MRI-based attenuation
correction methods. The reconstructed activity in the lesions was compared
to the reconstructed activity in micro-PET images reconstructed with micro-
CT-based attenuation correction. UTE-MRI-based attenuation correction
leads to errors of 2 - 3 % in all spheres, demonstrating the feasibility of using
this method for micro-PET attenuation correction. As in the micro-SPECT
study, uniform MRI-based attenuation correction only led to slightly larger
errors. It can be used in most studies as a simpler alternative.
In chapter 7, we applied our method to human data. As described in
chapter 2, the most important applications of clinical PET-MRI will probably
be situated in neurology, cardiology and oncology. In the first part of the
chapter, a human brain PET study with 5 patients is described. PET, CT and
MRI data sets were available for all patients. Segmented UTE-MRI-based
and CT-based attenuation maps were derived. The classification accuracy
of the UTE-MRI-based attenuation maps was 85 - 95 % in all patients,
with tissue/air discrimination of 95 % or higher. As the PET raw data was
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not available, simulated PET data was obtained and reconstructed with CT-
based and UTE-MRI-based attenuation correction. Visual comparison of the
reconstructed PET images did not show artificial hot spots or cold spots.
Quantitative evaluation in clinically relevant VOIs showed an average error
of 3 % and a maximum error of 9 %. These results indicate that our method
could be used for clinical brain PET imaging.
We also evaluated the feasibility of using our method for thoracic imag-
ing, such as cardiac imaging. This was done on a single human thorax data
set. As only CT and UTE-MRI images were available, PET images were
simulated. First, a UTE-MRI-based attenuation map was derived by using
a simple mapping, as was done in the previous studies. However, due to
the local and regional inhomogeneity of the UTE-MRI images, there were
too many errors in this attenuation map. A more sophisticated method was
therefore developed, which used Markov random field (MRF) segmentation
to segment the lungs and only detected bone in the spine region. Recon-
struction of the PET images with this attenuation map showed average
quantitative errors in VOIs in the lung, heart and spine of approximately 5
%. Visual comparison of the reconstructed PET images showed quite good
results in the lungs and soft tissue, apart from an artificial hot spot that
was created in the center of the lungs. Although these results indicate that
quantification in the heart is quite accurate with our method, they also show
it can only be used for cardiac studies with caution.
To evaluate the applicability of our method to oncology, whole-body data
sets are needed. This was not done for two reasons. First, we did not have
the possibility to obtain such data sets. Second, and more important, the
application of our method to clinical whole-body imaging is not feasible at
the moment. In the last section of chapter 7, the reasons for this were
given. The most important problems with our method include the difficulty
of discriminating all five relevant tissue types on MRI image intensity alone,
the long acquisition time of UTE sequences and the fact that motion is
currently not compensated in the UTE sequence. Our method has also
not been evaluated in other regions of the body, such as the pelvis or the
abdomen. Apart from these limitations specific for UTE, some general issues
also need to be considered for whole-body MRI-based attenuation correction.
Two specific problems are field-of-view truncation and MRI coil attenuation.
These considerations lead to the conclusion that more work is needed to
allow whole-body UTE-MRI-based attenuation correction.
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8.2 Final conclusion
In this thesis, we have first determined the requirements for MRI-based at-
tenuation correction in human and small animal imaging. Based on these
requirements, a method was proposed which uses MRI images acquired with
UTE sequences to allow the discrimination of all tissue types relevant for
attenuation correction. We have shown that air, lung, soft tissue and bone
can be discriminated with our method. We have also shown that using the
attenuation map derived with our method, accurate quantification can be
achieved in small animal studies (micro-PET and micro-SPECT) and human
brain PET studies. It would be interesting to perform a clinical brain study
with more subjects, in which the reliability of our method could be evaluated
better. This would also allow to test if the method can be fully automated,
which will be necessary if it is to be used in clinical practice. More work is
also needed on the subject of human thoracic or whole-body imaging.
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Appendix A
Detailed results of the
simulation studies
In this appendix, the relative quantitative differences calculated in the sim-
ulation studies described in chapter 3 are listed. This is done for all three
simulation studies, all lesions and all attenuation maps that were described.
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A.1 Rat study
Brain Lung Liver
Lesion 1 2 3 4 5 6 7
1 Number of tissue classes
5 class 0.3 -0.3 -1.0 -0.4 -0.1 1.1 0.0
Lung replaced by air -0.2 -0.1 -8.2 -2.7 -8.3 0.2 -0.3
Cortical bone replaced by soft tissue -0.4 -0.2 0.4 0.3 -0.2 -0.5 -0.8
Contour -0.9 -0.8 4.1 1.5 4.8 0.1 -1.2
Table A.1: Relative error (in %) in lesions 1 - 7 of the rat study in images reconstructed with all attenuation maps: part 1 (number
of tissue classes). The location of the lesions is listed in table 3.1. The attenuation maps used for comparison are listed in table 3.4.
Spine Colon Femur
Lesion 8 9 10 11 12 13 14 15
1 Number of tissue classes
5 class 0.3 -0.4 0.3 0.2 0.1 1.3 0.4 -0.3
Lung replaced by air -0.3 0.3 -0.1 0.6 0.0 0.0 0.3 -0.4
Cortical bone replaced by soft tissue -1.5 -1.1 -0.8 0.7 -0.1 0.1 -0.8 -1.8
Contour -1.3 -2.9 -1.5 -0.7 -0.1 0.4 -0.1 -2.2
Table A.2: Relative error (in %) in lesions 8-15 of the rat study in images reconstructed with all attenuation maps: part 1 (number
of tissue classes). The location of the lesions is listed in table 3.1. The attenuation maps used for comparison are listed in table 3.4.
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Brain Lung Liver
Lesion 1 2 3 4 5 6 7
3.1 Random tissue misclassification
5 % errors lung => air 0.1 -0.1 -0.8 -0.5 -0.9 -0.3 -0.4
10 % errors lung => air -0.2 -0.4 -1.4 0.5 -0.8 0.1 -0.2
20 % errors lung => air -0.4 -0.5 -1.6 -0.2 -2.4 0.6 0.1
5 % errors lung => soft tissue 0.2 -0.1 -0.2 0.4 0.2 0.4 -0.1
10 % errors lung => soft tissue -0.4 0.0 0.9 0.2 1.3 -0.5 -0.4
20 % errors lung => soft tissue -0.2 -0.3 1.1 1.7 0.2 -0.3 -0.5
5 % errors lung => cortical bone -0.4 -0.2 -0.3 0.8 0.6 -0.6 -0.3
10 % errors lung => cortical bone -0.3 0.0 1.0 1.0 1.7 0.3 0.1
20 % errors lung => cortical bone -0.4 -0.2 1.7 0.7 1.6 -0.4 -1.2
5 % errors cortical bone => soft tissue -0.4 0.1 -0.5 0.0 -0.3 -0.8 -0.9
10 % errors cortical bone => soft tissue 0.5 -0.7 0.0 1.3 -0.2 -0.4 -1.0
20 % errors cortical bone => soft tissue 0.1 -0.1 -0.3 -0.5 -0.2 0.0 -0.7
5 % errors cortical bone => lung -0.1 -0.3 -0.3 0.7 -0.4 -0.2 -0.3
10 % errors cortical bone => lung -0.2 -0.1 -0.7 0.3 0.1 0.3 -0.6
20 % errors cortical bone => lung -0.7 -0.1 -0.7 0.8 0.6 -0.4 -0.3
5 % errors cortical bone => air -0.4 0.3 -0.3 0.1 0.1 -0.8 -0.7
10 % errors cortical bone => air -0.3 -0.2 0.1 0.7 0.3 -0.4 -1.4
20 % errors cortical bone => air -0.2 -0.2 -0.1 0.1 0.5 -0.8 -0.6
Table A.3: Relative error (in %) in lesions 1 - 7 of the rat study in images reconstructed with all attenuation maps: part 2 (random
tissue misclassification). The location of the lesions is listed in table 3.1. The attenuation maps used for comparison are listed in
table 3.4.
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Spine Colon Femur
Lesion 8 9 10 11 12 13 14 15
3.1 Random tissue misclassification
5 % errors lung => air 0.0 0.0 -0.1 0.7 0.2 0.1 -0.2 -0.7
10 % errors lung => air 0.1 0.3 -0.1 0.4 0.2 0.6 0.5 -0.7
20 % errors lung => air 0.0 0.2 0.2 0.4 -0.2 0.8 0.4 -0.3
5 % errors lung => soft tissue 0.5 0.3 0.3 0.9 -0.4 -0.4 0.5 -0.6
10 % errors lung => soft tissue -0.4 -0.1 -0.1 0.6 0.5 0.0 0.3 -0.4
20 % errors lung => soft tissue 0.4 -0.9 -0.1 0.4 0.2 0.1 -0.4 -0.3
5 % errors lung => cortical bone 0.0 -0.1 -0.2 0.6 0.5 0.7 0.6 -0.5
10 % errors lung => cortical bone 0.3 -0.7 0.3 0.1 0.2 0.2 0.3 -0.7
20 % errors lung => cortical bone 0.4 -0.2 -0.3 0.6 0.6 0.2 0.9 -0.7
5 % errors cortical bone => soft tissue 0.1 -0.1 0.2 0.9 0.1 -0.1 1.0 -0.4
10 % errors cortical bone => soft tissue -0.3 0.1 -0.5 0.9 0.1 0.1 0.8 -0.8
20 % errors cortical bone => soft tissue -0.2 -0.4 -0.5 0.6 0.2 0.6 0.2 -0.6
5 % errors cortical bone => lung -0.3 -0.5 0.2 0.1 0.4 0.1 0.2 -0.8
10 % errors cortical bone => lung -0.3 -0.4 0.0 0.3 0.4 0.4 0.4 -1.0
20 % errors cortical bone => lung -0.1 -0.7 -0.4 0.4 0.3 0.2 -0.1 -1.5
5 % errors cortical bone => air -0.1 -0.6 -0.6 0.8 0.2 0.1 0.8 -1.0
10 % errors cortical bone => air -0.6 -0.7 -0.6 0.9 -0.1 0.4 -0.2 -1.0
20 % errors cortical bone => air 0.0 -1.6 -0.4 0.7 0.7 0.4 0.5 -1.4
Table A.4: Relative error (in %) in lesions 8-15 of the rat study in images reconstructed with all attenuation maps: part 2 (random
tissue misclassification). The location of the lesions is listed in table 3.1. The attenuation maps used for comparison are listed in
table 3.4.
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A.2 Human brain study
Lesion 1 2 3 4 5 6
1 Number of tissue classes
Cortical bone replaced by soft tissue -7.0 -2.9 -6.7 -3.8 -7.6 -3.6
Cortical bone replaced by air -21.0 -9.1 -20.2 -11.5 -22.8 -11.1
Contour -4.0 27.2 -4.1 2.4 14.1 -1.2
2 Inter-patient variability
Cortical bone segmented value + 1SD 0.3 0.1 0.3 0.1 0.3 0.1
Cortical bone segmented value + 2SD 0.6 0.2 0.6 0.3 0.6 0.3
3.1 Random tissue misclassification
5 % errors cortical bone => soft tissue -0.5 -0.2 -0.3 -0.2 -0.5 -0.2
10 % errors cortical bone => soft tissue -0.7 -0.2 -0.7 -0.4 -0.8 -0.4
20 % errors cortical bone => soft tissue -1.5 -0.7 -1.4 -0.7 -1.3 -0.7
5 % errors cortical bone => air -1.2 -0.4 -1.6 -0.5 -1.5 -0.5
10 % errors cortical bone => air -2.4 -0.6 -2.6 -1.3 -2.8 -1.1
20 % errors cortical bone => air -4.1 -1.8 -3.9 -2.4 -4.4 -2.5
3.2 Distance-to-interface dependent tissue misclassification
5 % errors cortical bone => soft tissue -0.4 -0.2 -0.6 -0.3 -0.3 -0.2
10 % errors cortical bone => soft tissue -0.8 -0.3 -0.8 -0.5 -0.8 -0.5
20 % errors cortical bone => soft tissue -1.5 -0.9 -1.7 -1.0 -1.7 -0.9
5 % errors cortical bone => air -1.2 -2.1 -0.4 -0.6 -3.0 -0.5
10 % errors cortical bone => air -2.5 -4.0 -1.0 -1.5 -6.7 -1.1
20 % errors cortical bone => air -3.0 -4.6 -1.0 -1.6 -7.5 -1.4
Table A.5: Relative error (in %) in all lesions of the human brain study in images reconstructed with all attenuation maps. The
location of the lesions is listed in table 3.5. The attenuation maps used for comparison are listed in table 3.4.
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A.3 Human whole-body study
Lung Liver Spine
Lesion 1 2 3 4 5 6 7 8 9
1 Number of tissue classes
7 class 0.3 0.3 0.2 0.2 0.5 0.4 1.0 1.9 0.9
Liver replaced by soft tissue -0.5 -0.4 -1.2 -0.4 -2.0 -1.1 -0.2 0.0 -0.4
Adipose tissue replaced by soft tissue 2.7 2.6 3.1 3.5 2.9 3.4 3.0 4.1 3.7
Spongeous bone replaced by soft tissue 0.0 -1.5 0.0 -0.1 -0.3 -0.2 -11.7 -11.9 -10.8
Lung replaced by air -45.5 -30.9 -25.4 -36.9 -0.1 0.1 -16.8 0.0 -2.6
Cortical bone replaced by soft tissue -2.1 -6.2 -2.7 -7.2 -2.2 -3.2 -15.6 -8.1 -17.5
2 Inter-patient variability
Lung segmented value + 1SD 12.4 9.4 5.9 9.8 0.0 0.0 3.8 0.0 0.6
Lung segmented value + 2SD 25.8 19.6 11.8 20.1 0.1 0.0 7.7 0.0 1.3
Cortical bone segmented value + 1SD 0.1 0.4 0.2 0.5 0.1 0.2 1.0 0.5 1.1
Cortical bone segmented value + 2SD 0.2 0.8 0.3 0.9 0.3 0.4 2.0 1.0 2.2
Table A.6: Relative error (in %) in lesions 1 - 9 of the human whole-body study in images reconstructed with all attenuation maps:
part 1 (number of tissue classes and inter-patient variability). The location of the lesions is listed in table 3.2. The attenuation maps
used for comparison are listed in table 3.4.
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Colon Prostate Femur
Lesion 10 11 12 13 14 15
1 Number of tissue classes
7 class 1.0 1.1 1.1 1.0 0.3 0.0
Liver replaced by soft tissue -0.4 -0.3 -0.3 -0.3 -0.3 0.0
Adipose tissue replaced by soft tissue 5.4 6.5 5.9 4.1 5.4 3.0
Spongeous bone replaced by soft tissue -0.1 -0.2 -0.4 -0.7 -1.7 -13.1
Lung replaced by air 0.0 0.0 0.0 0.0 0.0 0.0
Cortical bone replaced by soft tissue -0.7 -0.9 -1.3 -3.5 -4.2 -5.5
2 Inter-patient variability
Lung segmented value + 1SD 0.0 0.0 0.0 0.0 0.0 0.0
Lung segmented value + 2SD 0.0 0.0 0.0 0.0 0.0 0.0
Cortical bone segmented value + 1SD 0.0 0.1 0.1 0.2 0.3 0.3
Cortical bone segmented value + 2SD 0.1 0.1 0.2 0.4 0.5 0.7
Table A.7: Relative error (in %) in lesions 10 - 15 of the human whole-body study in images reconstructed with all attenuation
maps: part 1 (number of tissue classes and inter-patient variability). The location of the lesions is listed in table 3.2. The attenuation
maps used for comparison are listed in table 3.4.
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Lung Liver Spine
Lesion 1 2 3 4 5 6 7 8 9
3.1 Random tissue misclassification
5 % errors lung => air -2.5 -1.9 -1.4 -2.2 0.0 0.0 -0.9 0.0 -0.2
10 % errors lung => air -5.3 -4.1 -2.3 -4.2 0.0 0.0 -1.9 0.0 -0.3
20 % errors lung => air -10.3 -7.0 -5.4 -8.7 0.0 0.0 -3.5 0.0 -0.6
5 % errors lung => soft tissue 6.0 7.5 3.3 5.5 0.0 0.0 2.1 0.0 0.4
10 % errors lung => soft tissue 15.0 12.1 7.5 12.3 0.0 0.0 4.0 0.0 0.7
20 % errors lung => soft tissue 33.5 20.5 13.9 21.8 0.1 -0.1 9.0 0.0 1.4
5 % errors lung => cortical bone 10.2 9.2 5.4 8.6 0.0 0.0 3.1 0.0 0.5
10 % errors lung => cortical bone 19.8 19.3 12.1 18.9 0.1 0.0 6.2 0.0 1.3
20 % errors lung => cortical bone 44.3 39.2 18.8 31.8 0.1 0.0 12.2 0.0 2.0
5 % errors cortical bone => soft tissue -0.1 -0.3 -0.1 -0.4 -0.1 -0.1 -0.7 -0.3 -0.8
10 % errors cortical bone => soft tissue -0.2 -0.7 -0.3 -0.8 -0.3 -0.2 -2.6 -0.8 -1.3
20 % errors cortical bone => soft tissue -0.4 -1.1 -0.6 -1.0 -0.4 -0.7 -3.2 -1.8 -3.6
5 % errors cortical bone => lung -0.4 -0.9 -0.4 -0.9 -0.3 -0.2 -2.5 -1.6 -2.6
10 % errors cortical bone => lung -0.5 -1.6 -0.8 -1.4 -0.6 -0.7 -5.6 -2.2 -4.7
20 % errors cortical bone => lung -1.5 -3.9 -1.7 -5.2 -1.3 -1.6 -7.3 -5.9 -9.0
5 % errors cortical bone => air -0.4 -1.0 -0.6 -1.1 -0.4 -0.3 -3.7 -1.4 -3.3
10 % errors cortical bone => air -0.7 -3.4 -1.1 -2.2 -0.8 -1.9 -5.1 -3.4 -5.5
20 % errors cortical bone => air -1.8 -4.3 -2.1 -5.9 -1.8 -2.1 -11.6 -5.8 -12.5
Table A.8: Relative error (in %) in lesions 1 - 9 of the human whole-body study in images reconstructed with all attenuation maps:
part 2 (random tissue misclassification). The location of the lesions is listed in table 3.2. The attenuation maps used for comparison
are listed in table 3.4.
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Colon Prostate Femur
Lesion 10 11 12 13 14 15
3.1 Random tissue misclassification
5 % errors lung => air 0.0 0.0 0.0 0.0 0.0 0.0
10 % errors lung => air 0.0 0.0 0.0 0.0 0.0 0.0
20 % errors lung => air 0.0 0.0 0.0 0.0 0.0 0.0
5 % errors lung => soft tissue 0.0 0.0 0.0 0.0 0.0 0.0
10 % errors lung => soft tissue 0.0 0.0 0.0 0.0 0.0 0.0
20 % errors lung => soft tissue 0.0 0.0 0.0 0.0 0.0 0.0
5 % errors lung => cortical bone 0.0 0.0 0.0 0.0 0.0 0.0
10 % errors lung => cortical bone 0.0 0.0 0.0 0.0 0.0 0.0
20 % errors lung => cortical bone 0.0 0.0 0.0 0.0 0.0 0.0
5 % errors cortical bone => soft tissue 0.0 0.0 -0.1 -0.1 -0.3 -0.3
10 % errors cortical bone => soft tissue -0.1 -0.1 -0.1 -0.4 -0.4 -0.5
20 % errors cortical bone => soft tissue -0.1 -0.2 -0.3 -0.7 -0.8 -1.1
5 % errors cortical bone => lung -0.1 -0.1 -0.2 -0.6 -0.8 -0.9
10 % errors cortical bone => lung -0.2 -0.2 -0.3 -1.1 -1.4 -1.7
20 % errors cortical bone => lung -0.6 -0.6 -0.9 -2.1 -2.4 -4.0
5 % errors cortical bone => air -0.2 -0.2 -0.3 -0.5 -0.9 -1.5
10 % errors cortical bone => air -0.1 -0.4 -0.4 -1.4 -1.7 -2.4
20 % errors cortical bone => air -0.4 -0.7 -1.0 -2.8 -3.6 -3.8
Table A.9: Relative error (in %) in lesions 10 - 15 of the human whole-body study in images reconstructed with all attenuation
maps: part 2 (random tissue misclassification). The location of the lesions is listed in table 3.2. The attenuation maps used for
comparison are listed in table 3.4.
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Lung Liver Spine
Lesion 1 2 3 4 5 6 7 8 9
3.2 Distance-to-interface dependent tissue misclassification
5 % errors lung => air -2.5 -1.9 -1.4 -2.0 0.0 0.0 -0.9 0.0 -0.1
10 % errors lung => air -5.5 -3.9 -2.6 -4.7 0.0 0.0 -1.7 0.0 -0.3
20 % errors lung => air -11.0 -7.7 -5.0 -8.6 0.0 0.0 -3.2 0.0 -0.4
5 % errors lung => soft tissue 8.2 8.0 4.1 6.2 0.0 0.0 2.3 0.0 0.6
10 % errors lung => soft tissue 13.4 17.6 12.3 12.6 0.1 0.0 4.5 0.0 1.2
20 % errors lung => soft tissue 31.2 29.8 20.9 28.5 0.2 0.0 8.1 0.0 2.6
5 % errors lung => cortical bone 1.2 13.9 2.7 7.1 0.1 0.0 4.8 0.0 1.1
10 % errors lung => cortical bone 3.0 25.6 5.6 12.9 0.2 0.0 9.1 0.0 2.1
20 % errors lung => cortical bone 6.1 45.8 8.6 23.0 0.3 -0.1 14.8 0.0 4.0
5 % errors cortical bone => soft tissue -0.1 -0.3 -0.1 -0.3 -0.1 -0.2 -0.8 -0.6 -0.9
10 % errors cortical bone => soft tissue -0.2 -0.6 -0.3 -0.5 -0.2 -0.4 -1.4 -0.8 -1.2
20 % errors cortical bone => soft tissue -0.4 -1.1 -0.6 -1.7 -0.5 -1.0 -3.5 -2.0 -3.4
5 % errors cortical bone => lung -0.1 -2.0 -0.6 -1.0 -0.1 0.0 -2.2 -1.4 -2.0
10 % errors cortical bone => lung -0.5 -3.2 -1.3 -3.3 -0.2 0.0 -3.7 -2.6 -4.1
20 % errors cortical bone => lung -1.5 -7.7 -2.0 -8.1 -0.3 0.0 -6.8 -5.3 -5.7
5 % errors cortical bone => air -0.5 -1.8 -0.5 -2.0 -0.5 -0.3 -3.0 -1.4 -3.0
10 % errors cortical bone => air -0.7 -1.7 -1.0 -2.2 -0.8 -1.5 -5.8 -3.1 -6.2
20 % errors cortical bone => air -1.5 -5.1 -1.9 -5.8 -1.8 -1.3 -12.4 -4.7 -10.1
Table A.10: Relative error (in %) in lesions 1 - 9 of the human whole-body study in images reconstructed with all attenuation maps:
part 3 (distance-to-interface dependent tissue misclassification). The location of the lesions is listed in table 3.2. The attenuation
maps used for comparison are listed in table 3.4.
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Colon Prostate Femur
Lesion 10 11 12 13 14 15
3.2 Distance-to-interface dependent tissue misclassification
5 % errors lung => air 0.0 0.0 0.0 0.0 0.0 0.0
10 % errors lung => air 0.0 0.0 0.0 0.0 0.0 0.0
20 % errors lung => air 0.0 0.0 0.0 0.0 0.0 0.0
5 % errors lung => soft tissue 0.0 0.0 0.0 0.0 0.0 0.0
10 % errors lung => soft tissue 0.0 0.0 0.0 0.0 0.0 0.0
20 % errors lung => soft tissue 0.0 0.0 0.0 0.0 0.0 0.0
5 % errors lung => cortical bone 0.0 0.0 0.0 0.0 0.0 0.0
10 % errors lung => cortical bone 0.0 0.0 0.0 0.0 0.0 0.0
20 % errors lung => cortical bone 0.0 0.0 0.0 0.0 0.0 0.0
5 % errors cortical bone => soft tissue 0.0 0.0 -0.1 -0.2 -0.3 -0.3
10 % errors cortical bone => soft tissue 0.0 -0.1 -0.1 -0.3 -0.4 -0.6
20 % errors cortical bone => soft tissue -0.1 -0.2 -0.2 -0.6 -0.8 -1.0
5 % errors cortical bone => lung -0.1 -0.2 -0.3 -0.5 -0.8 -1.0
10 % errors cortical bone => lung -0.3 -0.3 -0.5 -1.3 -1.5 -2.0
20 % errors cortical bone => lung -0.4 -0.4 -0.9 -2.2 -2.6 -3.0
5 % errors cortical bone => air -0.1 -0.2 -0.2 -0.5 -0.7 -0.5
10 % errors cortical bone => air -0.4 -0.4 -0.6 -1.3 -1.4 -1.3
20 % errors cortical bone => air -0.3 -0.6 -0.8 -2.4 -2.4 -2.5
Table A.11: Relative error (in %) in lesions 10 - 15 of the human whole-body study in images reconstructed with all attenuation
maps: part 3 (distance-to-interface dependent tissue misclassification). The location of the lesions is listed in table 3.2. The
attenuation maps used for comparison are listed in table 3.4.
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